| 1 |
aliceblue |
42 |
6.7e-04 |
1.000 |
2 |
GO:0034315 |
BP |
regulation of Arp2/3 complex-mediated actin nucleation |
| 2 |
aliceblue |
42 |
1.1e-03 |
1.000 |
2 |
GO:0060065 |
BP |
uterus development |
| 3 |
aliceblue |
42 |
1.1e-03 |
1.000 |
3 |
GO:0030838 |
BP |
positive regulation of actin filament polymerization |
| 4 |
aliceblue |
42 |
2.0e-03 |
1.000 |
2 |
GO:0051125 |
BP |
regulation of actin nucleation |
| 5 |
aliceblue |
42 |
2.3e-03 |
1.000 |
2 |
GO:0035115 |
BP |
embryonic forelimb morphogenesis |
| 6 |
aliceblue |
42 |
2.5e-03 |
1.000 |
2 |
GO:0034314 |
BP |
Arp2/3 complex-mediated actin nucleation |
| 7 |
aliceblue |
42 |
2.8e-03 |
1.000 |
1 |
GO:0031549 |
BP |
negative regulation of brain-derived neurotrophic factor receptor signaling pathway |
| 8 |
aliceblue |
42 |
2.8e-03 |
1.000 |
1 |
GO:0038115 |
BP |
chemokine (C-C motif) ligand 19 signaling pathway |
| 9 |
aliceblue |
42 |
2.8e-03 |
1.000 |
1 |
GO:2000522 |
BP |
positive regulation of immunological synapse formation |
| 10 |
aliceblue |
42 |
2.8e-03 |
1.000 |
1 |
GO:2000526 |
BP |
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| 11 |
antiquewhite |
31 |
5.2e-04 |
1.000 |
3 |
GO:0051213 |
MF |
dioxygenase activity |
| 12 |
antiquewhite |
31 |
2.1e-03 |
1.000 |
1 |
GO:0034203 |
BP |
glycolipid translocation |
| 13 |
antiquewhite |
31 |
2.1e-03 |
1.000 |
1 |
GO:1902045 |
BP |
negative regulation of Fas signaling pathway |
| 14 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:0002038 |
BP |
positive regulation of L-glutamate import across plasma membrane |
| 15 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:1902044 |
BP |
regulation of Fas signaling pathway |
| 16 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:1905799 |
BP |
regulation of intraciliary retrograde transport |
| 17 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:1990108 |
BP |
protein linear deubiquitination |
| 18 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:2000504 |
BP |
positive regulation of blood vessel remodeling |
| 19 |
antiquewhite |
31 |
4.2e-03 |
1.000 |
1 |
GO:0036117 |
CC |
hyaluranon cable |
| 20 |
antiquewhite |
31 |
6.2e-03 |
1.000 |
1 |
GO:0045226 |
BP |
extracellular polysaccharide biosynthetic process |
| 21 |
antiquewhite1 |
47 |
5.7e-05 |
1.000 |
3 |
GO:0046039 |
BP |
GTP metabolic process |
| 22 |
antiquewhite1 |
47 |
1.2e-04 |
1.000 |
2 |
GO:0006777 |
BP |
Mo-molybdopterin cofactor biosynthetic process |
| 23 |
antiquewhite1 |
47 |
1.7e-04 |
1.000 |
2 |
GO:0032324 |
BP |
molybdopterin cofactor biosynthetic process |
| 24 |
antiquewhite1 |
47 |
1.7e-04 |
1.000 |
2 |
GO:0043545 |
BP |
molybdopterin cofactor metabolic process |
| 25 |
antiquewhite1 |
47 |
4.5e-04 |
1.000 |
2 |
GO:0001771 |
BP |
immunological synapse formation |
| 26 |
antiquewhite1 |
47 |
8.5e-04 |
1.000 |
3 |
GO:0042278 |
BP |
purine nucleoside metabolic process |
| 27 |
antiquewhite1 |
47 |
1.1e-03 |
1.000 |
3 |
GO:0042058 |
BP |
regulation of epidermal growth factor receptor signaling pathway |
| 28 |
antiquewhite1 |
47 |
1.2e-03 |
1.000 |
4 |
GO:0032388 |
BP |
positive regulation of intracellular transport |
| 29 |
antiquewhite1 |
47 |
1.4e-03 |
1.000 |
3 |
GO:1901184 |
BP |
regulation of ERBB signaling pathway |
| 30 |
antiquewhite1 |
47 |
2.0e-03 |
1.000 |
3 |
GO:0006641 |
BP |
triglyceride metabolic process |
| 31 |
antiquewhite2 |
54 |
3.5e-05 |
0.630 |
3 |
GO:0043951 |
BP |
negative regulation of cAMP-mediated signaling |
| 32 |
antiquewhite2 |
54 |
3.8e-05 |
0.690 |
2 |
GO:0004118 |
MF |
cGMP-stimulated cyclic-nucleotide phosphodiesterase activity |
| 33 |
antiquewhite2 |
54 |
3.8e-05 |
0.690 |
2 |
GO:0036132 |
MF |
13-prostaglandin reductase activity |
| 34 |
antiquewhite2 |
54 |
3.8e-05 |
0.690 |
2 |
GO:0047522 |
MF |
15-oxoprostaglandin 13-oxidase activity |
| 35 |
antiquewhite2 |
54 |
1.2e-04 |
1.000 |
3 |
GO:2000310 |
BP |
regulation of NMDA receptor activity |
| 36 |
antiquewhite2 |
54 |
1.3e-04 |
1.000 |
2 |
GO:0010754 |
BP |
negative regulation of cGMP-mediated signaling |
| 37 |
antiquewhite2 |
54 |
1.3e-04 |
1.000 |
2 |
GO:0046069 |
BP |
cGMP catabolic process |
| 38 |
antiquewhite2 |
54 |
1.4e-04 |
1.000 |
5 |
GO:2001257 |
BP |
regulation of cation channel activity |
| 39 |
antiquewhite2 |
54 |
3.4e-04 |
1.000 |
3 |
GO:0043949 |
BP |
regulation of cAMP-mediated signaling |
| 40 |
antiquewhite2 |
54 |
3.5e-04 |
1.000 |
2 |
GO:0000338 |
BP |
protein deneddylation |
| 41 |
antiquewhite4 |
70 |
4.3e-04 |
1.000 |
5 |
GO:0017137 |
MF |
Rab GTPase binding |
| 42 |
antiquewhite4 |
70 |
8.2e-04 |
1.000 |
5 |
GO:0000775 |
CC |
chromosome, centromeric region |
| 43 |
antiquewhite4 |
70 |
9.1e-04 |
1.000 |
3 |
GO:0005160 |
MF |
transforming growth factor beta receptor binding |
| 44 |
antiquewhite4 |
70 |
9.2e-04 |
1.000 |
8 |
GO:0051020 |
MF |
GTPase binding |
| 45 |
antiquewhite4 |
70 |
1.0e-03 |
1.000 |
2 |
GO:0070700 |
MF |
BMP receptor binding |
| 46 |
antiquewhite4 |
70 |
1.8e-03 |
1.000 |
3 |
GO:0060389 |
BP |
pathway-restricted SMAD protein phosphorylation |
| 47 |
antiquewhite4 |
70 |
1.9e-03 |
1.000 |
3 |
GO:0055008 |
BP |
cardiac muscle tissue morphogenesis |
| 48 |
antiquewhite4 |
70 |
2.2e-03 |
1.000 |
4 |
GO:0030509 |
BP |
BMP signaling pathway |
| 49 |
antiquewhite4 |
70 |
2.6e-03 |
1.000 |
3 |
GO:0060415 |
BP |
muscle tissue morphogenesis |
| 50 |
antiquewhite4 |
70 |
2.9e-03 |
1.000 |
4 |
GO:0071773 |
BP |
cellular response to BMP stimulus |
| 51 |
bisque4 |
84 |
6.0e-04 |
1.000 |
2 |
GO:0061303 |
BP |
cornea development in camera-type eye |
| 52 |
bisque4 |
84 |
1.6e-03 |
1.000 |
3 |
GO:0016538 |
MF |
cyclin-dependent protein serine/threonine kinase regulator activity |
| 53 |
bisque4 |
84 |
3.1e-03 |
1.000 |
3 |
GO:0071300 |
BP |
cellular response to retinoic acid |
| 54 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0002642 |
BP |
positive regulation of immunoglobulin biosynthetic process |
| 55 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0048250 |
BP |
iron import into the mitochondrion |
| 56 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0060739 |
BP |
mesenchymal-epithelial cell signaling involved in prostate gland development |
| 57 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0062030 |
BP |
negative regulation of stress granule assembly |
| 58 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0090096 |
BP |
positive regulation of metanephric cap mesenchymal cell proliferation |
| 59 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:0090301 |
BP |
negative regulation of neural crest formation |
| 60 |
bisque4 |
84 |
5.4e-03 |
1.000 |
1 |
GO:1901094 |
BP |
negative regulation of protein homotetramerization |
| 61 |
black |
266 |
8.2e-04 |
1.000 |
3 |
GO:0016251 |
MF |
RNA polymerase II general transcription initiation factor activity |
| 62 |
black |
266 |
1.7e-03 |
1.000 |
3 |
GO:0060547 |
BP |
negative regulation of necrotic cell death |
| 63 |
black |
266 |
1.8e-03 |
1.000 |
2 |
GO:0006574 |
BP |
valine catabolic process |
| 64 |
black |
266 |
1.8e-03 |
1.000 |
2 |
GO:1905538 |
MF |
polysome binding |
| 65 |
black |
266 |
2.6e-03 |
1.000 |
3 |
GO:0007289 |
BP |
spermatid nucleus differentiation |
| 66 |
black |
266 |
3.0e-03 |
1.000 |
2 |
GO:0035093 |
BP |
spermatogenesis, exchange of chromosomal proteins |
| 67 |
black |
266 |
3.6e-03 |
1.000 |
6 |
GO:0070268 |
BP |
cornification |
| 68 |
black |
266 |
3.7e-03 |
1.000 |
3 |
GO:0097186 |
BP |
amelogenesis |
| 69 |
black |
266 |
4.0e-03 |
1.000 |
7 |
GO:0097730 |
CC |
non-motile cilium |
| 70 |
black |
266 |
4.5e-03 |
1.000 |
2 |
GO:0006573 |
BP |
valine metabolic process |
| 71 |
blue |
535 |
4.0e-04 |
1.000 |
9 |
GO:0036126 |
CC |
sperm flagellum |
| 72 |
blue |
535 |
5.6e-04 |
1.000 |
9 |
GO:0097729 |
CC |
9+2 motile cilium |
| 73 |
blue |
535 |
8.2e-04 |
1.000 |
3 |
GO:0097084 |
BP |
vascular smooth muscle cell development |
| 74 |
blue |
535 |
1.2e-03 |
1.000 |
4 |
GO:0033189 |
BP |
response to vitamin A |
| 75 |
blue |
535 |
1.3e-03 |
1.000 |
2 |
GO:0010796 |
BP |
regulation of multivesicular body size |
| 76 |
blue |
535 |
1.3e-03 |
1.000 |
2 |
GO:0042721 |
CC |
TIM22 mitochondrial import inner membrane insertion complex |
| 77 |
blue |
535 |
2.6e-03 |
1.000 |
4 |
GO:0033962 |
BP |
cytoplasmic mRNA processing body assembly |
| 78 |
blue |
535 |
2.9e-03 |
1.000 |
17 |
GO:0045765 |
BP |
regulation of angiogenesis |
| 79 |
blue |
535 |
3.7e-03 |
1.000 |
2 |
GO:0002074 |
BP |
extraocular skeletal muscle development |
| 80 |
blue |
535 |
3.7e-03 |
1.000 |
2 |
GO:0016267 |
BP |
O-glycan processing, core 1 |
| 81 |
blue1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0102559 |
MF |
protein-(glutamine-N5) methyltransferase activity |
| 82 |
blue1 |
33 |
3.1e-03 |
1.000 |
4 |
GO:0005525 |
MF |
GTP binding |
| 83 |
blue1 |
33 |
3.4e-03 |
1.000 |
4 |
GO:0001883 |
MF |
purine nucleoside binding |
| 84 |
blue1 |
33 |
3.4e-03 |
1.000 |
4 |
GO:0032549 |
MF |
ribonucleoside binding |
| 85 |
blue1 |
33 |
3.7e-03 |
1.000 |
4 |
GO:0001882 |
MF |
nucleoside binding |
| 86 |
blue1 |
33 |
3.7e-03 |
1.000 |
4 |
GO:0032561 |
MF |
guanyl ribonucleotide binding |
| 87 |
blue1 |
33 |
6.4e-03 |
1.000 |
1 |
GO:0099562 |
BP |
maintenance of postsynaptic density structure |
| 88 |
blue1 |
33 |
6.4e-03 |
1.000 |
1 |
GO:1904694 |
BP |
negative regulation of vascular smooth muscle contraction |
| 89 |
blue1 |
33 |
6.4e-03 |
1.000 |
1 |
GO:0046695 |
CC |
SLIK (SAGA-like) complex |
| 90 |
blue1 |
33 |
8.4e-03 |
1.000 |
6 |
GO:0006886 |
BP |
intracellular protein transport |
| 91 |
blue2 |
63 |
1.1e-04 |
1.000 |
2 |
GO:0006344 |
BP |
maintenance of chromatin silencing |
| 92 |
blue2 |
63 |
1.3e-04 |
1.000 |
4 |
GO:0006342 |
BP |
chromatin silencing |
| 93 |
blue2 |
63 |
2.0e-04 |
1.000 |
3 |
GO:0034451 |
CC |
centriolar satellite |
| 94 |
blue2 |
63 |
2.5e-04 |
1.000 |
4 |
GO:0045814 |
BP |
negative regulation of gene expression, epigenetic |
| 95 |
blue2 |
63 |
3.3e-04 |
1.000 |
3 |
GO:0031463 |
CC |
Cul3-RING ubiquitin ligase complex |
| 96 |
blue2 |
63 |
5.1e-04 |
1.000 |
10 |
GO:0070925 |
BP |
organelle assembly |
| 97 |
blue2 |
63 |
1.1e-03 |
1.000 |
8 |
GO:0010638 |
BP |
positive regulation of organelle organization |
| 98 |
blue2 |
63 |
1.3e-03 |
1.000 |
3 |
GO:0044380 |
BP |
protein localization to cytoskeleton |
| 99 |
blue2 |
63 |
1.3e-03 |
1.000 |
9 |
GO:0010564 |
BP |
regulation of cell cycle process |
| 100 |
blue2 |
63 |
1.4e-03 |
1.000 |
5 |
GO:0016458 |
BP |
gene silencing |
| 101 |
blue3 |
46 |
8.1e-04 |
1.000 |
4 |
GO:0043112 |
BP |
receptor metabolic process |
| 102 |
blue3 |
46 |
1.2e-03 |
1.000 |
2 |
GO:0035145 |
CC |
exon-exon junction complex |
| 103 |
blue3 |
46 |
2.0e-03 |
1.000 |
2 |
GO:0005942 |
CC |
phosphatidylinositol 3-kinase complex |
| 104 |
blue3 |
46 |
2.2e-03 |
1.000 |
2 |
GO:0004407 |
MF |
histone deacetylase activity |
| 105 |
blue3 |
46 |
2.3e-03 |
1.000 |
2 |
GO:0033558 |
MF |
protein deacetylase activity |
| 106 |
blue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0060404 |
BP |
axonemal microtubule depolymerization |
| 107 |
blue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0070462 |
BP |
plus-end specific microtubule depolymerization |
| 108 |
blue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0071561 |
CC |
nucleus-vacuole junction |
| 109 |
blue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0019767 |
MF |
IgE receptor activity |
| 110 |
blue3 |
46 |
3.5e-03 |
1.000 |
3 |
GO:0003774 |
MF |
motor activity |
| 111 |
blue4 |
52 |
2.4e-04 |
1.000 |
17 |
GO:0016787 |
MF |
hydrolase activity |
| 112 |
blue4 |
52 |
1.2e-03 |
1.000 |
2 |
GO:0016849 |
MF |
phosphorus-oxygen lyase activity |
| 113 |
blue4 |
52 |
2.7e-03 |
1.000 |
2 |
GO:0001835 |
BP |
blastocyst hatching |
| 114 |
blue4 |
52 |
3.1e-03 |
1.000 |
3 |
GO:0001824 |
BP |
blastocyst development |
| 115 |
blue4 |
52 |
3.3e-03 |
1.000 |
4 |
GO:0006888 |
BP |
ER to Golgi vesicle-mediated transport |
| 116 |
blue4 |
52 |
3.4e-03 |
1.000 |
1 |
GO:0005993 |
BP |
trehalose catabolic process |
| 117 |
blue4 |
52 |
3.4e-03 |
1.000 |
1 |
GO:0032972 |
BP |
regulation of muscle filament sliding speed |
| 118 |
blue4 |
52 |
3.4e-03 |
1.000 |
1 |
GO:0046086 |
BP |
adenosine biosynthetic process |
| 119 |
blue4 |
52 |
3.4e-03 |
1.000 |
1 |
GO:0062029 |
BP |
positive regulation of stress granule assembly |
| 120 |
blue4 |
52 |
3.4e-03 |
1.000 |
1 |
GO:0003948 |
MF |
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity |
| 121 |
blueviolet |
53 |
1.5e-04 |
1.000 |
2 |
GO:0014719 |
BP |
skeletal muscle satellite cell activation |
| 122 |
blueviolet |
53 |
7.9e-04 |
1.000 |
2 |
GO:0006910 |
BP |
phagocytosis, recognition |
| 123 |
blueviolet |
53 |
1.4e-03 |
1.000 |
2 |
GO:0019883 |
BP |
antigen processing and presentation of endogenous antigen |
| 124 |
blueviolet |
53 |
1.7e-03 |
1.000 |
3 |
GO:0002718 |
BP |
regulation of cytokine production involved in immune response |
| 125 |
blueviolet |
53 |
2.1e-03 |
1.000 |
10 |
GO:0007155 |
BP |
cell adhesion |
| 126 |
blueviolet |
53 |
2.9e-03 |
1.000 |
3 |
GO:0002367 |
BP |
cytokine production involved in immune response |
| 127 |
blueviolet |
53 |
3.2e-03 |
1.000 |
2 |
GO:1904680 |
MF |
peptide transmembrane transporter activity |
| 128 |
blueviolet |
53 |
3.3e-03 |
1.000 |
1 |
GO:0018276 |
BP |
isopeptide cross-linking via N6-glycyl-L-lysine |
| 129 |
blueviolet |
53 |
3.3e-03 |
1.000 |
1 |
GO:0032597 |
BP |
B cell receptor transport into membrane raft |
| 130 |
blueviolet |
53 |
3.3e-03 |
1.000 |
1 |
GO:0032600 |
BP |
chemokine receptor transport out of membrane raft |
| 131 |
brown |
363 |
2.5e-04 |
1.000 |
3 |
GO:2000210 |
BP |
positive regulation of anoikis |
| 132 |
brown |
363 |
3.7e-04 |
1.000 |
128 |
GO:0005829 |
CC |
cytosol |
| 133 |
brown |
363 |
5.6e-04 |
1.000 |
2 |
GO:0098907 |
BP |
regulation of SA node cell action potential |
| 134 |
brown |
363 |
1.2e-03 |
1.000 |
6 |
GO:0034394 |
BP |
protein localization to cell surface |
| 135 |
brown |
363 |
1.4e-03 |
1.000 |
4 |
GO:0095500 |
BP |
acetylcholine receptor signaling pathway |
| 136 |
brown |
363 |
1.7e-03 |
1.000 |
2 |
GO:0007207 |
BP |
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway |
| 137 |
brown |
363 |
1.9e-03 |
1.000 |
3 |
GO:0071025 |
BP |
RNA surveillance |
| 138 |
brown |
363 |
1.9e-03 |
1.000 |
4 |
GO:0001835 |
BP |
blastocyst hatching |
| 139 |
brown |
363 |
1.9e-03 |
1.000 |
4 |
GO:1905144 |
BP |
response to acetylcholine |
| 140 |
brown |
363 |
1.9e-03 |
1.000 |
4 |
GO:1905145 |
BP |
cellular response to acetylcholine |
| 141 |
brown1 |
48 |
9.1e-04 |
1.000 |
5 |
GO:0031965 |
CC |
nuclear membrane |
| 142 |
brown1 |
48 |
1.2e-03 |
1.000 |
2 |
GO:0043153 |
BP |
entrainment of circadian clock by photoperiod |
| 143 |
brown1 |
48 |
1.7e-03 |
1.000 |
2 |
GO:0009648 |
BP |
photoperiodism |
| 144 |
brown1 |
48 |
2.2e-03 |
1.000 |
2 |
GO:0009649 |
BP |
entrainment of circadian clock |
| 145 |
brown1 |
48 |
2.6e-03 |
1.000 |
19 |
GO:0031981 |
CC |
nuclear lumen |
| 146 |
brown1 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0035998 |
BP |
7,8-dihydroneopterin 3’-triphosphate biosynthetic process |
| 147 |
brown1 |
48 |
3.1e-03 |
1.000 |
1 |
GO:1903576 |
BP |
response to L-arginine |
| 148 |
brown1 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0003934 |
MF |
GTP cyclohydrolase I activity |
| 149 |
brown1 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0004152 |
MF |
dihydroorotate dehydrogenase activity |
| 150 |
brown1 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0017178 |
MF |
diphthine-ammonia ligase activity |
| 151 |
brown2 |
61 |
1.6e-04 |
1.000 |
2 |
GO:0090315 |
BP |
negative regulation of protein targeting to membrane |
| 152 |
brown2 |
61 |
7.0e-04 |
1.000 |
2 |
GO:0006241 |
BP |
CTP biosynthetic process |
| 153 |
brown2 |
61 |
1.5e-03 |
1.000 |
3 |
GO:0005977 |
BP |
glycogen metabolic process |
| 154 |
brown2 |
61 |
1.6e-03 |
1.000 |
2 |
GO:0006206 |
BP |
pyrimidine nucleobase metabolic process |
| 155 |
brown2 |
61 |
2.3e-03 |
1.000 |
2 |
GO:0009220 |
BP |
pyrimidine ribonucleotide biosynthetic process |
| 156 |
brown2 |
61 |
2.6e-03 |
1.000 |
3 |
GO:0006112 |
BP |
energy reserve metabolic process |
| 157 |
brown2 |
61 |
3.0e-03 |
1.000 |
3 |
GO:0006368 |
BP |
transcription elongation from RNA polymerase II promoter |
| 158 |
brown2 |
61 |
3.2e-03 |
1.000 |
2 |
GO:0009083 |
BP |
branched-chain amino acid catabolic process |
| 159 |
brown2 |
61 |
3.7e-03 |
1.000 |
4 |
GO:1905475 |
BP |
regulation of protein localization to membrane |
| 160 |
brown2 |
61 |
3.8e-03 |
1.000 |
2 |
GO:0046134 |
BP |
pyrimidine nucleoside biosynthetic process |
| 161 |
brown3 |
34 |
4.5e-04 |
1.000 |
2 |
GO:0010759 |
BP |
positive regulation of macrophage chemotaxis |
| 162 |
brown3 |
34 |
7.6e-04 |
1.000 |
2 |
GO:1905523 |
BP |
positive regulation of macrophage migration |
| 163 |
brown3 |
34 |
1.5e-03 |
1.000 |
2 |
GO:0010758 |
BP |
regulation of macrophage chemotaxis |
| 164 |
brown3 |
34 |
2.3e-03 |
1.000 |
1 |
GO:1903755 |
BP |
positive regulation of SUMO transferase activity |
| 165 |
brown3 |
34 |
2.3e-03 |
1.000 |
1 |
GO:1990356 |
CC |
sumoylated E2 ligase complex |
| 166 |
brown3 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0004876 |
MF |
complement component C3a receptor activity |
| 167 |
brown3 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0008507 |
MF |
sodium:iodide symporter activity |
| 168 |
brown3 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0061656 |
MF |
SUMO conjugating enzyme activity |
| 169 |
brown3 |
34 |
2.4e-03 |
1.000 |
2 |
GO:0048246 |
BP |
macrophage chemotaxis |
| 170 |
brown3 |
34 |
2.6e-03 |
1.000 |
2 |
GO:0071622 |
BP |
regulation of granulocyte chemotaxis |
| 171 |
brown4 |
86 |
6.6e-04 |
1.000 |
4 |
GO:0072384 |
BP |
organelle transport along microtubule |
| 172 |
brown4 |
86 |
1.8e-03 |
1.000 |
3 |
GO:0047496 |
BP |
vesicle transport along microtubule |
| 173 |
brown4 |
86 |
3.3e-03 |
1.000 |
2 |
GO:1902074 |
BP |
response to salt |
| 174 |
brown4 |
86 |
4.5e-03 |
1.000 |
4 |
GO:0006612 |
BP |
protein targeting to membrane |
| 175 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:0005998 |
BP |
xylulose catabolic process |
| 176 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:0018395 |
BP |
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine |
| 177 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:0046293 |
BP |
formaldehyde biosynthetic process |
| 178 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:0070078 |
BP |
histone H3-R2 demethylation |
| 179 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:0070079 |
BP |
histone H4-R3 demethylation |
| 180 |
brown4 |
86 |
5.8e-03 |
1.000 |
1 |
GO:1900483 |
BP |
regulation of protein targeting to vacuolar membrane |
| 181 |
chocolate2 |
32 |
8.4e-04 |
1.000 |
16 |
GO:0031981 |
CC |
nuclear lumen |
| 182 |
chocolate2 |
32 |
2.0e-03 |
1.000 |
3 |
GO:0007098 |
BP |
centrosome cycle |
| 183 |
chocolate2 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0043257 |
CC |
laminin-8 complex |
| 184 |
chocolate2 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0052731 |
MF |
phosphocholine phosphatase activity |
| 185 |
chocolate2 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0052732 |
MF |
phosphoethanolamine phosphatase activity |
| 186 |
chocolate2 |
32 |
2.3e-03 |
1.000 |
2 |
GO:0050913 |
BP |
sensory perception of bitter taste |
| 187 |
chocolate2 |
32 |
2.3e-03 |
1.000 |
3 |
GO:0031023 |
BP |
microtubule organizing center organization |
| 188 |
chocolate2 |
32 |
4.4e-03 |
1.000 |
1 |
GO:0021812 |
BP |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration |
| 189 |
chocolate2 |
32 |
4.4e-03 |
1.000 |
1 |
GO:0005606 |
CC |
laminin-1 complex |
| 190 |
chocolate2 |
32 |
4.4e-03 |
1.000 |
1 |
GO:0005607 |
CC |
laminin-2 complex |
| 191 |
chocolate3 |
37 |
8.0e-04 |
1.000 |
2 |
GO:0036499 |
BP |
PERK-mediated unfolded protein response |
| 192 |
chocolate3 |
37 |
1.3e-03 |
1.000 |
2 |
GO:0010453 |
BP |
regulation of cell fate commitment |
| 193 |
chocolate3 |
37 |
1.3e-03 |
1.000 |
2 |
GO:0001891 |
CC |
phagocytic cup |
| 194 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:0035874 |
BP |
cellular response to copper ion starvation |
| 195 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:0097185 |
BP |
cellular response to azide |
| 196 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:1903721 |
BP |
positive regulation of I-kappaB phosphorylation |
| 197 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:1904905 |
BP |
negative regulation of endothelial cell-matrix adhesion via fibronectin |
| 198 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:0033593 |
CC |
BRCA2-MAGE-D1 complex |
| 199 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:0052597 |
MF |
diamine oxidase activity |
| 200 |
chocolate3 |
37 |
2.2e-03 |
1.000 |
1 |
GO:0052598 |
MF |
histamine oxidase activity |
| 201 |
chocolate4 |
47 |
4.2e-05 |
0.760 |
3 |
GO:0071480 |
BP |
cellular response to gamma radiation |
| 202 |
chocolate4 |
47 |
3.2e-04 |
1.000 |
3 |
GO:2000272 |
BP |
negative regulation of signaling receptor activity |
| 203 |
chocolate4 |
47 |
3.9e-04 |
1.000 |
4 |
GO:0007034 |
BP |
vacuolar transport |
| 204 |
chocolate4 |
47 |
4.1e-04 |
1.000 |
3 |
GO:0010332 |
BP |
response to gamma radiation |
| 205 |
chocolate4 |
47 |
4.2e-04 |
1.000 |
4 |
GO:0048660 |
BP |
regulation of smooth muscle cell proliferation |
| 206 |
chocolate4 |
47 |
4.4e-04 |
1.000 |
4 |
GO:0048659 |
BP |
smooth muscle cell proliferation |
| 207 |
chocolate4 |
47 |
4.7e-04 |
1.000 |
2 |
GO:0045176 |
BP |
apical protein localization |
| 208 |
chocolate4 |
47 |
7.5e-04 |
1.000 |
3 |
GO:0071479 |
BP |
cellular response to ionizing radiation |
| 209 |
chocolate4 |
47 |
7.7e-04 |
1.000 |
2 |
GO:0061952 |
BP |
midbody abscission |
| 210 |
chocolate4 |
47 |
8.3e-04 |
1.000 |
3 |
GO:0000281 |
BP |
mitotic cytokinesis |
| 211 |
coral |
51 |
1.2e-03 |
1.000 |
3 |
GO:0045638 |
BP |
negative regulation of myeloid cell differentiation |
| 212 |
coral |
51 |
1.5e-03 |
1.000 |
5 |
GO:0006402 |
BP |
mRNA catabolic process |
| 213 |
coral |
51 |
1.9e-03 |
1.000 |
7 |
GO:0019439 |
BP |
aromatic compound catabolic process |
| 214 |
coral |
51 |
2.3e-03 |
1.000 |
5 |
GO:0006401 |
BP |
RNA catabolic process |
| 215 |
coral |
51 |
2.7e-03 |
1.000 |
2 |
GO:0008574 |
MF |
ATP-dependent microtubule motor activity, plus-end-directed |
| 216 |
coral |
51 |
2.8e-03 |
1.000 |
3 |
GO:0070268 |
BP |
cornification |
| 217 |
coral |
51 |
3.0e-03 |
1.000 |
2 |
GO:0045671 |
BP |
negative regulation of osteoclast differentiation |
| 218 |
coral |
51 |
3.4e-03 |
1.000 |
1 |
GO:0010526 |
BP |
negative regulation of transposition, RNA-mediated |
| 219 |
coral |
51 |
3.4e-03 |
1.000 |
1 |
GO:0014810 |
BP |
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
| 220 |
coral |
51 |
3.4e-03 |
1.000 |
1 |
GO:0035548 |
BP |
negative regulation of interferon-beta secretion |
| 221 |
coral1 |
75 |
8.0e-05 |
1.000 |
2 |
GO:1902746 |
BP |
regulation of lens fiber cell differentiation |
| 222 |
coral1 |
75 |
3.6e-04 |
1.000 |
4 |
GO:0072422 |
BP |
signal transduction involved in DNA damage checkpoint |
| 223 |
coral1 |
75 |
3.8e-04 |
1.000 |
4 |
GO:0072395 |
BP |
signal transduction involved in cell cycle checkpoint |
| 224 |
coral1 |
75 |
4.0e-04 |
1.000 |
2 |
GO:0002138 |
BP |
retinoic acid biosynthetic process |
| 225 |
coral1 |
75 |
1.0e-03 |
1.000 |
23 |
GO:0035556 |
BP |
intracellular signal transduction |
| 226 |
coral1 |
75 |
1.1e-03 |
1.000 |
10 |
GO:0030855 |
BP |
epithelial cell differentiation |
| 227 |
coral1 |
75 |
1.3e-03 |
1.000 |
3 |
GO:0030858 |
BP |
positive regulation of epithelial cell differentiation |
| 228 |
coral1 |
75 |
1.4e-03 |
1.000 |
4 |
GO:0044774 |
BP |
mitotic DNA integrity checkpoint |
| 229 |
coral1 |
75 |
1.8e-03 |
1.000 |
7 |
GO:0019787 |
MF |
ubiquitin-like protein transferase activity |
| 230 |
coral1 |
75 |
2.0e-03 |
1.000 |
4 |
GO:0050680 |
BP |
negative regulation of epithelial cell proliferation |
| 231 |
coral2 |
70 |
2.0e-04 |
1.000 |
2 |
GO:1990349 |
BP |
gap junction-mediated intercellular transport |
| 232 |
coral2 |
70 |
1.3e-03 |
1.000 |
2 |
GO:0005243 |
MF |
gap junction channel activity |
| 233 |
coral2 |
70 |
2.0e-03 |
1.000 |
8 |
GO:0005509 |
MF |
calcium ion binding |
| 234 |
coral2 |
70 |
2.3e-03 |
1.000 |
2 |
GO:0005922 |
CC |
connexin complex |
| 235 |
coral2 |
70 |
2.9e-03 |
1.000 |
2 |
GO:0022829 |
MF |
wide pore channel activity |
| 236 |
coral2 |
70 |
3.3e-03 |
1.000 |
2 |
GO:0080154 |
BP |
regulation of fertilization |
| 237 |
coral2 |
70 |
3.3e-03 |
1.000 |
2 |
GO:0016493 |
MF |
C-C chemokine receptor activity |
| 238 |
coral2 |
70 |
3.6e-03 |
1.000 |
2 |
GO:0019957 |
MF |
C-C chemokine binding |
| 239 |
coral2 |
70 |
4.0e-03 |
1.000 |
2 |
GO:0004950 |
MF |
chemokine receptor activity |
| 240 |
coral2 |
70 |
4.5e-03 |
1.000 |
1 |
GO:0021509 |
BP |
roof plate formation |
| 241 |
coral3 |
58 |
2.3e-03 |
1.000 |
3 |
GO:0006094 |
BP |
gluconeogenesis |
| 242 |
coral3 |
58 |
2.6e-03 |
1.000 |
3 |
GO:0019319 |
BP |
hexose biosynthetic process |
| 243 |
coral3 |
58 |
3.3e-03 |
1.000 |
3 |
GO:0042562 |
MF |
hormone binding |
| 244 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0006193 |
BP |
ITP catabolic process |
| 245 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0006624 |
BP |
vacuolar protein processing |
| 246 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0010045 |
BP |
response to nickel cation |
| 247 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0045556 |
BP |
positive regulation of TRAIL biosynthetic process |
| 248 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0072703 |
BP |
cellular response to methyl methanesulfonate |
| 249 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0001512 |
MF |
dihydronicotinamide riboside quinone reductase activity |
| 250 |
coral3 |
58 |
3.7e-03 |
1.000 |
1 |
GO:0004578 |
MF |
chitobiosyldiphosphodolichol beta-mannosyltransferase activity |
| 251 |
coral4 |
47 |
2.0e-04 |
1.000 |
5 |
GO:0051896 |
BP |
regulation of protein kinase B signaling |
| 252 |
coral4 |
47 |
3.4e-04 |
1.000 |
5 |
GO:0043491 |
BP |
protein kinase B signaling |
| 253 |
coral4 |
47 |
6.4e-04 |
1.000 |
3 |
GO:0120193 |
BP |
tight junction organization |
| 254 |
coral4 |
47 |
7.3e-04 |
1.000 |
4 |
GO:0051897 |
BP |
positive regulation of protein kinase B signaling |
| 255 |
coral4 |
47 |
7.6e-04 |
1.000 |
2 |
GO:0060977 |
BP |
coronary vasculature morphogenesis |
| 256 |
coral4 |
47 |
1.0e-03 |
1.000 |
2 |
GO:0005521 |
MF |
lamin binding |
| 257 |
coral4 |
47 |
1.2e-03 |
1.000 |
2 |
GO:0045780 |
BP |
positive regulation of bone resorption |
| 258 |
coral4 |
47 |
1.6e-03 |
1.000 |
3 |
GO:0010717 |
BP |
regulation of epithelial to mesenchymal transition |
| 259 |
coral4 |
47 |
2.2e-03 |
1.000 |
2 |
GO:0070723 |
BP |
response to cholesterol |
| 260 |
coral4 |
47 |
3.1e-03 |
1.000 |
2 |
GO:0035115 |
BP |
embryonic forelimb morphogenesis |
| 261 |
cornflowerblue |
41 |
1.6e-04 |
1.000 |
2 |
GO:0072718 |
BP |
response to cisplatin |
| 262 |
cornflowerblue |
41 |
2.4e-03 |
1.000 |
3 |
GO:0007189 |
BP |
adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| 263 |
cornflowerblue |
41 |
2.5e-03 |
1.000 |
2 |
GO:0010575 |
BP |
positive regulation of vascular endothelial growth factor production |
| 264 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:0002882 |
BP |
positive regulation of chronic inflammatory response to non-antigenic stimulus |
| 265 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:0009159 |
BP |
deoxyribonucleoside monophosphate catabolic process |
| 266 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:0021687 |
BP |
cerebellar molecular layer morphogenesis |
| 267 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:0021688 |
BP |
cerebellar molecular layer formation |
| 268 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:0060853 |
BP |
Notch signaling pathway involved in arterial endothelial cell fate commitment |
| 269 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:1901006 |
BP |
ubiquinone-6 biosynthetic process |
| 270 |
cornflowerblue |
41 |
2.8e-03 |
1.000 |
1 |
GO:1904199 |
BP |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization |
| 271 |
cornsilk |
32 |
9.3e-05 |
1.000 |
2 |
GO:0046085 |
BP |
adenosine metabolic process |
| 272 |
cornsilk |
32 |
1.6e-04 |
1.000 |
2 |
GO:0001973 |
BP |
adenosine receptor signaling pathway |
| 273 |
cornsilk |
32 |
5.3e-04 |
1.000 |
2 |
GO:0002313 |
BP |
mature B cell differentiation involved in immune response |
| 274 |
cornsilk |
32 |
5.8e-04 |
1.000 |
4 |
GO:0009612 |
BP |
response to mechanical stimulus |
| 275 |
cornsilk |
32 |
9.2e-04 |
1.000 |
2 |
GO:0002335 |
BP |
mature B cell differentiation |
| 276 |
cornsilk |
32 |
9.2e-04 |
1.000 |
2 |
GO:0006144 |
BP |
purine nucleobase metabolic process |
| 277 |
cornsilk |
32 |
1.1e-03 |
1.000 |
6 |
GO:0002366 |
BP |
leukocyte activation involved in immune response |
| 278 |
cornsilk |
32 |
1.2e-03 |
1.000 |
6 |
GO:0002263 |
BP |
cell activation involved in immune response |
| 279 |
cornsilk |
32 |
1.4e-03 |
1.000 |
6 |
GO:0005773 |
CC |
vacuole |
| 280 |
cornsilk |
32 |
1.6e-03 |
1.000 |
5 |
GO:0042119 |
BP |
neutrophil activation |
| 281 |
cyan |
176 |
1.1e-04 |
1.000 |
6 |
GO:0021954 |
BP |
central nervous system neuron development |
| 282 |
cyan |
176 |
3.7e-04 |
1.000 |
8 |
GO:0021953 |
BP |
central nervous system neuron differentiation |
| 283 |
cyan |
176 |
4.0e-04 |
1.000 |
2 |
GO:0060689 |
BP |
cell differentiation involved in salivary gland development |
| 284 |
cyan |
176 |
8.6e-04 |
1.000 |
5 |
GO:0008135 |
MF |
translation factor activity, RNA binding |
| 285 |
cyan |
176 |
9.4e-04 |
1.000 |
4 |
GO:0045599 |
BP |
negative regulation of fat cell differentiation |
| 286 |
cyan |
176 |
1.3e-03 |
1.000 |
2 |
GO:0044245 |
BP |
polysaccharide digestion |
| 287 |
cyan |
176 |
1.3e-03 |
1.000 |
2 |
GO:0000125 |
CC |
PCAF complex |
| 288 |
cyan |
176 |
1.3e-03 |
1.000 |
6 |
GO:0045598 |
BP |
regulation of fat cell differentiation |
| 289 |
cyan |
176 |
1.6e-03 |
1.000 |
8 |
GO:0045444 |
BP |
fat cell differentiation |
| 290 |
cyan |
176 |
1.9e-03 |
1.000 |
2 |
GO:1902416 |
BP |
positive regulation of mRNA binding |
| 291 |
darkgoldenrod4 |
32 |
3.4e-04 |
1.000 |
2 |
GO:0032754 |
BP |
positive regulation of interleukin-5 production |
| 292 |
darkgoldenrod4 |
32 |
6.7e-04 |
1.000 |
2 |
GO:0032674 |
BP |
regulation of interleukin-5 production |
| 293 |
darkgoldenrod4 |
32 |
7.5e-04 |
1.000 |
2 |
GO:0032634 |
BP |
interleukin-5 production |
| 294 |
darkgoldenrod4 |
32 |
1.0e-03 |
1.000 |
3 |
GO:0016363 |
CC |
nuclear matrix |
| 295 |
darkgoldenrod4 |
32 |
1.8e-03 |
1.000 |
3 |
GO:0034399 |
CC |
nuclear periphery |
| 296 |
darkgoldenrod4 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0018021 |
BP |
peptidyl-histidine methylation |
| 297 |
darkgoldenrod4 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0045407 |
BP |
positive regulation of interleukin-5 biosynthetic process |
| 298 |
darkgoldenrod4 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0071528 |
BP |
tRNA re-export from nucleus |
| 299 |
darkgoldenrod4 |
32 |
2.2e-03 |
1.000 |
1 |
GO:0090326 |
BP |
positive regulation of locomotion involved in locomotory behavior |
| 300 |
darkgoldenrod4 |
32 |
2.2e-03 |
1.000 |
1 |
GO:1903181 |
BP |
positive regulation of dopamine biosynthetic process |
| 301 |
darkgreen |
135 |
5.4e-05 |
0.980 |
20 |
GO:0042493 |
BP |
response to drug |
| 302 |
darkgreen |
135 |
2.4e-04 |
1.000 |
2 |
GO:0035359 |
BP |
negative regulation of peroxisome proliferator activated receptor signaling pathway |
| 303 |
darkgreen |
135 |
3.3e-04 |
1.000 |
9 |
GO:0098656 |
BP |
anion transmembrane transport |
| 304 |
darkgreen |
135 |
4.8e-04 |
1.000 |
2 |
GO:0045918 |
BP |
negative regulation of cytolysis |
| 305 |
darkgreen |
135 |
7.3e-04 |
1.000 |
3 |
GO:0030728 |
BP |
ovulation |
| 306 |
darkgreen |
135 |
8.5e-04 |
1.000 |
3 |
GO:0030431 |
BP |
sleep |
| 307 |
darkgreen |
135 |
8.5e-04 |
1.000 |
3 |
GO:0015491 |
MF |
cation:cation antiporter activity |
| 308 |
darkgreen |
135 |
8.8e-04 |
1.000 |
7 |
GO:0015893 |
BP |
drug transport |
| 309 |
darkgreen |
135 |
1.2e-03 |
1.000 |
2 |
GO:0046833 |
BP |
positive regulation of RNA export from nucleus |
| 310 |
darkgreen |
135 |
1.8e-03 |
1.000 |
5 |
GO:0045471 |
BP |
response to ethanol |
| 311 |
darkgrey |
142 |
8.1e-05 |
1.000 |
2 |
GO:0002590 |
BP |
negative regulation of antigen processing and presentation of peptide antigen via MHC class I |
| 312 |
darkgrey |
142 |
9.6e-04 |
1.000 |
8 |
GO:0015980 |
BP |
energy derivation by oxidation of organic compounds |
| 313 |
darkgrey |
142 |
1.0e-03 |
1.000 |
6 |
GO:0050773 |
BP |
regulation of dendrite development |
| 314 |
darkgrey |
142 |
1.1e-03 |
1.000 |
17 |
GO:0055114 |
BP |
oxidation-reduction process |
| 315 |
darkgrey |
142 |
1.2e-03 |
1.000 |
2 |
GO:0097550 |
CC |
transcriptional preinitiation complex |
| 316 |
darkgrey |
142 |
1.2e-03 |
1.000 |
11 |
GO:0006091 |
BP |
generation of precursor metabolites and energy |
| 317 |
darkgrey |
142 |
1.4e-03 |
1.000 |
3 |
GO:0032839 |
CC |
dendrite cytoplasm |
| 318 |
darkgrey |
142 |
1.5e-03 |
1.000 |
5 |
GO:0072089 |
BP |
stem cell proliferation |
| 319 |
darkgrey |
142 |
2.5e-03 |
1.000 |
6 |
GO:0045333 |
BP |
cellular respiration |
| 320 |
darkgrey |
142 |
2.6e-03 |
1.000 |
4 |
GO:0060998 |
BP |
regulation of dendritic spine development |
| 321 |
darkmagenta |
101 |
1.2e-03 |
1.000 |
2 |
GO:0005388 |
MF |
calcium-transporting ATPase activity |
| 322 |
darkmagenta |
101 |
1.6e-03 |
1.000 |
12 |
GO:0017111 |
MF |
nucleoside-triphosphatase activity |
| 323 |
darkmagenta |
101 |
2.2e-03 |
1.000 |
7 |
GO:0046942 |
BP |
carboxylic acid transport |
| 324 |
darkmagenta |
101 |
2.6e-03 |
1.000 |
12 |
GO:0016462 |
MF |
pyrophosphatase activity |
| 325 |
darkmagenta |
101 |
4.0e-03 |
1.000 |
5 |
GO:0061138 |
BP |
morphogenesis of a branching epithelium |
| 326 |
darkmagenta |
101 |
4.1e-03 |
1.000 |
3 |
GO:0060688 |
BP |
regulation of morphogenesis of a branching structure |
| 327 |
darkmagenta |
101 |
4.9e-03 |
1.000 |
2 |
GO:0097320 |
BP |
plasma membrane tubulation |
| 328 |
darkmagenta |
101 |
4.9e-03 |
1.000 |
2 |
GO:2000001 |
BP |
regulation of DNA damage checkpoint |
| 329 |
darkmagenta |
101 |
5.0e-03 |
1.000 |
17 |
GO:0006811 |
BP |
ion transport |
| 330 |
darkmagenta |
101 |
5.2e-03 |
1.000 |
5 |
GO:0001763 |
BP |
morphogenesis of a branching structure |
| 331 |
darkolivegreen |
99 |
7.6e-04 |
1.000 |
3 |
GO:0050718 |
BP |
positive regulation of interleukin-1 beta secretion |
| 332 |
darkolivegreen |
99 |
8.1e-04 |
1.000 |
5 |
GO:0050715 |
BP |
positive regulation of cytokine secretion |
| 333 |
darkolivegreen |
99 |
8.5e-04 |
1.000 |
2 |
GO:2001181 |
BP |
positive regulation of interleukin-10 secretion |
| 334 |
darkolivegreen |
99 |
1.0e-03 |
1.000 |
3 |
GO:0050716 |
BP |
positive regulation of interleukin-1 secretion |
| 335 |
darkolivegreen |
99 |
1.1e-03 |
1.000 |
2 |
GO:0042415 |
BP |
norepinephrine metabolic process |
| 336 |
darkolivegreen |
99 |
1.4e-03 |
1.000 |
2 |
GO:0009415 |
BP |
response to water |
| 337 |
darkolivegreen |
99 |
1.9e-03 |
1.000 |
6 |
GO:0030246 |
MF |
carbohydrate binding |
| 338 |
darkolivegreen |
99 |
2.2e-03 |
1.000 |
3 |
GO:0032731 |
BP |
positive regulation of interleukin-1 beta production |
| 339 |
darkolivegreen |
99 |
2.2e-03 |
1.000 |
3 |
GO:0050706 |
BP |
regulation of interleukin-1 beta secretion |
| 340 |
darkolivegreen |
99 |
2.2e-03 |
1.000 |
2 |
GO:0072608 |
BP |
interleukin-10 secretion |
| 341 |
darkolivegreen1 |
47 |
9.2e-04 |
1.000 |
2 |
GO:0008278 |
CC |
cohesin complex |
| 342 |
darkolivegreen1 |
47 |
1.4e-03 |
1.000 |
2 |
GO:0033233 |
BP |
regulation of protein sumoylation |
| 343 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0031283 |
BP |
negative regulation of guanylate cyclase activity |
| 344 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0072303 |
BP |
positive regulation of glomerular metanephric mesangial cell proliferation |
| 345 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0097045 |
BP |
phosphatidylserine exposure on blood platelet |
| 346 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:1900758 |
BP |
negative regulation of D-amino-acid oxidase activity |
| 347 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:1902618 |
BP |
cellular response to fluoride |
| 348 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0035003 |
CC |
subapical complex |
| 349 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0001850 |
MF |
complement component C3a binding |
| 350 |
darkolivegreen1 |
47 |
3.3e-03 |
1.000 |
1 |
GO:0008817 |
MF |
cob(I)yrinic acid a,c-diamide adenosyltransferase activity |
| 351 |
darkolivegreen2 |
48 |
5.0e-05 |
0.900 |
2 |
GO:0072553 |
BP |
terminal button organization |
| 352 |
darkolivegreen2 |
48 |
8.5e-04 |
1.000 |
2 |
GO:0070233 |
BP |
negative regulation of T cell apoptotic process |
| 353 |
darkolivegreen2 |
48 |
9.7e-04 |
1.000 |
2 |
GO:1902473 |
BP |
regulation of protein localization to synapse |
| 354 |
darkolivegreen2 |
48 |
1.1e-03 |
1.000 |
4 |
GO:0031345 |
BP |
negative regulation of cell projection organization |
| 355 |
darkolivegreen2 |
48 |
1.9e-03 |
1.000 |
3 |
GO:0003727 |
MF |
single-stranded RNA binding |
| 356 |
darkolivegreen2 |
48 |
2.5e-03 |
1.000 |
3 |
GO:0098693 |
BP |
regulation of synaptic vesicle cycle |
| 357 |
darkolivegreen2 |
48 |
2.6e-03 |
1.000 |
2 |
GO:0043029 |
BP |
T cell homeostasis |
| 358 |
darkolivegreen2 |
48 |
2.6e-03 |
1.000 |
2 |
GO:0070232 |
BP |
regulation of T cell apoptotic process |
| 359 |
darkolivegreen2 |
48 |
2.9e-03 |
1.000 |
1 |
GO:0018917 |
BP |
fluorene metabolic process |
| 360 |
darkolivegreen2 |
48 |
2.9e-03 |
1.000 |
1 |
GO:0021503 |
BP |
neural fold bending |
| 361 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0002362 |
BP |
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment |
| 362 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0002458 |
BP |
peripheral T cell tolerance induction |
| 363 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0002851 |
BP |
positive regulation of peripheral T cell tolerance induction |
| 364 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0002878 |
BP |
negative regulation of acute inflammatory response to non-antigenic stimulus |
| 365 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0045819 |
BP |
positive regulation of glycogen catabolic process |
| 366 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0099040 |
BP |
ceramide translocation |
| 367 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:1902203 |
BP |
negative regulation of hepatocyte growth factor receptor signaling pathway |
| 368 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:2000761 |
BP |
positive regulation of N-terminal peptidyl-lysine acetylation |
| 369 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:2001113 |
BP |
negative regulation of cellular response to hepatocyte growth factor stimulus |
| 370 |
darkolivegreen4 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0070176 |
CC |
DRM complex |
| 371 |
darkorange |
124 |
5.4e-04 |
1.000 |
3 |
GO:0019865 |
MF |
immunoglobulin binding |
| 372 |
darkorange |
124 |
6.4e-04 |
1.000 |
2 |
GO:0051256 |
BP |
mitotic spindle midzone assembly |
| 373 |
darkorange |
124 |
1.3e-03 |
1.000 |
2 |
GO:0000022 |
BP |
mitotic spindle elongation |
| 374 |
darkorange |
124 |
1.3e-03 |
1.000 |
2 |
GO:0051255 |
BP |
spindle midzone assembly |
| 375 |
darkorange |
124 |
1.4e-03 |
1.000 |
20 |
GO:0002682 |
BP |
regulation of immune system process |
| 376 |
darkorange |
124 |
1.8e-03 |
1.000 |
2 |
GO:0045617 |
BP |
negative regulation of keratinocyte differentiation |
| 377 |
darkorange |
124 |
2.3e-03 |
1.000 |
2 |
GO:0002638 |
BP |
negative regulation of immunoglobulin production |
| 378 |
darkorange |
124 |
2.3e-03 |
1.000 |
2 |
GO:0033690 |
BP |
positive regulation of osteoblast proliferation |
| 379 |
darkorange |
124 |
2.3e-03 |
1.000 |
2 |
GO:0015929 |
MF |
hexosaminidase activity |
| 380 |
darkorange |
124 |
2.8e-03 |
1.000 |
3 |
GO:0030857 |
BP |
negative regulation of epithelial cell differentiation |
| 381 |
darkorange2 |
81 |
1.2e-04 |
1.000 |
3 |
GO:0032809 |
CC |
neuronal cell body membrane |
| 382 |
darkorange2 |
81 |
1.2e-04 |
1.000 |
3 |
GO:0044298 |
CC |
cell body membrane |
| 383 |
darkorange2 |
81 |
2.9e-04 |
1.000 |
2 |
GO:0048254 |
BP |
snoRNA localization |
| 384 |
darkorange2 |
81 |
4.3e-04 |
1.000 |
2 |
GO:0048387 |
BP |
negative regulation of retinoic acid receptor signaling pathway |
| 385 |
darkorange2 |
81 |
6.0e-04 |
1.000 |
2 |
GO:0070878 |
MF |
primary miRNA binding |
| 386 |
darkorange2 |
81 |
6.2e-04 |
1.000 |
4 |
GO:0045778 |
BP |
positive regulation of ossification |
| 387 |
darkorange2 |
81 |
7.9e-04 |
1.000 |
2 |
GO:0070314 |
BP |
G1 to G0 transition |
| 388 |
darkorange2 |
81 |
8.9e-04 |
1.000 |
8 |
GO:0022613 |
BP |
ribonucleoprotein complex biogenesis |
| 389 |
darkorange2 |
81 |
1.0e-03 |
1.000 |
9 |
GO:0044772 |
BP |
mitotic cell cycle phase transition |
| 390 |
darkorange2 |
81 |
1.1e-03 |
1.000 |
6 |
GO:0000082 |
BP |
G1/S transition of mitotic cell cycle |
| 391 |
darkred |
129 |
1.4e-04 |
1.000 |
3 |
GO:0035435 |
BP |
phosphate ion transmembrane transport |
| 392 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:0010593 |
BP |
negative regulation of lamellipodium assembly |
| 393 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:0015709 |
BP |
thiosulfate transport |
| 394 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:0015729 |
BP |
oxaloacetate transport |
| 395 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:1902356 |
BP |
oxaloacetate(2-) transmembrane transport |
| 396 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:0015117 |
MF |
thiosulfate transmembrane transporter activity |
| 397 |
darkred |
129 |
2.3e-04 |
1.000 |
2 |
GO:0015131 |
MF |
oxaloacetate transmembrane transporter activity |
| 398 |
darkred |
129 |
3.6e-04 |
1.000 |
4 |
GO:0002686 |
BP |
negative regulation of leukocyte migration |
| 399 |
darkred |
129 |
4.0e-04 |
1.000 |
7 |
GO:0002685 |
BP |
regulation of leukocyte migration |
| 400 |
darkred |
129 |
4.5e-04 |
1.000 |
2 |
GO:0071423 |
BP |
malate transmembrane transport |
| 401 |
darkseagreen |
36 |
7.6e-04 |
1.000 |
10 |
GO:0042802 |
MF |
identical protein binding |
| 402 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0007072 |
BP |
positive regulation of transcription involved in exit from mitosis |
| 403 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0009234 |
BP |
menaquinone biosynthetic process |
| 404 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0032194 |
BP |
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate |
| 405 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0042371 |
BP |
vitamin K biosynthetic process |
| 406 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:1902251 |
BP |
negative regulation of erythrocyte apoptotic process |
| 407 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0005731 |
CC |
nucleolus organizer region |
| 408 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0043540 |
CC |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex |
| 409 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0018467 |
MF |
formaldehyde dehydrogenase activity |
| 410 |
darkseagreen |
36 |
2.3e-03 |
1.000 |
1 |
GO:0047127 |
MF |
thiomorpholine-carboxylate dehydrogenase activity |
| 411 |
darkseagreen1 |
40 |
2.5e-06 |
0.046 |
4 |
GO:0050999 |
BP |
regulation of nitric-oxide synthase activity |
| 412 |
darkseagreen1 |
40 |
4.8e-05 |
0.880 |
4 |
GO:0051341 |
BP |
regulation of oxidoreductase activity |
| 413 |
darkseagreen1 |
40 |
1.2e-04 |
1.000 |
8 |
GO:0080135 |
BP |
regulation of cellular response to stress |
| 414 |
darkseagreen1 |
40 |
1.4e-04 |
1.000 |
2 |
GO:0051001 |
BP |
negative regulation of nitric-oxide synthase activity |
| 415 |
darkseagreen1 |
40 |
3.0e-04 |
1.000 |
2 |
GO:0032769 |
BP |
negative regulation of monooxygenase activity |
| 416 |
darkseagreen1 |
40 |
4.7e-04 |
1.000 |
3 |
GO:0003684 |
MF |
damaged DNA binding |
| 417 |
darkseagreen1 |
40 |
6.0e-04 |
1.000 |
3 |
GO:2001021 |
BP |
negative regulation of response to DNA damage stimulus |
| 418 |
darkseagreen1 |
40 |
8.0e-04 |
1.000 |
4 |
GO:0071478 |
BP |
cellular response to radiation |
| 419 |
darkseagreen1 |
40 |
8.2e-04 |
1.000 |
24 |
GO:0019222 |
BP |
regulation of metabolic process |
| 420 |
darkseagreen1 |
40 |
9.8e-04 |
1.000 |
6 |
GO:0006281 |
BP |
DNA repair |
| 421 |
darkseagreen2 |
46 |
1.0e-04 |
1.000 |
3 |
GO:2000249 |
BP |
regulation of actin cytoskeleton reorganization |
| 422 |
darkseagreen2 |
46 |
2.5e-04 |
1.000 |
2 |
GO:0035374 |
MF |
chondroitin sulfate binding |
| 423 |
darkseagreen2 |
46 |
9.3e-04 |
1.000 |
2 |
GO:0072576 |
BP |
liver morphogenesis |
| 424 |
darkseagreen2 |
46 |
1.3e-03 |
1.000 |
3 |
GO:0006835 |
BP |
dicarboxylic acid transport |
| 425 |
darkseagreen2 |
46 |
2.0e-03 |
1.000 |
10 |
GO:1902494 |
CC |
catalytic complex |
| 426 |
darkseagreen2 |
46 |
2.2e-03 |
1.000 |
3 |
GO:0031532 |
BP |
actin cytoskeleton reorganization |
| 427 |
darkseagreen2 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0030421 |
BP |
defecation |
| 428 |
darkseagreen2 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0035037 |
BP |
sperm entry |
| 429 |
darkseagreen2 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0060345 |
BP |
spleen trabecula formation |
| 430 |
darkseagreen2 |
46 |
3.1e-03 |
1.000 |
1 |
GO:1903712 |
BP |
cysteine transmembrane transport |
| 431 |
darkseagreen3 |
54 |
7.6e-05 |
1.000 |
11 |
GO:0005768 |
CC |
endosome |
| 432 |
darkseagreen3 |
54 |
1.4e-04 |
1.000 |
5 |
GO:2001242 |
BP |
regulation of intrinsic apoptotic signaling pathway |
| 433 |
darkseagreen3 |
54 |
2.4e-04 |
1.000 |
5 |
GO:0007051 |
BP |
spindle organization |
| 434 |
darkseagreen3 |
54 |
2.9e-04 |
1.000 |
6 |
GO:0097193 |
BP |
intrinsic apoptotic signaling pathway |
| 435 |
darkseagreen3 |
54 |
4.9e-04 |
1.000 |
2 |
GO:0051409 |
BP |
response to nitrosative stress |
| 436 |
darkseagreen3 |
54 |
5.3e-04 |
1.000 |
6 |
GO:0016050 |
BP |
vesicle organization |
| 437 |
darkseagreen3 |
54 |
8.4e-04 |
1.000 |
4 |
GO:0007098 |
BP |
centrosome cycle |
| 438 |
darkseagreen3 |
54 |
8.9e-04 |
1.000 |
2 |
GO:0045779 |
BP |
negative regulation of bone resorption |
| 439 |
darkseagreen3 |
54 |
9.1e-04 |
1.000 |
3 |
GO:0006303 |
BP |
double-strand break repair via nonhomologous end joining |
| 440 |
darkseagreen3 |
54 |
9.6e-04 |
1.000 |
7 |
GO:1902532 |
BP |
negative regulation of intracellular signal transduction |
| 441 |
darkseagreen4 |
69 |
4.4e-04 |
1.000 |
2 |
GO:0015368 |
MF |
calcium:cation antiporter activity |
| 442 |
darkseagreen4 |
69 |
5.9e-04 |
1.000 |
2 |
GO:0000774 |
MF |
adenyl-nucleotide exchange factor activity |
| 443 |
darkseagreen4 |
69 |
9.7e-04 |
1.000 |
3 |
GO:0001912 |
BP |
positive regulation of leukocyte mediated cytotoxicity |
| 444 |
darkseagreen4 |
69 |
3.0e-03 |
1.000 |
3 |
GO:0001910 |
BP |
regulation of leukocyte mediated cytotoxicity |
| 445 |
darkseagreen4 |
69 |
3.8e-03 |
1.000 |
2 |
GO:0001916 |
BP |
positive regulation of T cell mediated cytotoxicity |
| 446 |
darkseagreen4 |
69 |
4.2e-03 |
1.000 |
2 |
GO:0015491 |
MF |
cation:cation antiporter activity |
| 447 |
darkseagreen4 |
69 |
4.6e-03 |
1.000 |
2 |
GO:0010664 |
BP |
negative regulation of striated muscle cell apoptotic process |
| 448 |
darkseagreen4 |
69 |
4.6e-03 |
1.000 |
1 |
GO:0006424 |
BP |
glutamyl-tRNA aminoacylation |
| 449 |
darkseagreen4 |
69 |
4.6e-03 |
1.000 |
1 |
GO:0035499 |
BP |
carnosine biosynthetic process |
| 450 |
darkseagreen4 |
69 |
4.6e-03 |
1.000 |
1 |
GO:1903801 |
BP |
L-leucine import across plasma membrane |
| 451 |
darkslateblue |
87 |
1.4e-04 |
1.000 |
4 |
GO:0002011 |
BP |
morphogenesis of an epithelial sheet |
| 452 |
darkslateblue |
87 |
4.4e-04 |
1.000 |
6 |
GO:0010810 |
BP |
regulation of cell-substrate adhesion |
| 453 |
darkslateblue |
87 |
4.7e-04 |
1.000 |
3 |
GO:0032435 |
BP |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
| 454 |
darkslateblue |
87 |
6.6e-04 |
1.000 |
2 |
GO:0048842 |
BP |
positive regulation of axon extension involved in axon guidance |
| 455 |
darkslateblue |
87 |
7.8e-04 |
1.000 |
3 |
GO:0017046 |
MF |
peptide hormone binding |
| 456 |
darkslateblue |
87 |
8.6e-04 |
1.000 |
10 |
GO:0097435 |
BP |
supramolecular fiber organization |
| 457 |
darkslateblue |
87 |
8.8e-04 |
1.000 |
2 |
GO:1902669 |
BP |
positive regulation of axon guidance |
| 458 |
darkslateblue |
87 |
8.8e-04 |
1.000 |
7 |
GO:0040013 |
BP |
negative regulation of locomotion |
| 459 |
darkslateblue |
87 |
1.2e-03 |
1.000 |
4 |
GO:0014033 |
BP |
neural crest cell differentiation |
| 460 |
darkslateblue |
87 |
1.3e-03 |
1.000 |
3 |
GO:2000059 |
BP |
negative regulation of ubiquitin-dependent protein catabolic process |
| 461 |
darkturquoise |
132 |
4.4e-04 |
1.000 |
2 |
GO:1902387 |
MF |
ceramide 1-phosphate binding |
| 462 |
darkturquoise |
132 |
5.6e-04 |
1.000 |
4 |
GO:0005548 |
MF |
phospholipid transporter activity |
| 463 |
darkturquoise |
132 |
7.3e-04 |
1.000 |
2 |
GO:0120009 |
BP |
intermembrane lipid transfer |
| 464 |
darkturquoise |
132 |
7.3e-04 |
1.000 |
2 |
GO:1902389 |
BP |
ceramide 1-phosphate transport |
| 465 |
darkturquoise |
132 |
7.3e-04 |
1.000 |
2 |
GO:1902388 |
MF |
ceramide 1-phosphate transporter activity |
| 466 |
darkturquoise |
132 |
7.6e-04 |
1.000 |
3 |
GO:0002335 |
BP |
mature B cell differentiation |
| 467 |
darkturquoise |
132 |
1.0e-03 |
1.000 |
7 |
GO:0016323 |
CC |
basolateral plasma membrane |
| 468 |
darkturquoise |
132 |
1.1e-03 |
1.000 |
2 |
GO:0106072 |
BP |
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| 469 |
darkturquoise |
132 |
1.1e-03 |
1.000 |
2 |
GO:0044354 |
CC |
macropinosome |
| 470 |
darkturquoise |
132 |
1.3e-03 |
1.000 |
11 |
GO:0060627 |
BP |
regulation of vesicle-mediated transport |
| 471 |
darkviolet |
62 |
1.1e-04 |
1.000 |
3 |
GO:0043325 |
MF |
phosphatidylinositol-3,4-bisphosphate binding |
| 472 |
darkviolet |
62 |
2.5e-04 |
1.000 |
2 |
GO:0003096 |
BP |
renal sodium ion transport |
| 473 |
darkviolet |
62 |
2.5e-04 |
1.000 |
2 |
GO:0032926 |
BP |
negative regulation of activin receptor signaling pathway |
| 474 |
darkviolet |
62 |
4.1e-04 |
1.000 |
4 |
GO:1902936 |
MF |
phosphatidylinositol bisphosphate binding |
| 475 |
darkviolet |
62 |
4.8e-04 |
1.000 |
3 |
GO:0001221 |
MF |
transcription cofactor binding |
| 476 |
darkviolet |
62 |
5.4e-04 |
1.000 |
11 |
GO:0007167 |
BP |
enzyme linked receptor protein signaling pathway |
| 477 |
darkviolet |
62 |
9.1e-04 |
1.000 |
2 |
GO:0030207 |
BP |
chondroitin sulfate catabolic process |
| 478 |
darkviolet |
62 |
9.1e-04 |
1.000 |
2 |
GO:0032429 |
BP |
regulation of phospholipase A2 activity |
| 479 |
darkviolet |
62 |
9.2e-04 |
1.000 |
3 |
GO:0006998 |
BP |
nuclear envelope organization |
| 480 |
darkviolet |
62 |
1.5e-03 |
1.000 |
3 |
GO:1903036 |
BP |
positive regulation of response to wounding |
| 481 |
deeppink |
51 |
3.7e-05 |
0.670 |
2 |
GO:0097296 |
BP |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| 482 |
deeppink |
51 |
2.5e-04 |
1.000 |
3 |
GO:0097300 |
BP |
programmed necrotic cell death |
| 483 |
deeppink |
51 |
3.4e-04 |
1.000 |
2 |
GO:0032471 |
BP |
negative regulation of endoplasmic reticulum calcium ion concentration |
| 484 |
deeppink |
51 |
3.4e-04 |
1.000 |
2 |
GO:1903715 |
BP |
regulation of aerobic respiration |
| 485 |
deeppink |
51 |
4.3e-04 |
1.000 |
3 |
GO:0070265 |
BP |
necrotic cell death |
| 486 |
deeppink |
51 |
5.4e-04 |
1.000 |
2 |
GO:2001269 |
BP |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| 487 |
deeppink |
51 |
1.2e-03 |
1.000 |
22 |
GO:0046872 |
MF |
metal ion binding |
| 488 |
deeppink |
51 |
1.7e-03 |
1.000 |
22 |
GO:0043169 |
MF |
cation binding |
| 489 |
deeppink |
51 |
1.8e-03 |
1.000 |
3 |
GO:0009060 |
BP |
aerobic respiration |
| 490 |
deeppink |
51 |
2.2e-03 |
1.000 |
2 |
GO:0032469 |
BP |
endoplasmic reticulum calcium ion homeostasis |
| 491 |
deeppink1 |
43 |
7.4e-04 |
1.000 |
2 |
GO:0005662 |
CC |
DNA replication factor A complex |
| 492 |
deeppink1 |
43 |
2.4e-03 |
1.000 |
2 |
GO:0030894 |
CC |
replisome |
| 493 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0000032 |
BP |
cell wall mannoprotein biosynthetic process |
| 494 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0000921 |
BP |
septin ring assembly |
| 495 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0061611 |
BP |
mannose to fructose-6-phosphate metabolic process |
| 496 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0071654 |
BP |
positive regulation of chemokine (C-C motif) ligand 1 production |
| 497 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0042564 |
CC |
NLS-dependent protein nuclear import complex |
| 498 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0004476 |
MF |
mannose-6-phosphate isomerase activity |
| 499 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0010844 |
MF |
recombination hotspot binding |
| 500 |
deeppink1 |
43 |
2.9e-03 |
1.000 |
1 |
GO:0019978 |
MF |
interleukin-3 binding |
| 501 |
deeppink2 |
35 |
5.7e-05 |
1.000 |
2 |
GO:0006477 |
BP |
protein sulfation |
| 502 |
deeppink2 |
35 |
1.2e-04 |
1.000 |
2 |
GO:0070652 |
CC |
HAUS complex |
| 503 |
deeppink2 |
35 |
1.3e-04 |
1.000 |
3 |
GO:0008146 |
MF |
sulfotransferase activity |
| 504 |
deeppink2 |
35 |
4.4e-04 |
1.000 |
2 |
GO:0051923 |
BP |
sulfation |
| 505 |
deeppink2 |
35 |
5.1e-04 |
1.000 |
2 |
GO:0002098 |
BP |
tRNA wobble uridine modification |
| 506 |
deeppink2 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0001692 |
BP |
histamine metabolic process |
| 507 |
deeppink2 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0001695 |
BP |
histamine catabolic process |
| 508 |
deeppink2 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0002144 |
CC |
cytosolic tRNA wobble base thiouridylase complex |
| 509 |
deeppink2 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0032422 |
MF |
purine-rich negative regulatory element binding |
| 510 |
deeppink2 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0046539 |
MF |
histamine N-methyltransferase activity |
| 511 |
dodgerblue4 |
30 |
1.5e-03 |
1.000 |
2 |
GO:0006471 |
BP |
protein ADP-ribosylation |
| 512 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0019358 |
BP |
nicotinate nucleotide salvage |
| 513 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0032458 |
BP |
slow endocytic recycling |
| 514 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0034355 |
BP |
NAD salvage |
| 515 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0090249 |
BP |
regulation of cell motility involved in somitogenic axis elongation |
| 516 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:1901231 |
BP |
positive regulation of non-canonical Wnt signaling pathway via JNK cascade |
| 517 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:1901233 |
BP |
negative regulation of convergent extension involved in axis elongation |
| 518 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0004140 |
MF |
dephospho-CoA kinase activity |
| 519 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0004516 |
MF |
nicotinate phosphoribosyltransferase activity |
| 520 |
dodgerblue4 |
30 |
2.1e-03 |
1.000 |
1 |
GO:0005169 |
MF |
neurotrophin TRKB receptor binding |
| 521 |
firebrick |
36 |
2.6e-04 |
1.000 |
2 |
GO:1903909 |
BP |
regulation of receptor clustering |
| 522 |
firebrick |
36 |
1.7e-03 |
1.000 |
2 |
GO:0048821 |
BP |
erythrocyte development |
| 523 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0015692 |
BP |
lead ion transport |
| 524 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0035444 |
BP |
nickel cation transmembrane transport |
| 525 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0035611 |
BP |
protein branching point deglutamylation |
| 526 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0140206 |
BP |
dipeptide import across plasma membrane |
| 527 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:1901494 |
BP |
regulation of cysteine metabolic process |
| 528 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:1903906 |
BP |
regulation of plasma membrane raft polarization |
| 529 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0070826 |
CC |
paraferritin complex |
| 530 |
firebrick |
36 |
2.2e-03 |
1.000 |
1 |
GO:0008682 |
MF |
2-octoprenyl-3-methyl-6-methoxy-1,4-benzoquinone hydroxylase activity |
| 531 |
firebrick2 |
49 |
1.1e-03 |
1.000 |
8 |
GO:0016604 |
CC |
nuclear body |
| 532 |
firebrick2 |
49 |
1.2e-03 |
1.000 |
2 |
GO:0097381 |
CC |
photoreceptor disc membrane |
| 533 |
firebrick2 |
49 |
2.1e-03 |
1.000 |
5 |
GO:0031253 |
CC |
cell projection membrane |
| 534 |
firebrick2 |
49 |
2.2e-03 |
1.000 |
3 |
GO:0032182 |
MF |
ubiquitin-like protein binding |
| 535 |
firebrick2 |
49 |
2.3e-03 |
1.000 |
2 |
GO:0031528 |
CC |
microvillus membrane |
| 536 |
firebrick2 |
49 |
2.5e-03 |
1.000 |
2 |
GO:0007603 |
BP |
phototransduction, visible light |
| 537 |
firebrick2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0035508 |
BP |
positive regulation of myosin-light-chain-phosphatase activity |
| 538 |
firebrick2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0060243 |
BP |
negative regulation of cell growth involved in contact inhibition |
| 539 |
firebrick2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0060764 |
BP |
cell-cell signaling involved in mammary gland development |
| 540 |
firebrick2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:1905349 |
BP |
ciliary transition zone assembly |
| 541 |
firebrick3 |
49 |
1.1e-04 |
1.000 |
2 |
GO:0061724 |
BP |
lipophagy |
| 542 |
firebrick3 |
49 |
1.1e-04 |
1.000 |
2 |
GO:1904504 |
BP |
positive regulation of lipophagy |
| 543 |
firebrick3 |
49 |
1.6e-04 |
1.000 |
2 |
GO:0019855 |
MF |
calcium channel inhibitor activity |
| 544 |
firebrick3 |
49 |
2.0e-04 |
1.000 |
4 |
GO:0006939 |
BP |
smooth muscle contraction |
| 545 |
firebrick3 |
49 |
2.7e-04 |
1.000 |
6 |
GO:0006936 |
BP |
muscle contraction |
| 546 |
firebrick3 |
49 |
5.6e-04 |
1.000 |
5 |
GO:0032412 |
BP |
regulation of ion transmembrane transporter activity |
| 547 |
firebrick3 |
49 |
5.9e-04 |
1.000 |
2 |
GO:0043201 |
BP |
response to leucine |
| 548 |
firebrick3 |
49 |
6.4e-04 |
1.000 |
5 |
GO:0007611 |
BP |
learning or memory |
| 549 |
firebrick3 |
49 |
6.6e-04 |
1.000 |
5 |
GO:0022898 |
BP |
regulation of transmembrane transporter activity |
| 550 |
firebrick3 |
49 |
7.0e-04 |
1.000 |
2 |
GO:0060077 |
CC |
inhibitory synapse |
| 551 |
firebrick4 |
65 |
5.1e-05 |
0.930 |
2 |
GO:0031262 |
CC |
Ndc80 complex |
| 552 |
firebrick4 |
65 |
3.5e-04 |
1.000 |
2 |
GO:0031666 |
BP |
positive regulation of lipopolysaccharide-mediated signaling pathway |
| 553 |
firebrick4 |
65 |
6.1e-04 |
1.000 |
5 |
GO:0000775 |
CC |
chromosome, centromeric region |
| 554 |
firebrick4 |
65 |
9.1e-04 |
1.000 |
2 |
GO:0051315 |
BP |
attachment of mitotic spindle microtubules to kinetochore |
| 555 |
firebrick4 |
65 |
9.5e-04 |
1.000 |
4 |
GO:0007043 |
BP |
cell-cell junction assembly |
| 556 |
firebrick4 |
65 |
1.3e-03 |
1.000 |
4 |
GO:0042542 |
BP |
response to hydrogen peroxide |
| 557 |
firebrick4 |
65 |
1.3e-03 |
1.000 |
2 |
GO:0034349 |
BP |
glial cell apoptotic process |
| 558 |
firebrick4 |
65 |
1.3e-03 |
1.000 |
2 |
GO:0035173 |
MF |
histone kinase activity |
| 559 |
firebrick4 |
65 |
1.7e-03 |
1.000 |
2 |
GO:0000778 |
CC |
condensed nuclear chromosome kinetochore |
| 560 |
firebrick4 |
65 |
2.0e-03 |
1.000 |
2 |
GO:0005922 |
CC |
connexin complex |
| 561 |
floralwhite |
88 |
3.2e-05 |
0.580 |
2 |
GO:0098641 |
MF |
cadherin binding involved in cell-cell adhesion |
| 562 |
floralwhite |
88 |
6.2e-05 |
1.000 |
5 |
GO:0009791 |
BP |
post-embryonic development |
| 563 |
floralwhite |
88 |
1.1e-04 |
1.000 |
5 |
GO:0001657 |
BP |
ureteric bud development |
| 564 |
floralwhite |
88 |
1.2e-04 |
1.000 |
5 |
GO:0072163 |
BP |
mesonephric epithelium development |
| 565 |
floralwhite |
88 |
1.2e-04 |
1.000 |
5 |
GO:0072164 |
BP |
mesonephric tubule development |
| 566 |
floralwhite |
88 |
1.5e-04 |
1.000 |
5 |
GO:0001823 |
BP |
mesonephros development |
| 567 |
floralwhite |
88 |
1.9e-04 |
1.000 |
3 |
GO:0035162 |
BP |
embryonic hemopoiesis |
| 568 |
floralwhite |
88 |
1.9e-04 |
1.000 |
2 |
GO:0003274 |
BP |
endocardial cushion fusion |
| 569 |
floralwhite |
88 |
1.9e-04 |
1.000 |
2 |
GO:0035481 |
BP |
positive regulation of Notch signaling pathway involved in heart induction |
| 570 |
floralwhite |
88 |
1.9e-04 |
1.000 |
2 |
GO:0061343 |
BP |
cell adhesion involved in heart morphogenesis |
| 571 |
green |
276 |
1.0e-03 |
1.000 |
2 |
GO:1901329 |
BP |
regulation of odontoblast differentiation |
| 572 |
green |
276 |
1.0e-03 |
1.000 |
2 |
GO:0015254 |
MF |
glycerol channel activity |
| 573 |
green |
276 |
1.1e-03 |
1.000 |
28 |
GO:0022857 |
MF |
transmembrane transporter activity |
| 574 |
green |
276 |
1.6e-03 |
1.000 |
4 |
GO:0030224 |
BP |
monocyte differentiation |
| 575 |
green |
276 |
1.9e-03 |
1.000 |
3 |
GO:0045655 |
BP |
regulation of monocyte differentiation |
| 576 |
green |
276 |
2.0e-03 |
1.000 |
2 |
GO:0015793 |
BP |
glycerol transport |
| 577 |
green |
276 |
2.0e-03 |
1.000 |
2 |
GO:0033299 |
BP |
secretion of lysosomal enzymes |
| 578 |
green |
276 |
2.0e-03 |
1.000 |
2 |
GO:0034436 |
BP |
glycoprotein transport |
| 579 |
green |
276 |
2.0e-03 |
1.000 |
2 |
GO:0098690 |
CC |
glycinergic synapse |
| 580 |
green |
276 |
2.0e-03 |
1.000 |
2 |
GO:0015168 |
MF |
glycerol transmembrane transporter activity |
| 581 |
green2 |
34 |
4.4e-04 |
1.000 |
5 |
GO:0005774 |
CC |
vacuolar membrane |
| 582 |
green2 |
34 |
5.6e-04 |
1.000 |
2 |
GO:0034501 |
BP |
protein localization to kinetochore |
| 583 |
green2 |
34 |
7.5e-04 |
1.000 |
3 |
GO:0034644 |
BP |
cellular response to UV |
| 584 |
green2 |
34 |
9.0e-04 |
1.000 |
2 |
GO:0071459 |
BP |
protein localization to chromosome, centromeric region |
| 585 |
green2 |
34 |
1.6e-03 |
1.000 |
4 |
GO:0005765 |
CC |
lysosomal membrane |
| 586 |
green2 |
34 |
2.0e-03 |
1.000 |
2 |
GO:0007094 |
BP |
mitotic spindle assembly checkpoint |
| 587 |
green2 |
34 |
2.1e-03 |
1.000 |
3 |
GO:0071482 |
BP |
cellular response to light stimulus |
| 588 |
green2 |
34 |
2.1e-03 |
1.000 |
3 |
GO:2001251 |
BP |
negative regulation of chromosome organization |
| 589 |
green2 |
34 |
2.3e-03 |
1.000 |
2 |
GO:0045841 |
BP |
negative regulation of mitotic metaphase/anaphase transition |
| 590 |
green2 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0018424 |
BP |
peptidyl-glutamic acid poly-ADP-ribosylation |
| 591 |
green3 |
45 |
2.0e-04 |
1.000 |
4 |
GO:0098693 |
BP |
regulation of synaptic vesicle cycle |
| 592 |
green3 |
45 |
5.1e-04 |
1.000 |
5 |
GO:0031334 |
BP |
positive regulation of protein complex assembly |
| 593 |
green3 |
45 |
9.6e-04 |
1.000 |
4 |
GO:0005741 |
CC |
mitochondrial outer membrane |
| 594 |
green3 |
45 |
9.7e-04 |
1.000 |
2 |
GO:1900242 |
BP |
regulation of synaptic vesicle endocytosis |
| 595 |
green3 |
45 |
1.4e-03 |
1.000 |
4 |
GO:0099504 |
BP |
synaptic vesicle cycle |
| 596 |
green3 |
45 |
1.7e-03 |
1.000 |
4 |
GO:0019867 |
CC |
outer membrane |
| 597 |
green3 |
45 |
1.7e-03 |
1.000 |
2 |
GO:0001783 |
BP |
B cell apoptotic process |
| 598 |
green3 |
45 |
1.7e-03 |
1.000 |
2 |
GO:0032461 |
BP |
positive regulation of protein oligomerization |
| 599 |
green3 |
45 |
2.1e-03 |
1.000 |
2 |
GO:1903421 |
BP |
regulation of synaptic vesicle recycling |
| 600 |
green3 |
45 |
2.3e-03 |
1.000 |
3 |
GO:0043473 |
BP |
pigmentation |
| 601 |
green4 |
53 |
3.7e-05 |
0.660 |
3 |
GO:1901687 |
BP |
glutathione derivative biosynthetic process |
| 602 |
green4 |
53 |
7.5e-05 |
1.000 |
3 |
GO:0004364 |
MF |
glutathione transferase activity |
| 603 |
green4 |
53 |
6.5e-04 |
1.000 |
3 |
GO:0006749 |
BP |
glutathione metabolic process |
| 604 |
green4 |
53 |
7.5e-04 |
1.000 |
6 |
GO:0006790 |
BP |
sulfur compound metabolic process |
| 605 |
green4 |
53 |
8.1e-04 |
1.000 |
3 |
GO:0016765 |
MF |
transferase activity, transferring alkyl or aryl (other than methyl) groups |
| 606 |
green4 |
53 |
1.4e-03 |
1.000 |
2 |
GO:0016246 |
BP |
RNA interference |
| 607 |
green4 |
53 |
1.6e-03 |
1.000 |
2 |
GO:0060216 |
BP |
definitive hemopoiesis |
| 608 |
green4 |
53 |
1.9e-03 |
1.000 |
2 |
GO:0004602 |
MF |
glutathione peroxidase activity |
| 609 |
green4 |
53 |
2.2e-03 |
1.000 |
3 |
GO:0060337 |
BP |
type I interferon signaling pathway |
| 610 |
green4 |
53 |
2.2e-03 |
1.000 |
3 |
GO:0071357 |
BP |
cellular response to type I interferon |
| 611 |
greenyellow |
208 |
1.8e-04 |
1.000 |
2 |
GO:1900235 |
BP |
negative regulation of Kit signaling pathway |
| 612 |
greenyellow |
208 |
5.4e-04 |
1.000 |
2 |
GO:0005896 |
CC |
interleukin-6 receptor complex |
| 613 |
greenyellow |
208 |
7.8e-04 |
1.000 |
3 |
GO:0000786 |
CC |
nucleosome |
| 614 |
greenyellow |
208 |
9.6e-04 |
1.000 |
4 |
GO:0005310 |
MF |
dicarboxylic acid transmembrane transporter activity |
| 615 |
greenyellow |
208 |
1.1e-03 |
1.000 |
2 |
GO:0038109 |
BP |
Kit signaling pathway |
| 616 |
greenyellow |
208 |
1.1e-03 |
1.000 |
2 |
GO:0000788 |
CC |
nuclear nucleosome |
| 617 |
greenyellow |
208 |
1.8e-03 |
1.000 |
2 |
GO:1904778 |
BP |
positive regulation of protein localization to cell cortex |
| 618 |
greenyellow |
208 |
1.8e-03 |
1.000 |
2 |
GO:0045569 |
MF |
TRAIL binding |
| 619 |
greenyellow |
208 |
2.3e-03 |
1.000 |
3 |
GO:0031069 |
BP |
hair follicle morphogenesis |
| 620 |
greenyellow |
208 |
2.6e-03 |
1.000 |
2 |
GO:0051902 |
BP |
negative regulation of mitochondrial depolarization |
| 621 |
grey |
78 |
1.2e-03 |
1.000 |
2 |
GO:0045945 |
BP |
positive regulation of transcription by RNA polymerase III |
| 622 |
grey |
78 |
4.9e-03 |
1.000 |
2 |
GO:0051787 |
MF |
misfolded protein binding |
| 623 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0002270 |
BP |
plasmacytoid dendritic cell activation |
| 624 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0006478 |
BP |
peptidyl-tyrosine sulfation |
| 625 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0016122 |
BP |
xanthophyll metabolic process |
| 626 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0033488 |
BP |
cholesterol biosynthetic process via 24,25-dihydrolanosterol |
| 627 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:1903720 |
BP |
negative regulation of I-kappaB phosphorylation |
| 628 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0036502 |
CC |
Derlin-1-VIMP complex |
| 629 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0008398 |
MF |
sterol 14-demethylase activity |
| 630 |
grey |
78 |
5.3e-03 |
1.000 |
1 |
GO:0008476 |
MF |
protein-tyrosine sulfotransferase activity |
| 631 |
grey60 |
142 |
5.0e-04 |
1.000 |
2 |
GO:0003431 |
BP |
growth plate cartilage chondrocyte development |
| 632 |
grey60 |
142 |
9.0e-04 |
1.000 |
3 |
GO:0071294 |
BP |
cellular response to zinc ion |
| 633 |
grey60 |
142 |
2.6e-03 |
1.000 |
3 |
GO:0045022 |
BP |
early endosome to late endosome transport |
| 634 |
grey60 |
142 |
3.6e-03 |
1.000 |
2 |
GO:1990403 |
BP |
embryonic brain development |
| 635 |
grey60 |
142 |
4.5e-03 |
1.000 |
7 |
GO:0001818 |
BP |
negative regulation of cytokine production |
| 636 |
grey60 |
142 |
5.2e-03 |
1.000 |
2 |
GO:0031581 |
BP |
hemidesmosome assembly |
| 637 |
grey60 |
142 |
5.5e-03 |
1.000 |
10 |
GO:0048037 |
MF |
cofactor binding |
| 638 |
grey60 |
142 |
6.2e-03 |
1.000 |
2 |
GO:0010273 |
BP |
detoxification of copper ion |
| 639 |
grey60 |
142 |
6.2e-03 |
1.000 |
2 |
GO:0060253 |
BP |
negative regulation of glial cell proliferation |
| 640 |
grey60 |
142 |
7.1e-03 |
1.000 |
2 |
GO:0006004 |
BP |
fucose metabolic process |
| 641 |
honeydew |
59 |
1.4e-03 |
1.000 |
2 |
GO:0038111 |
BP |
interleukin-7-mediated signaling pathway |
| 642 |
honeydew |
59 |
2.1e-03 |
1.000 |
2 |
GO:0042135 |
BP |
neurotransmitter catabolic process |
| 643 |
honeydew |
59 |
2.6e-03 |
1.000 |
2 |
GO:2000678 |
BP |
negative regulation of transcription regulatory region DNA binding |
| 644 |
honeydew |
59 |
3.2e-03 |
1.000 |
2 |
GO:0098761 |
BP |
cellular response to interleukin-7 |
| 645 |
honeydew |
59 |
4.0e-03 |
1.000 |
1 |
GO:0018979 |
BP |
trichloroethylene metabolic process |
| 646 |
honeydew |
59 |
4.0e-03 |
1.000 |
1 |
GO:0036304 |
BP |
umbilical cord morphogenesis |
| 647 |
honeydew |
59 |
4.0e-03 |
1.000 |
1 |
GO:0051102 |
BP |
DNA ligation involved in DNA recombination |
| 648 |
honeydew |
59 |
4.0e-03 |
1.000 |
1 |
GO:2000820 |
BP |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| 649 |
honeydew |
59 |
4.0e-03 |
1.000 |
1 |
GO:0004969 |
MF |
histamine receptor activity |
| 650 |
honeydew |
59 |
5.2e-03 |
1.000 |
3 |
GO:0006892 |
BP |
post-Golgi vesicle-mediated transport |
| 651 |
honeydew1 |
69 |
3.5e-04 |
1.000 |
3 |
GO:0043403 |
BP |
skeletal muscle tissue regeneration |
| 652 |
honeydew1 |
69 |
6.2e-04 |
1.000 |
2 |
GO:0035947 |
BP |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter |
| 653 |
honeydew1 |
69 |
7.7e-04 |
1.000 |
5 |
GO:0065004 |
BP |
protein-DNA complex assembly |
| 654 |
honeydew1 |
69 |
8.5e-04 |
1.000 |
5 |
GO:0046328 |
BP |
regulation of JNK cascade |
| 655 |
honeydew1 |
69 |
1.2e-03 |
1.000 |
4 |
GO:0010906 |
BP |
regulation of glucose metabolic process |
| 656 |
honeydew1 |
69 |
1.4e-03 |
1.000 |
2 |
GO:1900402 |
BP |
regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter |
| 657 |
honeydew1 |
69 |
1.6e-03 |
1.000 |
5 |
GO:0007254 |
BP |
JNK cascade |
| 658 |
honeydew1 |
69 |
1.9e-03 |
1.000 |
8 |
GO:0003712 |
MF |
transcription coregulator activity |
| 659 |
honeydew1 |
69 |
2.0e-03 |
1.000 |
2 |
GO:0050908 |
BP |
detection of light stimulus involved in visual perception |
| 660 |
honeydew1 |
69 |
2.0e-03 |
1.000 |
2 |
GO:0001222 |
MF |
transcription corepressor binding |
| 661 |
indianred |
28 |
5.1e-04 |
1.000 |
2 |
GO:0051497 |
BP |
negative regulation of stress fiber assembly |
| 662 |
indianred |
28 |
6.3e-04 |
1.000 |
2 |
GO:0032232 |
BP |
negative regulation of actin filament bundle assembly |
| 663 |
indianred |
28 |
8.4e-04 |
1.000 |
4 |
GO:2000146 |
BP |
negative regulation of cell motility |
| 664 |
indianred |
28 |
1.0e-03 |
1.000 |
4 |
GO:0040029 |
BP |
regulation of gene expression, epigenetic |
| 665 |
indianred |
28 |
1.3e-03 |
1.000 |
4 |
GO:0051271 |
BP |
negative regulation of cellular component movement |
| 666 |
indianred |
28 |
1.5e-03 |
1.000 |
4 |
GO:0040013 |
BP |
negative regulation of locomotion |
| 667 |
indianred |
28 |
1.7e-03 |
1.000 |
2 |
GO:0034405 |
BP |
response to fluid shear stress |
| 668 |
indianred |
28 |
1.8e-03 |
1.000 |
2 |
GO:0046688 |
BP |
response to copper ion |
| 669 |
indianred |
28 |
1.9e-03 |
1.000 |
1 |
GO:0000256 |
BP |
allantoin catabolic process |
| 670 |
indianred |
28 |
1.9e-03 |
1.000 |
1 |
GO:1903492 |
BP |
response to acetylsalicylate |
| 671 |
indianred1 |
34 |
2.2e-03 |
1.000 |
5 |
GO:0016569 |
BP |
covalent chromatin modification |
| 672 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0036268 |
BP |
swimming |
| 673 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0061921 |
BP |
peptidyl-lysine propionylation |
| 674 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0140067 |
BP |
peptidyl-lysine butyrylation |
| 675 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:2000805 |
BP |
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled |
| 676 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0044715 |
MF |
8-oxo-dGDP phosphatase activity |
| 677 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0061920 |
MF |
protein propionyltransferase activity |
| 678 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0140065 |
MF |
peptide butyryltransferase activity |
| 679 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0140068 |
MF |
histone crotonyltransferase activity |
| 680 |
indianred1 |
34 |
2.4e-03 |
1.000 |
1 |
GO:0140069 |
MF |
histone butyryltransferase activity |
| 681 |
indianred2 |
50 |
3.5e-04 |
1.000 |
3 |
GO:0016706 |
MF |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors |
| 682 |
indianred2 |
50 |
3.8e-04 |
1.000 |
8 |
GO:0048812 |
BP |
neuron projection morphogenesis |
| 683 |
indianred2 |
50 |
4.7e-04 |
1.000 |
6 |
GO:0045666 |
BP |
positive regulation of neuron differentiation |
| 684 |
indianred2 |
50 |
4.7e-04 |
1.000 |
8 |
GO:0048858 |
BP |
cell projection morphogenesis |
| 685 |
indianred2 |
50 |
5.5e-04 |
1.000 |
8 |
GO:0032990 |
BP |
cell part morphogenesis |
| 686 |
indianred2 |
50 |
9.4e-04 |
1.000 |
5 |
GO:0010976 |
BP |
positive regulation of neuron projection development |
| 687 |
indianred2 |
50 |
1.1e-03 |
1.000 |
7 |
GO:0048667 |
BP |
cell morphogenesis involved in neuron differentiation |
| 688 |
indianred2 |
50 |
1.6e-03 |
1.000 |
2 |
GO:0061003 |
BP |
positive regulation of dendritic spine morphogenesis |
| 689 |
indianred2 |
50 |
1.8e-03 |
1.000 |
6 |
GO:0050769 |
BP |
positive regulation of neurogenesis |
| 690 |
indianred2 |
50 |
1.8e-03 |
1.000 |
3 |
GO:0050772 |
BP |
positive regulation of axonogenesis |
| 691 |
indianred3 |
55 |
3.4e-03 |
1.000 |
2 |
GO:0018200 |
BP |
peptidyl-glutamic acid modification |
| 692 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0001080 |
BP |
nitrogen catabolite activation of transcription from RNA polymerase II promoter |
| 693 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0034255 |
BP |
regulation of urea metabolic process |
| 694 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0035445 |
BP |
borate transmembrane transport |
| 695 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0038185 |
BP |
intracellular bile acid receptor signaling pathway |
| 696 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0046203 |
BP |
spermidine catabolic process |
| 697 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0046713 |
BP |
borate transport |
| 698 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0070267 |
BP |
oncosis |
| 699 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:0071602 |
BP |
phytosphingosine biosynthetic process |
| 700 |
indianred3 |
55 |
3.8e-03 |
1.000 |
1 |
GO:1901307 |
BP |
positive regulation of spermidine biosynthetic process |
| 701 |
indianred4 |
64 |
3.5e-04 |
1.000 |
2 |
GO:0098909 |
BP |
regulation of cardiac muscle cell action potential involved in regulation of contraction |
| 702 |
indianred4 |
64 |
9.1e-04 |
1.000 |
2 |
GO:1901077 |
BP |
regulation of relaxation of muscle |
| 703 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0090226 |
BP |
regulation of microtubule nucleation by Ran protein signal transduction |
| 704 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0098905 |
BP |
regulation of bundle of His cell action potential |
| 705 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0106089 |
BP |
negative regulation of cell adhesion involved in sprouting angiogenesis |
| 706 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:1901557 |
BP |
response to fenofibrate |
| 707 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:1990744 |
BP |
primary miRNA methylation |
| 708 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0031511 |
CC |
Mis6-Sim4 complex |
| 709 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0061828 |
CC |
apical tubulobulbar complex |
| 710 |
indianred4 |
64 |
4.2e-03 |
1.000 |
1 |
GO:0061829 |
CC |
basal tubulobulbar complex |
| 711 |
ivory |
91 |
7.1e-04 |
1.000 |
2 |
GO:0031666 |
BP |
positive regulation of lipopolysaccharide-mediated signaling pathway |
| 712 |
ivory |
91 |
1.7e-03 |
1.000 |
23 |
GO:0032268 |
BP |
regulation of cellular protein metabolic process |
| 713 |
ivory |
91 |
2.0e-03 |
1.000 |
24 |
GO:0051246 |
BP |
regulation of protein metabolic process |
| 714 |
ivory |
91 |
3.9e-03 |
1.000 |
2 |
GO:0007289 |
BP |
spermatid nucleus differentiation |
| 715 |
ivory |
91 |
4.4e-03 |
1.000 |
2 |
GO:0031664 |
BP |
regulation of lipopolysaccharide-mediated signaling pathway |
| 716 |
ivory |
91 |
4.9e-03 |
1.000 |
2 |
GO:0048305 |
BP |
immunoglobulin secretion |
| 717 |
ivory |
91 |
5.2e-03 |
1.000 |
16 |
GO:0051247 |
BP |
positive regulation of protein metabolic process |
| 718 |
ivory |
91 |
5.5e-03 |
1.000 |
5 |
GO:0007281 |
BP |
germ cell development |
| 719 |
ivory |
91 |
5.9e-03 |
1.000 |
1 |
GO:0002470 |
BP |
plasmacytoid dendritic cell antigen processing and presentation |
| 720 |
ivory |
91 |
5.9e-03 |
1.000 |
1 |
GO:0061445 |
BP |
endocardial cushion cell fate commitment |
| 721 |
lavender |
35 |
5.4e-05 |
0.980 |
2 |
GO:0002175 |
BP |
protein localization to paranode region of axon |
| 722 |
lavender |
35 |
5.4e-05 |
0.980 |
2 |
GO:0071205 |
BP |
protein localization to juxtaparanode region of axon |
| 723 |
lavender |
35 |
1.1e-04 |
1.000 |
2 |
GO:0030913 |
BP |
paranodal junction assembly |
| 724 |
lavender |
35 |
1.1e-04 |
1.000 |
2 |
GO:0033270 |
CC |
paranode region of axon |
| 725 |
lavender |
35 |
1.9e-04 |
1.000 |
2 |
GO:0099612 |
BP |
protein localization to axon |
| 726 |
lavender |
35 |
4.3e-04 |
1.000 |
10 |
GO:0030030 |
BP |
cell projection organization |
| 727 |
lavender |
35 |
9.0e-04 |
1.000 |
2 |
GO:0032288 |
BP |
myelin assembly |
| 728 |
lavender |
35 |
1.1e-03 |
1.000 |
7 |
GO:0030334 |
BP |
regulation of cell migration |
| 729 |
lavender |
35 |
1.4e-03 |
1.000 |
4 |
GO:0034329 |
BP |
cell junction assembly |
| 730 |
lavender |
35 |
1.6e-03 |
1.000 |
7 |
GO:2000145 |
BP |
regulation of cell motility |
| 731 |
lavenderblush |
34 |
9.3e-05 |
1.000 |
2 |
GO:0097371 |
MF |
MDM2/MDM4 family protein binding |
| 732 |
lavenderblush |
34 |
2.2e-03 |
1.000 |
1 |
GO:1905590 |
BP |
fibronectin fibril organization |
| 733 |
lavenderblush |
34 |
2.2e-03 |
1.000 |
1 |
GO:0070931 |
CC |
Golgi-associated vesicle lumen |
| 734 |
lavenderblush |
34 |
2.2e-03 |
1.000 |
1 |
GO:0070119 |
MF |
ciliary neurotrophic factor binding |
| 735 |
lavenderblush |
34 |
2.8e-03 |
1.000 |
10 |
GO:0005856 |
CC |
cytoskeleton |
| 736 |
lavenderblush |
34 |
3.7e-03 |
1.000 |
2 |
GO:0031018 |
BP |
endocrine pancreas development |
| 737 |
lavenderblush |
34 |
4.3e-03 |
1.000 |
1 |
GO:0000390 |
BP |
spliceosomal complex disassembly |
| 738 |
lavenderblush |
34 |
4.3e-03 |
1.000 |
1 |
GO:0002384 |
BP |
hepatic immune response |
| 739 |
lavenderblush |
34 |
4.3e-03 |
1.000 |
1 |
GO:0030328 |
BP |
prenylcysteine catabolic process |
| 740 |
lavenderblush |
34 |
4.3e-03 |
1.000 |
1 |
GO:0030329 |
BP |
prenylcysteine metabolic process |
| 741 |
lavenderblush1 |
46 |
9.1e-05 |
1.000 |
2 |
GO:0008611 |
BP |
ether lipid biosynthetic process |
| 742 |
lavenderblush1 |
46 |
1.9e-04 |
1.000 |
2 |
GO:0046485 |
BP |
ether lipid metabolic process |
| 743 |
lavenderblush1 |
46 |
2.5e-04 |
1.000 |
2 |
GO:0006662 |
BP |
glycerol ether metabolic process |
| 744 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0006580 |
BP |
ethanolamine metabolic process |
| 745 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0009104 |
BP |
lipopolysaccharide catabolic process |
| 746 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:1904681 |
BP |
response to 3-methylcholanthrene |
| 747 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0099065 |
CC |
integral component of spine apparatus membrane |
| 748 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0099631 |
CC |
postsynaptic endocytic zone cytoplasmic component |
| 749 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0004313 |
MF |
[acyl-carrier-protein] S-acetyltransferase activity |
| 750 |
lavenderblush1 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0004314 |
MF |
[acyl-carrier-protein] S-malonyltransferase activity |
| 751 |
lavenderblush2 |
63 |
6.4e-05 |
1.000 |
3 |
GO:0071880 |
BP |
adenylate cyclase-activating adrenergic receptor signaling pathway |
| 752 |
lavenderblush2 |
63 |
8.6e-05 |
1.000 |
3 |
GO:0071875 |
BP |
adrenergic receptor signaling pathway |
| 753 |
lavenderblush2 |
63 |
2.3e-04 |
1.000 |
2 |
GO:0003958 |
MF |
NADPH-hemoprotein reductase activity |
| 754 |
lavenderblush2 |
63 |
6.8e-04 |
1.000 |
2 |
GO:0004935 |
MF |
adrenergic receptor activity |
| 755 |
lavenderblush2 |
63 |
7.1e-04 |
1.000 |
5 |
GO:0008016 |
BP |
regulation of heart contraction |
| 756 |
lavenderblush2 |
63 |
9.9e-04 |
1.000 |
2 |
GO:0016653 |
MF |
oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor |
| 757 |
lavenderblush2 |
63 |
1.1e-03 |
1.000 |
5 |
GO:0060047 |
BP |
heart contraction |
| 758 |
lavenderblush2 |
63 |
1.3e-03 |
1.000 |
5 |
GO:0003015 |
BP |
heart process |
| 759 |
lavenderblush2 |
63 |
1.6e-03 |
1.000 |
2 |
GO:0010181 |
MF |
FMN binding |
| 760 |
lavenderblush2 |
63 |
2.0e-03 |
1.000 |
2 |
GO:0046655 |
BP |
folic acid metabolic process |
| 761 |
lavenderblush3 |
76 |
1.6e-03 |
1.000 |
3 |
GO:0008375 |
MF |
acetylglucosaminyltransferase activity |
| 762 |
lavenderblush3 |
76 |
2.5e-03 |
1.000 |
2 |
GO:0016442 |
CC |
RISC complex |
| 763 |
lavenderblush3 |
76 |
2.5e-03 |
1.000 |
2 |
GO:0005521 |
MF |
lamin binding |
| 764 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0001698 |
BP |
gastrin-induced gastric acid secretion |
| 765 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0010780 |
BP |
meiotic DNA double-strand break formation involved in reciprocal meiotic recombination |
| 766 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0070145 |
BP |
mitochondrial asparaginyl-tRNA aminoacylation |
| 767 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0090187 |
BP |
positive regulation of pancreatic juice secretion |
| 768 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0101030 |
BP |
tRNA-guanine transglycosylation |
| 769 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0106047 |
BP |
polyamine deacetylation |
| 770 |
lavenderblush3 |
76 |
5.1e-03 |
1.000 |
1 |
GO:0106048 |
BP |
spermidine deacetylation |
| 771 |
lightblue1 |
29 |
7.3e-04 |
1.000 |
2 |
GO:0046475 |
BP |
glycerophospholipid catabolic process |
| 772 |
lightblue1 |
29 |
8.8e-04 |
1.000 |
2 |
GO:0034369 |
BP |
plasma lipoprotein particle remodeling |
| 773 |
lightblue1 |
29 |
8.8e-04 |
1.000 |
2 |
GO:0031528 |
CC |
microvillus membrane |
| 774 |
lightblue1 |
29 |
1.5e-03 |
1.000 |
2 |
GO:0015695 |
BP |
organic cation transport |
| 775 |
lightblue1 |
29 |
1.6e-03 |
1.000 |
3 |
GO:0008037 |
BP |
cell recognition |
| 776 |
lightblue1 |
29 |
2.0e-03 |
1.000 |
1 |
GO:0002149 |
BP |
hypochlorous acid biosynthetic process |
| 777 |
lightblue1 |
29 |
2.0e-03 |
1.000 |
1 |
GO:0006437 |
BP |
tyrosyl-tRNA aminoacylation |
| 778 |
lightblue1 |
29 |
2.0e-03 |
1.000 |
1 |
GO:0010849 |
BP |
regulation of proton-transporting ATPase activity, rotational mechanism |
| 779 |
lightblue1 |
29 |
2.0e-03 |
1.000 |
1 |
GO:0015920 |
BP |
lipopolysaccharide transport |
| 780 |
lightblue1 |
29 |
2.0e-03 |
1.000 |
1 |
GO:0051086 |
BP |
chaperone mediated protein folding independent of cofactor |
| 781 |
lightblue2 |
34 |
1.9e-03 |
1.000 |
2 |
GO:0032205 |
BP |
negative regulation of telomere maintenance |
| 782 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0030209 |
BP |
dermatan sulfate catabolic process |
| 783 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0030211 |
BP |
heparin catabolic process |
| 784 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0062026 |
BP |
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process |
| 785 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0003940 |
MF |
L-iduronidase activity |
| 786 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0004343 |
MF |
glucosamine 6-phosphate N-acetyltransferase activity |
| 787 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:0004838 |
MF |
L-tyrosine:2-oxoglutarate aminotransferase activity |
| 788 |
lightblue2 |
34 |
2.2e-03 |
1.000 |
1 |
GO:1990444 |
MF |
F-box domain binding |
| 789 |
lightblue2 |
34 |
2.4e-03 |
1.000 |
2 |
GO:0042162 |
MF |
telomeric DNA binding |
| 790 |
lightblue2 |
34 |
2.9e-03 |
1.000 |
2 |
GO:0016233 |
BP |
telomere capping |
| 791 |
lightblue3 |
46 |
2.2e-03 |
1.000 |
2 |
GO:0097431 |
CC |
mitotic spindle pole |
| 792 |
lightblue3 |
46 |
2.5e-03 |
1.000 |
2 |
GO:0045777 |
BP |
positive regulation of blood pressure |
| 793 |
lightblue3 |
46 |
2.7e-03 |
1.000 |
2 |
GO:0032094 |
BP |
response to food |
| 794 |
lightblue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0003311 |
BP |
pancreatic D cell differentiation |
| 795 |
lightblue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0090104 |
BP |
pancreatic epsilon cell differentiation |
| 796 |
lightblue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0035805 |
CC |
egg coat |
| 797 |
lightblue3 |
46 |
2.8e-03 |
1.000 |
1 |
GO:0098595 |
CC |
perivitelline space |
| 798 |
lightblue3 |
46 |
4.2e-03 |
1.000 |
2 |
GO:0030669 |
CC |
clathrin-coated endocytic vesicle membrane |
| 799 |
lightblue3 |
46 |
5.5e-03 |
1.000 |
2 |
GO:0035036 |
BP |
sperm-egg recognition |
| 800 |
lightblue3 |
46 |
5.5e-03 |
1.000 |
1 |
GO:0010734 |
BP |
negative regulation of protein glutathionylation |
| 801 |
lightblue4 |
53 |
3.3e-04 |
1.000 |
2 |
GO:0048755 |
BP |
branching morphogenesis of a nerve |
| 802 |
lightblue4 |
53 |
4.2e-04 |
1.000 |
2 |
GO:1990909 |
CC |
Wnt signalosome |
| 803 |
lightblue4 |
53 |
6.1e-04 |
1.000 |
3 |
GO:0022029 |
BP |
telencephalon cell migration |
| 804 |
lightblue4 |
53 |
6.4e-04 |
1.000 |
2 |
GO:0021535 |
BP |
cell migration in hindbrain |
| 805 |
lightblue4 |
53 |
6.5e-04 |
1.000 |
3 |
GO:0021885 |
BP |
forebrain cell migration |
| 806 |
lightblue4 |
53 |
7.8e-04 |
1.000 |
4 |
GO:0061351 |
BP |
neural precursor cell proliferation |
| 807 |
lightblue4 |
53 |
1.1e-03 |
1.000 |
5 |
GO:0021700 |
BP |
developmental maturation |
| 808 |
lightblue4 |
53 |
1.4e-03 |
1.000 |
3 |
GO:0007193 |
BP |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| 809 |
lightblue4 |
53 |
1.6e-03 |
1.000 |
2 |
GO:0097440 |
CC |
apical dendrite |
| 810 |
lightblue4 |
53 |
2.0e-03 |
1.000 |
3 |
GO:2000177 |
BP |
regulation of neural precursor cell proliferation |
| 811 |
lightcoral |
66 |
1.1e-04 |
1.000 |
2 |
GO:0002865 |
BP |
negative regulation of acute inflammatory response to antigenic stimulus |
| 812 |
lightcoral |
66 |
2.7e-04 |
1.000 |
2 |
GO:0098837 |
CC |
postsynaptic recycling endosome |
| 813 |
lightcoral |
66 |
3.8e-04 |
1.000 |
2 |
GO:0002862 |
BP |
negative regulation of inflammatory response to antigenic stimulus |
| 814 |
lightcoral |
66 |
3.8e-04 |
1.000 |
2 |
GO:0150094 |
BP |
amyloid-beta clearance by cellular catabolic process |
| 815 |
lightcoral |
66 |
8.0e-04 |
1.000 |
2 |
GO:0002674 |
BP |
negative regulation of acute inflammatory response |
| 816 |
lightcoral |
66 |
8.0e-04 |
1.000 |
2 |
GO:0098845 |
CC |
postsynaptic endosome |
| 817 |
lightcoral |
66 |
9.8e-04 |
1.000 |
2 |
GO:0005652 |
CC |
nuclear lamina |
| 818 |
lightcoral |
66 |
1.0e-03 |
1.000 |
4 |
GO:0030968 |
BP |
endoplasmic reticulum unfolded protein response |
| 819 |
lightcoral |
66 |
1.0e-03 |
1.000 |
3 |
GO:0071398 |
BP |
cellular response to fatty acid |
| 820 |
lightcoral |
66 |
1.2e-03 |
1.000 |
3 |
GO:0050994 |
BP |
regulation of lipid catabolic process |
| 821 |
lightcyan |
141 |
1.2e-04 |
1.000 |
3 |
GO:0005952 |
CC |
cAMP-dependent protein kinase complex |
| 822 |
lightcyan |
141 |
1.2e-04 |
1.000 |
7 |
GO:0031023 |
BP |
microtubule organizing center organization |
| 823 |
lightcyan |
141 |
2.5e-04 |
1.000 |
2 |
GO:0071001 |
CC |
U4/U6 snRNP |
| 824 |
lightcyan |
141 |
2.6e-04 |
1.000 |
4 |
GO:0007099 |
BP |
centriole replication |
| 825 |
lightcyan |
141 |
2.6e-04 |
1.000 |
5 |
GO:0051298 |
BP |
centrosome duplication |
| 826 |
lightcyan |
141 |
2.7e-04 |
1.000 |
27 |
GO:0006508 |
BP |
proteolysis |
| 827 |
lightcyan |
141 |
3.2e-04 |
1.000 |
4 |
GO:0098534 |
BP |
centriole assembly |
| 828 |
lightcyan |
141 |
4.9e-04 |
1.000 |
6 |
GO:0043280 |
BP |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| 829 |
lightcyan |
141 |
5.0e-04 |
1.000 |
2 |
GO:0090611 |
BP |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway |
| 830 |
lightcyan |
141 |
6.2e-04 |
1.000 |
6 |
GO:0007098 |
BP |
centrosome cycle |
| 831 |
lightcyan1 |
96 |
1.7e-04 |
1.000 |
7 |
GO:0019882 |
BP |
antigen processing and presentation |
| 832 |
lightcyan1 |
96 |
2.4e-04 |
1.000 |
2 |
GO:0032010 |
CC |
phagolysosome |
| 833 |
lightcyan1 |
96 |
4.9e-04 |
1.000 |
6 |
GO:0048002 |
BP |
antigen processing and presentation of peptide antigen |
| 834 |
lightcyan1 |
96 |
6.1e-04 |
1.000 |
2 |
GO:0002118 |
BP |
aggressive behavior |
| 835 |
lightcyan1 |
96 |
6.1e-04 |
1.000 |
2 |
GO:0008172 |
MF |
S-methyltransferase activity |
| 836 |
lightcyan1 |
96 |
8.5e-04 |
1.000 |
2 |
GO:0016176 |
MF |
superoxide-generating NADPH oxidase activator activity |
| 837 |
lightcyan1 |
96 |
1.7e-03 |
1.000 |
4 |
GO:0019886 |
BP |
antigen processing and presentation of exogenous peptide antigen via MHC class II |
| 838 |
lightcyan1 |
96 |
1.8e-03 |
1.000 |
4 |
GO:0002495 |
BP |
antigen processing and presentation of peptide antigen via MHC class II |
| 839 |
lightcyan1 |
96 |
1.9e-03 |
1.000 |
4 |
GO:0002504 |
BP |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| 840 |
lightcyan1 |
96 |
2.2e-03 |
1.000 |
2 |
GO:0043020 |
CC |
NADPH oxidase complex |
| 841 |
lightgreen |
139 |
1.5e-04 |
1.000 |
4 |
GO:0032924 |
BP |
activin receptor signaling pathway |
| 842 |
lightgreen |
139 |
2.4e-04 |
1.000 |
2 |
GO:0018636 |
MF |
phenanthrene 9,10-monooxygenase activity |
| 843 |
lightgreen |
139 |
2.5e-04 |
1.000 |
3 |
GO:0060841 |
BP |
venous blood vessel development |
| 844 |
lightgreen |
139 |
2.5e-04 |
1.000 |
3 |
GO:0048185 |
MF |
activin binding |
| 845 |
lightgreen |
139 |
4.9e-04 |
1.000 |
2 |
GO:0071395 |
BP |
cellular response to jasmonic acid stimulus |
| 846 |
lightgreen |
139 |
4.9e-04 |
1.000 |
2 |
GO:0047115 |
MF |
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
| 847 |
lightgreen |
139 |
5.4e-04 |
1.000 |
3 |
GO:0032925 |
BP |
regulation of activin receptor signaling pathway |
| 848 |
lightgreen |
139 |
7.5e-04 |
1.000 |
3 |
GO:0006379 |
BP |
mRNA cleavage |
| 849 |
lightgreen |
139 |
8.0e-04 |
1.000 |
2 |
GO:0047086 |
MF |
ketosteroid monooxygenase activity |
| 850 |
lightgreen |
139 |
8.7e-04 |
1.000 |
3 |
GO:0001945 |
BP |
lymph vessel development |
| 851 |
lightpink |
29 |
5.1e-04 |
1.000 |
2 |
GO:0001223 |
MF |
transcription coactivator binding |
| 852 |
lightpink |
29 |
5.6e-04 |
1.000 |
4 |
GO:0019318 |
BP |
hexose metabolic process |
| 853 |
lightpink |
29 |
9.4e-04 |
1.000 |
4 |
GO:0005996 |
BP |
monosaccharide metabolic process |
| 854 |
lightpink |
29 |
9.9e-04 |
1.000 |
2 |
GO:0031624 |
MF |
ubiquitin conjugating enzyme binding |
| 855 |
lightpink |
29 |
1.2e-03 |
1.000 |
2 |
GO:0044390 |
MF |
ubiquitin-like protein conjugating enzyme binding |
| 856 |
lightpink |
29 |
1.9e-03 |
1.000 |
1 |
GO:0072366 |
BP |
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter |
| 857 |
lightpink |
29 |
2.2e-03 |
1.000 |
2 |
GO:0001221 |
MF |
transcription cofactor binding |
| 858 |
lightpink |
29 |
2.4e-03 |
1.000 |
5 |
GO:0005975 |
BP |
carbohydrate metabolic process |
| 859 |
lightpink |
29 |
2.4e-03 |
1.000 |
2 |
GO:0004879 |
MF |
nuclear receptor activity |
| 860 |
lightpink |
29 |
2.4e-03 |
1.000 |
2 |
GO:0098531 |
MF |
transcription factor activity, direct ligand regulated sequence-specific DNA binding |
| 861 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0002276 |
BP |
basophil activation involved in immune response |
| 862 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0045575 |
BP |
basophil activation |
| 863 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0099551 |
BP |
trans-synaptic signaling by neuropeptide, modulating synaptic transmission |
| 864 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0030735 |
MF |
carnosine N-methyltransferase activity |
| 865 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0031073 |
MF |
cholesterol 26-hydroxylase activity |
| 866 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0047749 |
MF |
cholestanetriol 26-monooxygenase activity |
| 867 |
lightpink1 |
47 |
3.1e-03 |
1.000 |
1 |
GO:0060175 |
MF |
brain-derived neurotrophic factor-activated receptor activity |
| 868 |
lightpink1 |
47 |
3.2e-03 |
1.000 |
2 |
GO:0048011 |
BP |
neurotrophin TRK receptor signaling pathway |
| 869 |
lightpink1 |
47 |
4.2e-03 |
1.000 |
2 |
GO:0038179 |
BP |
neurotrophin signaling pathway |
| 870 |
lightpink1 |
47 |
4.2e-03 |
1.000 |
2 |
GO:0043276 |
BP |
anoikis |
| 871 |
lightpink2 |
49 |
8.4e-04 |
1.000 |
3 |
GO:0046782 |
BP |
regulation of viral transcription |
| 872 |
lightpink2 |
49 |
1.1e-03 |
1.000 |
3 |
GO:0000792 |
CC |
heterochromatin |
| 873 |
lightpink2 |
49 |
1.9e-03 |
1.000 |
2 |
GO:1903203 |
BP |
regulation of oxidative stress-induced neuron death |
| 874 |
lightpink2 |
49 |
2.1e-03 |
1.000 |
2 |
GO:0036475 |
BP |
neuron death in response to oxidative stress |
| 875 |
lightpink2 |
49 |
2.3e-03 |
1.000 |
2 |
GO:0032897 |
BP |
negative regulation of viral transcription |
| 876 |
lightpink2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0003131 |
BP |
mesodermal-endodermal cell signaling |
| 877 |
lightpink2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0006062 |
BP |
sorbitol catabolic process |
| 878 |
lightpink2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0034150 |
BP |
toll-like receptor 6 signaling pathway |
| 879 |
lightpink2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0035978 |
BP |
histone H2A-S139 phosphorylation |
| 880 |
lightpink2 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0051160 |
BP |
L-xylitol catabolic process |
| 881 |
lightpink3 |
62 |
1.5e-06 |
0.028 |
7 |
GO:0010469 |
BP |
regulation of signaling receptor activity |
| 882 |
lightpink3 |
62 |
1.7e-05 |
0.310 |
2 |
GO:0046177 |
BP |
D-gluconate catabolic process |
| 883 |
lightpink3 |
62 |
3.0e-05 |
0.550 |
3 |
GO:0035855 |
BP |
megakaryocyte development |
| 884 |
lightpink3 |
62 |
1.9e-04 |
1.000 |
3 |
GO:2000310 |
BP |
regulation of NMDA receptor activity |
| 885 |
lightpink3 |
62 |
2.5e-04 |
1.000 |
2 |
GO:0004972 |
MF |
NMDA glutamate receptor activity |
| 886 |
lightpink3 |
62 |
3.1e-04 |
1.000 |
3 |
GO:2000273 |
BP |
positive regulation of signaling receptor activity |
| 887 |
lightpink3 |
62 |
4.8e-04 |
1.000 |
3 |
GO:0008328 |
CC |
ionotropic glutamate receptor complex |
| 888 |
lightpink3 |
62 |
6.0e-04 |
1.000 |
2 |
GO:0017146 |
CC |
NMDA selective glutamate receptor complex |
| 889 |
lightpink3 |
62 |
1.3e-03 |
1.000 |
2 |
GO:0004970 |
MF |
ionotropic glutamate receptor activity |
| 890 |
lightpink3 |
62 |
1.3e-03 |
1.000 |
3 |
GO:1900449 |
BP |
regulation of glutamate receptor signaling pathway |
| 891 |
lightpink4 |
76 |
4.7e-04 |
1.000 |
2 |
GO:0034464 |
CC |
BBSome |
| 892 |
lightpink4 |
76 |
4.8e-04 |
1.000 |
4 |
GO:0046620 |
BP |
regulation of organ growth |
| 893 |
lightpink4 |
76 |
8.0e-04 |
1.000 |
2 |
GO:0002091 |
BP |
negative regulation of receptor internalization |
| 894 |
lightpink4 |
76 |
1.1e-03 |
1.000 |
4 |
GO:0003158 |
BP |
endothelium development |
| 895 |
lightpink4 |
76 |
2.0e-03 |
1.000 |
2 |
GO:0015125 |
MF |
bile acid transmembrane transporter activity |
| 896 |
lightpink4 |
76 |
2.3e-03 |
1.000 |
2 |
GO:0010181 |
MF |
FMN binding |
| 897 |
lightpink4 |
76 |
2.3e-03 |
1.000 |
4 |
GO:0042737 |
BP |
drug catabolic process |
| 898 |
lightpink4 |
76 |
3.3e-03 |
1.000 |
2 |
GO:0048261 |
BP |
negative regulation of receptor-mediated endocytosis |
| 899 |
lightpink4 |
76 |
3.7e-03 |
1.000 |
2 |
GO:0086064 |
BP |
cell communication by electrical coupling involved in cardiac conduction |
| 900 |
lightpink4 |
76 |
4.8e-03 |
1.000 |
1 |
GO:0003294 |
BP |
atrial ventricular junction remodeling |
| 901 |
lightskyblue2 |
29 |
2.4e-04 |
1.000 |
4 |
GO:0030027 |
CC |
lamellipodium |
| 902 |
lightskyblue2 |
29 |
3.0e-04 |
1.000 |
3 |
GO:0042136 |
BP |
neurotransmitter biosynthetic process |
| 903 |
lightskyblue2 |
29 |
4.1e-04 |
1.000 |
4 |
GO:0000287 |
MF |
magnesium ion binding |
| 904 |
lightskyblue2 |
29 |
1.1e-03 |
1.000 |
3 |
GO:0042133 |
BP |
neurotransmitter metabolic process |
| 905 |
lightskyblue2 |
29 |
1.3e-03 |
1.000 |
2 |
GO:0008266 |
MF |
poly(U) RNA binding |
| 906 |
lightskyblue2 |
29 |
1.6e-03 |
1.000 |
2 |
GO:0008187 |
MF |
poly-pyrimidine tract binding |
| 907 |
lightskyblue2 |
29 |
1.9e-03 |
1.000 |
1 |
GO:0006571 |
BP |
tyrosine biosynthetic process |
| 908 |
lightskyblue2 |
29 |
1.9e-03 |
1.000 |
1 |
GO:0008292 |
BP |
acetylcholine biosynthetic process |
| 909 |
lightskyblue2 |
29 |
1.9e-03 |
1.000 |
1 |
GO:0014739 |
BP |
positive regulation of muscle hyperplasia |
| 910 |
lightskyblue2 |
29 |
1.9e-03 |
1.000 |
1 |
GO:0032475 |
BP |
otolith formation |
| 911 |
lightskyblue3 |
35 |
1.9e-04 |
1.000 |
2 |
GO:0006122 |
BP |
mitochondrial electron transport, ubiquinol to cytochrome c |
| 912 |
lightskyblue3 |
35 |
1.6e-03 |
1.000 |
2 |
GO:2000781 |
BP |
positive regulation of double-strand break repair |
| 913 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0000160 |
BP |
phosphorelay signal transduction system |
| 914 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0033388 |
BP |
putrescine biosynthetic process from arginine |
| 915 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0033389 |
BP |
putrescine biosynthetic process from arginine, using agmatinase |
| 916 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0034059 |
BP |
response to anoxia |
| 917 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0071454 |
BP |
cellular response to anoxia |
| 918 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0099627 |
BP |
neurotransmitter receptor cycle |
| 919 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0099630 |
BP |
postsynaptic neurotransmitter receptor cycle |
| 920 |
lightskyblue3 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0004686 |
MF |
elongation factor-2 kinase activity |
| 921 |
lightskyblue4 |
47 |
2.5e-05 |
0.450 |
2 |
GO:0031302 |
CC |
intrinsic component of endosome membrane |
| 922 |
lightskyblue4 |
47 |
5.4e-04 |
1.000 |
2 |
GO:0010314 |
MF |
phosphatidylinositol-5-phosphate binding |
| 923 |
lightskyblue4 |
47 |
2.4e-03 |
1.000 |
2 |
GO:0070273 |
MF |
phosphatidylinositol-4-phosphate binding |
| 924 |
lightskyblue4 |
47 |
2.8e-03 |
1.000 |
2 |
GO:0019825 |
MF |
oxygen binding |
| 925 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0003226 |
BP |
right ventricular compact myocardium morphogenesis |
| 926 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0007174 |
BP |
epidermal growth factor catabolic process |
| 927 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0009789 |
BP |
positive regulation of abscisic acid-activated signaling pathway |
| 928 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0010814 |
BP |
substance P catabolic process |
| 929 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0010816 |
BP |
calcitonin catabolic process |
| 930 |
lightskyblue4 |
47 |
2.9e-03 |
1.000 |
1 |
GO:0034959 |
BP |
endothelin maturation |
| 931 |
lightslateblue |
56 |
1.0e-03 |
1.000 |
4 |
GO:0006606 |
BP |
protein import into nucleus |
| 932 |
lightslateblue |
56 |
1.6e-03 |
1.000 |
4 |
GO:0051170 |
BP |
import into nucleus |
| 933 |
lightslateblue |
56 |
2.1e-03 |
1.000 |
2 |
GO:0071800 |
BP |
podosome assembly |
| 934 |
lightslateblue |
56 |
2.8e-03 |
1.000 |
2 |
GO:0007202 |
BP |
activation of phospholipase C activity |
| 935 |
lightslateblue |
56 |
2.9e-03 |
1.000 |
3 |
GO:0032231 |
BP |
regulation of actin filament bundle assembly |
| 936 |
lightslateblue |
56 |
3.0e-03 |
1.000 |
4 |
GO:0017038 |
BP |
protein import |
| 937 |
lightslateblue |
56 |
3.4e-03 |
1.000 |
3 |
GO:0003727 |
MF |
single-stranded RNA binding |
| 938 |
lightslateblue |
56 |
3.6e-03 |
1.000 |
1 |
GO:0003065 |
BP |
positive regulation of heart rate by epinephrine |
| 939 |
lightslateblue |
56 |
3.6e-03 |
1.000 |
1 |
GO:0009088 |
BP |
threonine biosynthetic process |
| 940 |
lightslateblue |
56 |
3.6e-03 |
1.000 |
1 |
GO:0021623 |
BP |
oculomotor nerve formation |
| 941 |
lightsteelblue |
66 |
4.5e-05 |
0.820 |
3 |
GO:1900153 |
BP |
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| 942 |
lightsteelblue |
66 |
1.2e-04 |
1.000 |
2 |
GO:0032286 |
BP |
central nervous system myelin maintenance |
| 943 |
lightsteelblue |
66 |
8.5e-04 |
1.000 |
2 |
GO:0060213 |
BP |
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| 944 |
lightsteelblue |
66 |
9.7e-04 |
1.000 |
3 |
GO:0061014 |
BP |
positive regulation of mRNA catabolic process |
| 945 |
lightsteelblue |
66 |
1.1e-03 |
1.000 |
3 |
GO:0045652 |
BP |
regulation of megakaryocyte differentiation |
| 946 |
lightsteelblue |
66 |
1.2e-03 |
1.000 |
2 |
GO:0043217 |
BP |
myelin maintenance |
| 947 |
lightsteelblue |
66 |
2.0e-03 |
1.000 |
2 |
GO:0050765 |
BP |
negative regulation of phagocytosis |
| 948 |
lightsteelblue |
66 |
2.2e-03 |
1.000 |
2 |
GO:1904706 |
BP |
negative regulation of vascular smooth muscle cell proliferation |
| 949 |
lightsteelblue |
66 |
2.3e-03 |
1.000 |
3 |
GO:0000288 |
BP |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| 950 |
lightsteelblue |
66 |
2.5e-03 |
1.000 |
3 |
GO:0030219 |
BP |
megakaryocyte differentiation |
| 951 |
lightsteelblue1 |
95 |
2.1e-04 |
1.000 |
3 |
GO:0021801 |
BP |
cerebral cortex radial glia guided migration |
| 952 |
lightsteelblue1 |
95 |
2.5e-04 |
1.000 |
3 |
GO:0046639 |
BP |
negative regulation of alpha-beta T cell differentiation |
| 953 |
lightsteelblue1 |
95 |
4.9e-04 |
1.000 |
3 |
GO:0021799 |
BP |
cerebral cortex radially oriented cell migration |
| 954 |
lightsteelblue1 |
95 |
7.9e-04 |
1.000 |
2 |
GO:0017151 |
MF |
DEAD/H-box RNA helicase binding |
| 955 |
lightsteelblue1 |
95 |
9.3e-04 |
1.000 |
3 |
GO:0046636 |
BP |
negative regulation of alpha-beta T cell activation |
| 956 |
lightsteelblue1 |
95 |
1.1e-03 |
1.000 |
6 |
GO:0042445 |
BP |
hormone metabolic process |
| 957 |
lightsteelblue1 |
95 |
1.2e-03 |
1.000 |
4 |
GO:0021549 |
BP |
cerebellum development |
| 958 |
lightsteelblue1 |
95 |
1.3e-03 |
1.000 |
3 |
GO:0045581 |
BP |
negative regulation of T cell differentiation |
| 959 |
lightsteelblue1 |
95 |
1.3e-03 |
1.000 |
2 |
GO:0060872 |
BP |
semicircular canal development |
| 960 |
lightsteelblue1 |
95 |
1.6e-03 |
1.000 |
3 |
GO:0021795 |
BP |
cerebral cortex cell migration |
| 961 |
lightyellow |
146 |
9.1e-04 |
1.000 |
2 |
GO:0042824 |
CC |
MHC class I peptide loading complex |
| 962 |
lightyellow |
146 |
1.9e-03 |
1.000 |
2 |
GO:0071316 |
BP |
cellular response to nicotine |
| 963 |
lightyellow |
146 |
1.9e-03 |
1.000 |
2 |
GO:1990247 |
MF |
N6-methyladenosine-containing RNA binding |
| 964 |
lightyellow |
146 |
1.9e-03 |
1.000 |
3 |
GO:0050690 |
BP |
regulation of defense response to virus by virus |
| 965 |
lightyellow |
146 |
4.2e-03 |
1.000 |
3 |
GO:0008188 |
MF |
neuropeptide receptor activity |
| 966 |
lightyellow |
146 |
5.4e-03 |
1.000 |
3 |
GO:0008536 |
MF |
Ran GTPase binding |
| 967 |
lightyellow |
146 |
5.7e-03 |
1.000 |
2 |
GO:0032433 |
CC |
filopodium tip |
| 968 |
lightyellow |
146 |
6.7e-03 |
1.000 |
2 |
GO:0019885 |
BP |
antigen processing and presentation of endogenous peptide antigen via MHC class I |
| 969 |
lightyellow |
146 |
6.7e-03 |
1.000 |
2 |
GO:0030506 |
MF |
ankyrin binding |
| 970 |
lightyellow |
146 |
8.9e-03 |
1.000 |
2 |
GO:0034375 |
BP |
high-density lipoprotein particle remodeling |
| 971 |
magenta |
221 |
6.2e-04 |
1.000 |
2 |
GO:1905024 |
BP |
regulation of membrane repolarization during ventricular cardiac muscle cell action potential |
| 972 |
magenta |
221 |
9.6e-04 |
1.000 |
3 |
GO:0005847 |
CC |
mRNA cleavage and polyadenylation specificity factor complex |
| 973 |
magenta |
221 |
1.2e-03 |
1.000 |
2 |
GO:1905031 |
BP |
regulation of membrane repolarization during cardiac muscle cell action potential |
| 974 |
magenta |
221 |
1.2e-03 |
1.000 |
2 |
GO:0044194 |
CC |
cytolytic granule |
| 975 |
magenta |
221 |
1.7e-03 |
1.000 |
3 |
GO:0005849 |
CC |
mRNA cleavage factor complex |
| 976 |
magenta |
221 |
2.0e-03 |
1.000 |
2 |
GO:0046958 |
BP |
nonassociative learning |
| 977 |
magenta |
221 |
2.0e-03 |
1.000 |
2 |
GO:0051725 |
BP |
protein de-ADP-ribosylation |
| 978 |
magenta |
221 |
2.6e-03 |
1.000 |
19 |
GO:0098655 |
BP |
cation transmembrane transport |
| 979 |
magenta |
221 |
2.9e-03 |
1.000 |
17 |
GO:0098662 |
BP |
inorganic cation transmembrane transport |
| 980 |
magenta |
221 |
3.0e-03 |
1.000 |
2 |
GO:0007191 |
BP |
adenylate cyclase-activating dopamine receptor signaling pathway |
| 981 |
magenta1 |
32 |
2.0e-03 |
1.000 |
1 |
GO:0033316 |
BP |
meiotic spindle assembly checkpoint |
| 982 |
magenta1 |
32 |
2.0e-03 |
1.000 |
1 |
GO:0045818 |
BP |
negative regulation of glycogen catabolic process |
| 983 |
magenta1 |
32 |
2.0e-03 |
1.000 |
1 |
GO:1903096 |
BP |
protein localization to meiotic spindle midzone |
| 984 |
magenta1 |
32 |
2.0e-03 |
1.000 |
1 |
GO:0036501 |
CC |
UFD1-NPL4 complex |
| 985 |
magenta1 |
32 |
3.8e-03 |
1.000 |
3 |
GO:0009124 |
BP |
nucleoside monophosphate biosynthetic process |
| 986 |
magenta1 |
32 |
4.0e-03 |
1.000 |
1 |
GO:0072344 |
BP |
rescue of stalled ribosome |
| 987 |
magenta1 |
32 |
4.0e-03 |
1.000 |
1 |
GO:1900220 |
BP |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis |
| 988 |
magenta1 |
32 |
4.0e-03 |
1.000 |
1 |
GO:1902103 |
BP |
negative regulation of metaphase/anaphase transition of meiotic cell cycle |
| 989 |
magenta1 |
32 |
4.0e-03 |
1.000 |
1 |
GO:1902437 |
BP |
positive regulation of male mating behavior |
| 990 |
magenta1 |
32 |
4.0e-03 |
1.000 |
1 |
GO:1990116 |
BP |
ribosome-associated ubiquitin-dependent protein catabolic process |
| 991 |
magenta2 |
39 |
2.6e-03 |
1.000 |
1 |
GO:0071584 |
BP |
negative regulation of zinc ion transmembrane import |
| 992 |
magenta2 |
39 |
2.6e-03 |
1.000 |
1 |
GO:0071585 |
BP |
detoxification of cadmium ion |
| 993 |
magenta2 |
39 |
2.6e-03 |
1.000 |
1 |
GO:0047263 |
MF |
N-acylsphingosine galactosyltransferase activity |
| 994 |
magenta2 |
39 |
2.6e-03 |
1.000 |
1 |
GO:1990081 |
MF |
trimethylamine receptor activity |
| 995 |
magenta2 |
39 |
3.8e-03 |
1.000 |
4 |
GO:0007606 |
BP |
sensory perception of chemical stimulus |
| 996 |
magenta2 |
39 |
4.0e-03 |
1.000 |
2 |
GO:0099061 |
CC |
integral component of postsynaptic density membrane |
| 997 |
magenta2 |
39 |
5.1e-03 |
1.000 |
1 |
GO:0007147 |
BP |
female meiosis II |
| 998 |
magenta2 |
39 |
5.1e-03 |
1.000 |
1 |
GO:0071579 |
BP |
regulation of zinc ion transport |
| 999 |
magenta2 |
39 |
5.1e-03 |
1.000 |
1 |
GO:0004021 |
MF |
L-alanine:2-oxoglutarate aminotransferase activity |
| 1000 |
magenta2 |
39 |
5.1e-03 |
1.000 |
1 |
GO:0004971 |
MF |
AMPA glutamate receptor activity |
| 1001 |
magenta3 |
54 |
9.1e-05 |
1.000 |
3 |
GO:0070979 |
BP |
protein K11-linked ubiquitination |
| 1002 |
magenta3 |
54 |
2.4e-04 |
1.000 |
2 |
GO:0085020 |
BP |
protein K6-linked ubiquitination |
| 1003 |
magenta3 |
54 |
8.6e-04 |
1.000 |
3 |
GO:0030521 |
BP |
androgen receptor signaling pathway |
| 1004 |
magenta3 |
54 |
9.4e-04 |
1.000 |
6 |
GO:0043161 |
BP |
proteasome-mediated ubiquitin-dependent protein catabolic process |
| 1005 |
magenta3 |
54 |
1.3e-03 |
1.000 |
3 |
GO:0031145 |
BP |
anaphase-promoting complex-dependent catabolic process |
| 1006 |
magenta3 |
54 |
1.5e-03 |
1.000 |
2 |
GO:0045830 |
BP |
positive regulation of isotype switching |
| 1007 |
magenta3 |
54 |
1.8e-03 |
1.000 |
6 |
GO:0010498 |
BP |
proteasomal protein catabolic process |
| 1008 |
magenta3 |
54 |
1.9e-03 |
1.000 |
2 |
GO:0005680 |
CC |
anaphase-promoting complex |
| 1009 |
magenta3 |
54 |
2.3e-03 |
1.000 |
2 |
GO:0007628 |
BP |
adult walking behavior |
| 1010 |
magenta3 |
54 |
2.5e-03 |
1.000 |
2 |
GO:0090659 |
BP |
walking behavior |
| 1011 |
magenta4 |
60 |
6.9e-04 |
1.000 |
3 |
GO:0036297 |
BP |
interstrand cross-link repair |
| 1012 |
magenta4 |
60 |
1.4e-03 |
1.000 |
2 |
GO:0006590 |
BP |
thyroid hormone generation |
| 1013 |
magenta4 |
60 |
2.3e-03 |
1.000 |
2 |
GO:0042403 |
BP |
thyroid hormone metabolic process |
| 1014 |
magenta4 |
60 |
2.3e-03 |
1.000 |
2 |
GO:0051307 |
BP |
meiotic chromosome separation |
| 1015 |
magenta4 |
60 |
3.5e-03 |
1.000 |
3 |
GO:0018958 |
BP |
phenol-containing compound metabolic process |
| 1016 |
magenta4 |
60 |
3.7e-03 |
1.000 |
2 |
GO:0043325 |
MF |
phosphatidylinositol-3,4-bisphosphate binding |
| 1017 |
magenta4 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0001207 |
BP |
histone displacement |
| 1018 |
magenta4 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0003285 |
BP |
septum secundum development |
| 1019 |
magenta4 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0003290 |
BP |
atrial septum secundum morphogenesis |
| 1020 |
magenta4 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0006435 |
BP |
threonyl-tRNA aminoacylation |
| 1021 |
maroon |
75 |
7.4e-05 |
1.000 |
2 |
GO:0004465 |
MF |
lipoprotein lipase activity |
| 1022 |
maroon |
75 |
8.2e-04 |
1.000 |
4 |
GO:0004620 |
MF |
phospholipase activity |
| 1023 |
maroon |
75 |
8.7e-04 |
1.000 |
2 |
GO:0034372 |
BP |
very-low-density lipoprotein particle remodeling |
| 1024 |
maroon |
75 |
1.1e-03 |
1.000 |
2 |
GO:0034370 |
BP |
triglyceride-rich lipoprotein particle remodeling |
| 1025 |
maroon |
75 |
1.4e-03 |
1.000 |
3 |
GO:0050661 |
MF |
NADP binding |
| 1026 |
maroon |
75 |
1.9e-03 |
1.000 |
4 |
GO:0016298 |
MF |
lipase activity |
| 1027 |
maroon |
75 |
2.5e-03 |
1.000 |
2 |
GO:0034375 |
BP |
high-density lipoprotein particle remodeling |
| 1028 |
maroon |
75 |
2.6e-03 |
1.000 |
6 |
GO:0016042 |
BP |
lipid catabolic process |
| 1029 |
maroon |
75 |
2.8e-03 |
1.000 |
2 |
GO:0034185 |
MF |
apolipoprotein binding |
| 1030 |
maroon |
75 |
3.0e-03 |
1.000 |
4 |
GO:0008201 |
MF |
heparin binding |
| 1031 |
mediumorchid |
72 |
1.2e-03 |
1.000 |
2 |
GO:2000194 |
BP |
regulation of female gonad development |
| 1032 |
mediumorchid |
72 |
1.3e-03 |
1.000 |
11 |
GO:0008092 |
MF |
cytoskeletal protein binding |
| 1033 |
mediumorchid |
72 |
2.4e-03 |
1.000 |
12 |
GO:0015630 |
CC |
microtubule cytoskeleton |
| 1034 |
mediumorchid |
72 |
2.6e-03 |
1.000 |
9 |
GO:0005815 |
CC |
microtubule organizing center |
| 1035 |
mediumorchid |
72 |
2.7e-03 |
1.000 |
20 |
GO:0008104 |
BP |
protein localization |
| 1036 |
mediumorchid |
72 |
3.2e-03 |
1.000 |
17 |
GO:0005856 |
CC |
cytoskeleton |
| 1037 |
mediumorchid |
72 |
3.5e-03 |
1.000 |
3 |
GO:0060998 |
BP |
regulation of dendritic spine development |
| 1038 |
mediumorchid |
72 |
3.8e-03 |
1.000 |
4 |
GO:0051017 |
BP |
actin filament bundle assembly |
| 1039 |
mediumorchid |
72 |
3.9e-03 |
1.000 |
4 |
GO:0061572 |
BP |
actin filament bundle organization |
| 1040 |
mediumorchid |
72 |
4.1e-03 |
1.000 |
2 |
GO:0045956 |
BP |
positive regulation of calcium ion-dependent exocytosis |
| 1041 |
mediumorchid3 |
31 |
2.0e-03 |
1.000 |
1 |
GO:0097222 |
BP |
mitochondrial mRNA polyadenylation |
| 1042 |
mediumorchid3 |
31 |
2.0e-03 |
1.000 |
1 |
GO:0004654 |
MF |
polyribonucleotide nucleotidyltransferase activity |
| 1043 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0000962 |
BP |
positive regulation of mitochondrial RNA catabolic process |
| 1044 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0035928 |
BP |
rRNA import into mitochondrion |
| 1045 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0090615 |
BP |
mitochondrial mRNA processing |
| 1046 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:2000627 |
BP |
positive regulation of miRNA catabolic process |
| 1047 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0019008 |
CC |
molybdopterin synthase complex |
| 1048 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0045025 |
CC |
mitochondrial degradosome |
| 1049 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:0030366 |
MF |
molybdopterin synthase activity |
| 1050 |
mediumorchid3 |
31 |
4.0e-03 |
1.000 |
1 |
GO:1990174 |
MF |
phosphodiesterase decapping endonuclease activity |
| 1051 |
mediumorchid4 |
34 |
4.5e-04 |
1.000 |
2 |
GO:1901317 |
BP |
regulation of flagellated sperm motility |
| 1052 |
mediumorchid4 |
34 |
8.5e-04 |
1.000 |
2 |
GO:0010667 |
BP |
negative regulation of cardiac muscle cell apoptotic process |
| 1053 |
mediumorchid4 |
34 |
9.2e-04 |
1.000 |
6 |
GO:0030003 |
BP |
cellular cation homeostasis |
| 1054 |
mediumorchid4 |
34 |
9.4e-04 |
1.000 |
8 |
GO:0048878 |
BP |
chemical homeostasis |
| 1055 |
mediumorchid4 |
34 |
9.4e-04 |
1.000 |
2 |
GO:0006541 |
BP |
glutamine metabolic process |
| 1056 |
mediumorchid4 |
34 |
1.0e-03 |
1.000 |
6 |
GO:0006873 |
BP |
cellular ion homeostasis |
| 1057 |
mediumorchid4 |
34 |
1.0e-03 |
1.000 |
2 |
GO:0048240 |
BP |
sperm capacitation |
| 1058 |
mediumorchid4 |
34 |
1.1e-03 |
1.000 |
2 |
GO:0010664 |
BP |
negative regulation of striated muscle cell apoptotic process |
| 1059 |
mediumorchid4 |
34 |
1.7e-03 |
1.000 |
6 |
GO:0055080 |
BP |
cation homeostasis |
| 1060 |
mediumorchid4 |
34 |
1.8e-03 |
1.000 |
4 |
GO:0021700 |
BP |
developmental maturation |
| 1061 |
mediumpurple |
48 |
1.2e-04 |
1.000 |
3 |
GO:1900015 |
BP |
regulation of cytokine production involved in inflammatory response |
| 1062 |
mediumpurple |
48 |
1.6e-04 |
1.000 |
3 |
GO:0002534 |
BP |
cytokine production involved in inflammatory response |
| 1063 |
mediumpurple |
48 |
3.5e-04 |
1.000 |
2 |
GO:0019206 |
MF |
nucleoside kinase activity |
| 1064 |
mediumpurple |
48 |
6.4e-04 |
1.000 |
2 |
GO:0043217 |
BP |
myelin maintenance |
| 1065 |
mediumpurple |
48 |
6.7e-04 |
1.000 |
3 |
GO:0002532 |
BP |
production of molecular mediator involved in inflammatory response |
| 1066 |
mediumpurple |
48 |
1.0e-03 |
1.000 |
2 |
GO:1900016 |
BP |
negative regulation of cytokine production involved in inflammatory response |
| 1067 |
mediumpurple |
48 |
1.2e-03 |
1.000 |
4 |
GO:0005798 |
CC |
Golgi-associated vesicle |
| 1068 |
mediumpurple |
48 |
2.9e-03 |
1.000 |
2 |
GO:0031624 |
MF |
ubiquitin conjugating enzyme binding |
| 1069 |
mediumpurple |
48 |
3.2e-03 |
1.000 |
1 |
GO:0001815 |
BP |
positive regulation of antibody-dependent cellular cytotoxicity |
| 1070 |
mediumpurple |
48 |
3.2e-03 |
1.000 |
1 |
GO:0008617 |
BP |
guanosine metabolic process |
| 1071 |
mediumpurple1 |
54 |
2.0e-04 |
1.000 |
2 |
GO:0016936 |
MF |
galactoside binding |
| 1072 |
mediumpurple1 |
54 |
2.8e-04 |
1.000 |
2 |
GO:0043305 |
BP |
negative regulation of mast cell degranulation |
| 1073 |
mediumpurple1 |
54 |
4.7e-04 |
1.000 |
2 |
GO:0033007 |
BP |
negative regulation of mast cell activation involved in immune response |
| 1074 |
mediumpurple1 |
54 |
8.5e-04 |
1.000 |
2 |
GO:0033004 |
BP |
negative regulation of mast cell activation |
| 1075 |
mediumpurple1 |
54 |
1.1e-03 |
1.000 |
3 |
GO:0032387 |
BP |
negative regulation of intracellular transport |
| 1076 |
mediumpurple1 |
54 |
1.2e-03 |
1.000 |
2 |
GO:0006388 |
BP |
tRNA splicing, via endonucleolytic cleavage and ligation |
| 1077 |
mediumpurple1 |
54 |
2.3e-03 |
1.000 |
18 |
GO:0033036 |
BP |
macromolecule localization |
| 1078 |
mediumpurple1 |
54 |
3.7e-03 |
1.000 |
1 |
GO:0000296 |
BP |
spermine transport |
| 1079 |
mediumpurple1 |
54 |
3.7e-03 |
1.000 |
1 |
GO:0003029 |
BP |
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling |
| 1080 |
mediumpurple1 |
54 |
3.7e-03 |
1.000 |
1 |
GO:0006557 |
BP |
S-adenosylmethioninamine biosynthetic process |
| 1081 |
mediumpurple2 |
63 |
1.8e-05 |
0.320 |
2 |
GO:2001076 |
BP |
positive regulation of metanephric ureteric bud development |
| 1082 |
mediumpurple2 |
63 |
1.1e-04 |
1.000 |
2 |
GO:2000346 |
BP |
negative regulation of hepatocyte proliferation |
| 1083 |
mediumpurple2 |
63 |
1.7e-04 |
1.000 |
2 |
GO:0007356 |
BP |
thorax and anterior abdomen determination |
| 1084 |
mediumpurple2 |
63 |
1.7e-04 |
1.000 |
2 |
GO:0035502 |
BP |
metanephric part of ureteric bud development |
| 1085 |
mediumpurple2 |
63 |
2.3e-04 |
1.000 |
6 |
GO:2000027 |
BP |
regulation of animal organ morphogenesis |
| 1086 |
mediumpurple2 |
63 |
2.6e-04 |
1.000 |
2 |
GO:0007354 |
BP |
zygotic determination of anterior/posterior axis, embryo |
| 1087 |
mediumpurple2 |
63 |
4.9e-04 |
1.000 |
2 |
GO:0044597 |
BP |
daunorubicin metabolic process |
| 1088 |
mediumpurple2 |
63 |
4.9e-04 |
1.000 |
2 |
GO:0044598 |
BP |
doxorubicin metabolic process |
| 1089 |
mediumpurple2 |
63 |
4.9e-04 |
1.000 |
2 |
GO:0060539 |
BP |
diaphragm development |
| 1090 |
mediumpurple2 |
63 |
9.5e-04 |
1.000 |
2 |
GO:2000345 |
BP |
regulation of hepatocyte proliferation |
| 1091 |
mediumpurple3 |
99 |
4.3e-04 |
1.000 |
2 |
GO:0035617 |
BP |
stress granule disassembly |
| 1092 |
mediumpurple3 |
99 |
1.2e-03 |
1.000 |
3 |
GO:0015872 |
BP |
dopamine transport |
| 1093 |
mediumpurple3 |
99 |
2.8e-03 |
1.000 |
2 |
GO:0000463 |
BP |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| 1094 |
mediumpurple3 |
99 |
3.3e-03 |
1.000 |
2 |
GO:0016018 |
MF |
cyclosporin A binding |
| 1095 |
mediumpurple3 |
99 |
3.6e-03 |
1.000 |
12 |
GO:0006887 |
BP |
exocytosis |
| 1096 |
mediumpurple3 |
99 |
4.2e-03 |
1.000 |
3 |
GO:0042273 |
BP |
ribosomal large subunit biogenesis |
| 1097 |
mediumpurple3 |
99 |
5.6e-03 |
1.000 |
2 |
GO:0000470 |
BP |
maturation of LSU-rRNA |
| 1098 |
mediumpurple3 |
99 |
5.6e-03 |
1.000 |
2 |
GO:0097440 |
CC |
apical dendrite |
| 1099 |
mediumpurple3 |
99 |
6.2e-03 |
1.000 |
4 |
GO:0003774 |
MF |
motor activity |
| 1100 |
mediumpurple3 |
99 |
6.3e-03 |
1.000 |
2 |
GO:0008329 |
MF |
signaling pattern recognition receptor activity |
| 1101 |
mediumpurple4 |
52 |
2.9e-04 |
1.000 |
2 |
GO:0031441 |
BP |
negative regulation of mRNA 3’-end processing |
| 1102 |
mediumpurple4 |
52 |
9.2e-04 |
1.000 |
2 |
GO:0008595 |
BP |
anterior/posterior axis specification, embryo |
| 1103 |
mediumpurple4 |
52 |
2.3e-03 |
1.000 |
2 |
GO:0031440 |
BP |
regulation of mRNA 3’-end processing |
| 1104 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:0003167 |
BP |
atrioventricular bundle cell differentiation |
| 1105 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:0098989 |
BP |
NMDA selective glutamate receptor signaling pathway |
| 1106 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:1903893 |
BP |
positive regulation of ATF6-mediated unfolded protein response |
| 1107 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:1904268 |
BP |
positive regulation of Schwann cell chemotaxis |
| 1108 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:0015538 |
MF |
sialic acid:proton symporter activity |
| 1109 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:0016844 |
MF |
strictosidine synthase activity |
| 1110 |
mediumpurple4 |
52 |
3.3e-03 |
1.000 |
1 |
GO:0086038 |
MF |
calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential |
| 1111 |
midnightblue |
140 |
2.5e-04 |
1.000 |
2 |
GO:0000379 |
BP |
tRNA-type intron splice site recognition and cleavage |
| 1112 |
midnightblue |
140 |
2.6e-04 |
1.000 |
3 |
GO:0008278 |
CC |
cohesin complex |
| 1113 |
midnightblue |
140 |
3.9e-04 |
1.000 |
3 |
GO:0060307 |
BP |
regulation of ventricular cardiac muscle cell membrane repolarization |
| 1114 |
midnightblue |
140 |
4.8e-04 |
1.000 |
7 |
GO:0016829 |
MF |
lyase activity |
| 1115 |
midnightblue |
140 |
5.0e-04 |
1.000 |
2 |
GO:0071611 |
BP |
granulocyte colony-stimulating factor production |
| 1116 |
midnightblue |
140 |
5.0e-04 |
1.000 |
2 |
GO:0000214 |
CC |
tRNA-intron endonuclease complex |
| 1117 |
midnightblue |
140 |
5.0e-04 |
1.000 |
2 |
GO:0000213 |
MF |
tRNA-intron endonuclease activity |
| 1118 |
midnightblue |
140 |
5.0e-04 |
1.000 |
2 |
GO:0050649 |
MF |
testosterone 6-beta-hydroxylase activity |
| 1119 |
midnightblue |
140 |
6.7e-04 |
1.000 |
3 |
GO:0099625 |
BP |
ventricular cardiac muscle cell membrane repolarization |
| 1120 |
midnightblue |
140 |
6.7e-04 |
1.000 |
3 |
GO:0035371 |
CC |
microtubule plus-end |
| 1121 |
mistyrose |
48 |
7.3e-04 |
1.000 |
2 |
GO:0042910 |
MF |
xenobiotic transmembrane transporter activity |
| 1122 |
mistyrose |
48 |
1.4e-03 |
1.000 |
6 |
GO:0010008 |
CC |
endosome membrane |
| 1123 |
mistyrose |
48 |
3.1e-03 |
1.000 |
1 |
GO:1900753 |
BP |
doxorubicin transport |
| 1124 |
mistyrose |
48 |
3.1e-03 |
1.000 |
1 |
GO:1903772 |
BP |
regulation of viral budding via host ESCRT complex |
| 1125 |
mistyrose |
48 |
3.1e-03 |
1.000 |
1 |
GO:1903774 |
BP |
positive regulation of viral budding via host ESCRT complex |
| 1126 |
mistyrose |
48 |
3.1e-03 |
1.000 |
1 |
GO:0043160 |
CC |
acrosomal lumen |
| 1127 |
mistyrose |
48 |
3.1e-03 |
1.000 |
1 |
GO:0005369 |
MF |
taurine:sodium symporter activity |
| 1128 |
mistyrose |
48 |
4.6e-03 |
1.000 |
3 |
GO:0031902 |
CC |
late endosome membrane |
| 1129 |
mistyrose |
48 |
6.2e-03 |
1.000 |
1 |
GO:0034684 |
CC |
integrin alphav-beta5 complex |
| 1130 |
mistyrose |
48 |
6.2e-03 |
1.000 |
1 |
GO:0097196 |
CC |
Shu complex |
| 1131 |
mistyrose4 |
31 |
9.3e-05 |
1.000 |
2 |
GO:0010739 |
BP |
positive regulation of protein kinase A signaling |
| 1132 |
mistyrose4 |
31 |
1.6e-04 |
1.000 |
2 |
GO:0090037 |
BP |
positive regulation of protein kinase C signaling |
| 1133 |
mistyrose4 |
31 |
4.0e-04 |
1.000 |
2 |
GO:0048311 |
BP |
mitochondrion distribution |
| 1134 |
mistyrose4 |
31 |
4.0e-04 |
1.000 |
2 |
GO:0090036 |
BP |
regulation of protein kinase C signaling |
| 1135 |
mistyrose4 |
31 |
5.3e-04 |
1.000 |
2 |
GO:0010738 |
BP |
regulation of protein kinase A signaling |
| 1136 |
mistyrose4 |
31 |
8.4e-04 |
1.000 |
3 |
GO:0007041 |
BP |
lysosomal transport |
| 1137 |
mistyrose4 |
31 |
1.3e-03 |
1.000 |
2 |
GO:0070528 |
BP |
protein kinase C signaling |
| 1138 |
mistyrose4 |
31 |
1.3e-03 |
1.000 |
2 |
GO:0030140 |
CC |
trans-Golgi network transport vesicle |
| 1139 |
mistyrose4 |
31 |
1.4e-03 |
1.000 |
3 |
GO:0042177 |
BP |
negative regulation of protein catabolic process |
| 1140 |
mistyrose4 |
31 |
1.6e-03 |
1.000 |
2 |
GO:0010737 |
BP |
protein kinase A signaling |
| 1141 |
moccasin |
45 |
4.0e-04 |
1.000 |
2 |
GO:0015347 |
MF |
sodium-independent organic anion transmembrane transporter activity |
| 1142 |
moccasin |
45 |
4.9e-04 |
1.000 |
2 |
GO:0043252 |
BP |
sodium-independent organic anion transport |
| 1143 |
moccasin |
45 |
9.3e-04 |
1.000 |
2 |
GO:0006047 |
BP |
UDP-N-acetylglucosamine metabolic process |
| 1144 |
moccasin |
45 |
2.0e-03 |
1.000 |
2 |
GO:0006085 |
BP |
acetyl-CoA biosynthetic process |
| 1145 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0006049 |
BP |
UDP-N-acetylglucosamine catabolic process |
| 1146 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0006392 |
BP |
transcription elongation from mitochondrial promoter |
| 1147 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0046657 |
BP |
folic acid catabolic process |
| 1148 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0051623 |
BP |
positive regulation of norepinephrine uptake |
| 1149 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0072229 |
BP |
metanephric proximal convoluted tubule development |
| 1150 |
moccasin |
45 |
3.1e-03 |
1.000 |
1 |
GO:0072749 |
BP |
cellular response to cytochalasin B |
| 1151 |
navajowhite |
53 |
5.7e-04 |
1.000 |
3 |
GO:0045171 |
CC |
intercellular bridge |
| 1152 |
navajowhite |
53 |
6.9e-04 |
1.000 |
7 |
GO:0005813 |
CC |
centrosome |
| 1153 |
navajowhite |
53 |
1.0e-03 |
1.000 |
2 |
GO:0005242 |
MF |
inward rectifier potassium channel activity |
| 1154 |
navajowhite |
53 |
1.2e-03 |
1.000 |
8 |
GO:0005815 |
CC |
microtubule organizing center |
| 1155 |
navajowhite |
53 |
1.9e-03 |
1.000 |
10 |
GO:0015630 |
CC |
microtubule cytoskeleton |
| 1156 |
navajowhite |
53 |
1.9e-03 |
1.000 |
2 |
GO:0043138 |
MF |
3’-5’ DNA helicase activity |
| 1157 |
navajowhite |
53 |
3.4e-03 |
1.000 |
6 |
GO:0010720 |
BP |
positive regulation of cell development |
| 1158 |
navajowhite |
53 |
3.5e-03 |
1.000 |
1 |
GO:0030474 |
BP |
spindle pole body duplication |
| 1159 |
navajowhite |
53 |
3.5e-03 |
1.000 |
1 |
GO:0035042 |
BP |
fertilization, exchange of chromosomal proteins |
| 1160 |
navajowhite |
53 |
3.5e-03 |
1.000 |
1 |
GO:0038192 |
BP |
gastric inhibitory peptide signaling pathway |
| 1161 |
navajowhite1 |
60 |
5.2e-04 |
1.000 |
3 |
GO:0060076 |
CC |
excitatory synapse |
| 1162 |
navajowhite1 |
60 |
1.2e-03 |
1.000 |
2 |
GO:0030299 |
BP |
intestinal cholesterol absorption |
| 1163 |
navajowhite1 |
60 |
1.6e-03 |
1.000 |
2 |
GO:0098856 |
BP |
intestinal lipid absorption |
| 1164 |
navajowhite1 |
60 |
1.8e-03 |
1.000 |
2 |
GO:0000062 |
MF |
fatty-acyl-CoA binding |
| 1165 |
navajowhite1 |
60 |
2.0e-03 |
1.000 |
2 |
GO:0044241 |
BP |
lipid digestion |
| 1166 |
navajowhite1 |
60 |
3.1e-03 |
1.000 |
2 |
GO:0035640 |
BP |
exploration behavior |
| 1167 |
navajowhite1 |
60 |
3.7e-03 |
1.000 |
2 |
GO:0005251 |
MF |
delayed rectifier potassium channel activity |
| 1168 |
navajowhite1 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0001081 |
BP |
nitrogen catabolite repression of transcription from RNA polymerase II promoter |
| 1169 |
navajowhite1 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0019085 |
BP |
early viral transcription |
| 1170 |
navajowhite1 |
60 |
4.0e-03 |
1.000 |
1 |
GO:0030103 |
BP |
vasopressin secretion |
| 1171 |
navajowhite2 |
79 |
1.1e-03 |
1.000 |
3 |
GO:0008542 |
BP |
visual learning |
| 1172 |
navajowhite2 |
79 |
1.4e-03 |
1.000 |
7 |
GO:0030133 |
CC |
transport vesicle |
| 1173 |
navajowhite2 |
79 |
1.4e-03 |
1.000 |
3 |
GO:0007632 |
BP |
visual behavior |
| 1174 |
navajowhite2 |
79 |
2.0e-03 |
1.000 |
2 |
GO:0099170 |
BP |
postsynaptic modulation of chemical synaptic transmission |
| 1175 |
navajowhite2 |
79 |
2.8e-03 |
1.000 |
4 |
GO:0097730 |
CC |
non-motile cilium |
| 1176 |
navajowhite2 |
79 |
3.9e-03 |
1.000 |
2 |
GO:0004190 |
MF |
aspartic-type endopeptidase activity |
| 1177 |
navajowhite2 |
79 |
4.3e-03 |
1.000 |
3 |
GO:0008306 |
BP |
associative learning |
| 1178 |
navajowhite2 |
79 |
4.3e-03 |
1.000 |
2 |
GO:0070001 |
MF |
aspartic-type peptidase activity |
| 1179 |
navajowhite2 |
79 |
4.8e-03 |
1.000 |
2 |
GO:0002092 |
BP |
positive regulation of receptor internalization |
| 1180 |
navajowhite2 |
79 |
5.1e-03 |
1.000 |
3 |
GO:0001750 |
CC |
photoreceptor outer segment |
| 1181 |
navajowhite3 |
40 |
1.7e-03 |
1.000 |
7 |
GO:0098657 |
BP |
import into cell |
| 1182 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:0002542 |
BP |
Factor XII activation |
| 1183 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:0014876 |
BP |
response to injury involved in regulation of muscle adaptation |
| 1184 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:0042431 |
BP |
indole metabolic process |
| 1185 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:1901128 |
BP |
gentamycin metabolic process |
| 1186 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:1901247 |
BP |
negative regulation of lung ciliated cell differentiation |
| 1187 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:1901251 |
BP |
positive regulation of lung goblet cell differentiation |
| 1188 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:1901684 |
BP |
arsenate ion transmembrane transport |
| 1189 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:1903660 |
BP |
negative regulation of complement-dependent cytotoxicity |
| 1190 |
navajowhite3 |
40 |
2.7e-03 |
1.000 |
1 |
GO:2000187 |
BP |
positive regulation of phosphate transmembrane transport |
| 1191 |
navajowhite4 |
27 |
1.8e-03 |
1.000 |
1 |
GO:0003868 |
MF |
4-hydroxyphenylpyruvate dioxygenase activity |
| 1192 |
navajowhite4 |
27 |
2.5e-03 |
1.000 |
3 |
GO:0006399 |
BP |
tRNA metabolic process |
| 1193 |
navajowhite4 |
27 |
3.1e-03 |
1.000 |
2 |
GO:0045815 |
BP |
positive regulation of gene expression, epigenetic |
| 1194 |
navajowhite4 |
27 |
3.5e-03 |
1.000 |
2 |
GO:0048306 |
MF |
calcium-dependent protein binding |
| 1195 |
navajowhite4 |
27 |
3.6e-03 |
1.000 |
1 |
GO:0071663 |
BP |
positive regulation of granzyme B production |
| 1196 |
navajowhite4 |
27 |
3.6e-03 |
1.000 |
1 |
GO:0051500 |
MF |
D-tyrosyl-tRNA(Tyr) deacylase activity |
| 1197 |
navajowhite4 |
27 |
5.0e-03 |
1.000 |
5 |
GO:0016032 |
BP |
viral process |
| 1198 |
navajowhite4 |
27 |
5.4e-03 |
1.000 |
1 |
GO:0019050 |
BP |
suppression by virus of host apoptotic process |
| 1199 |
navajowhite4 |
27 |
5.4e-03 |
1.000 |
1 |
GO:0034473 |
BP |
U1 snRNA 3’-end processing |
| 1200 |
navajowhite4 |
27 |
5.4e-03 |
1.000 |
1 |
GO:0034476 |
BP |
U5 snRNA 3’-end processing |
| 1201 |
orange |
131 |
4.0e-04 |
1.000 |
12 |
GO:0043299 |
BP |
leukocyte degranulation |
| 1202 |
orange |
131 |
5.8e-04 |
1.000 |
11 |
GO:0005635 |
CC |
nuclear envelope |
| 1203 |
orange |
131 |
5.9e-04 |
1.000 |
11 |
GO:0043312 |
BP |
neutrophil degranulation |
| 1204 |
orange |
131 |
5.9e-04 |
1.000 |
16 |
GO:0006887 |
BP |
exocytosis |
| 1205 |
orange |
131 |
6.3e-04 |
1.000 |
11 |
GO:0002283 |
BP |
neutrophil activation involved in immune response |
| 1206 |
orange |
131 |
7.5e-04 |
1.000 |
11 |
GO:0002446 |
BP |
neutrophil mediated immunity |
| 1207 |
orange |
131 |
7.7e-04 |
1.000 |
11 |
GO:0042119 |
BP |
neutrophil activation |
| 1208 |
orange |
131 |
1.2e-03 |
1.000 |
13 |
GO:0002366 |
BP |
leukocyte activation involved in immune response |
| 1209 |
orange |
131 |
1.2e-03 |
1.000 |
13 |
GO:0002263 |
BP |
cell activation involved in immune response |
| 1210 |
orange |
131 |
1.4e-03 |
1.000 |
5 |
GO:1904813 |
CC |
ficolin-1-rich granule lumen |
| 1211 |
orange3 |
30 |
1.9e-03 |
1.000 |
1 |
GO:0060212 |
BP |
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| 1212 |
orange3 |
30 |
1.9e-03 |
1.000 |
1 |
GO:1904983 |
BP |
glycine import into mitochondrion |
| 1213 |
orange3 |
30 |
1.9e-03 |
1.000 |
1 |
GO:0042272 |
CC |
nuclear RNA export factor complex |
| 1214 |
orange3 |
30 |
3.7e-03 |
1.000 |
1 |
GO:0032089 |
MF |
NACHT domain binding |
| 1215 |
orange3 |
30 |
5.6e-03 |
1.000 |
1 |
GO:0052905 |
MF |
tRNA (guanine(9)-N(1))-methyltransferase activity |
| 1216 |
orange3 |
30 |
7.5e-03 |
1.000 |
1 |
GO:0008186 |
MF |
RNA-dependent ATPase activity |
| 1217 |
orange3 |
30 |
7.5e-03 |
1.000 |
1 |
GO:0009019 |
MF |
tRNA (guanine-N1-)-methyltransferase activity |
| 1218 |
orange3 |
30 |
7.5e-03 |
1.000 |
1 |
GO:0102953 |
MF |
hypoglycin A gamma-glutamyl transpeptidase activity |
| 1219 |
orange3 |
30 |
7.5e-03 |
1.000 |
1 |
GO:0103068 |
MF |
leukotriene C4 gamma-glutamyl transferase activity |
| 1220 |
orange3 |
30 |
8.2e-03 |
1.000 |
2 |
GO:0032588 |
CC |
trans-Golgi network membrane |
| 1221 |
orange4 |
35 |
4.4e-04 |
1.000 |
2 |
GO:0039535 |
BP |
regulation of RIG-I signaling pathway |
| 1222 |
orange4 |
35 |
5.9e-04 |
1.000 |
2 |
GO:0039529 |
BP |
RIG-I signaling pathway |
| 1223 |
orange4 |
35 |
9.5e-04 |
1.000 |
2 |
GO:0039528 |
BP |
cytoplasmic pattern recognition receptor signaling pathway in response to virus |
| 1224 |
orange4 |
35 |
1.7e-03 |
1.000 |
2 |
GO:0045948 |
BP |
positive regulation of translational initiation |
| 1225 |
orange4 |
35 |
2.1e-03 |
1.000 |
2 |
GO:0061157 |
BP |
mRNA destabilization |
| 1226 |
orange4 |
35 |
2.1e-03 |
1.000 |
2 |
GO:2001240 |
BP |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| 1227 |
orange4 |
35 |
2.1e-03 |
1.000 |
3 |
GO:0017148 |
BP |
negative regulation of translation |
| 1228 |
orange4 |
35 |
2.2e-03 |
1.000 |
2 |
GO:0050779 |
BP |
RNA destabilization |
| 1229 |
orange4 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0034642 |
BP |
mitochondrion migration along actin filament |
| 1230 |
orange4 |
35 |
2.4e-03 |
1.000 |
1 |
GO:0061048 |
BP |
negative regulation of branching involved in lung morphogenesis |
| 1231 |
orangered |
53 |
1.8e-04 |
1.000 |
2 |
GO:0034392 |
BP |
negative regulation of smooth muscle cell apoptotic process |
| 1232 |
orangered |
53 |
7.3e-04 |
1.000 |
3 |
GO:0016328 |
CC |
lateral plasma membrane |
| 1233 |
orangered |
53 |
7.9e-04 |
1.000 |
2 |
GO:0014029 |
BP |
neural crest formation |
| 1234 |
orangered |
53 |
2.5e-03 |
1.000 |
2 |
GO:0034391 |
BP |
regulation of smooth muscle cell apoptotic process |
| 1235 |
orangered |
53 |
3.2e-03 |
1.000 |
2 |
GO:0051019 |
MF |
mitogen-activated protein kinase binding |
| 1236 |
orangered |
53 |
3.5e-03 |
1.000 |
1 |
GO:0002930 |
BP |
trabecular meshwork development |
| 1237 |
orangered |
53 |
3.5e-03 |
1.000 |
1 |
GO:0010424 |
BP |
DNA methylation on cytosine within a CG sequence |
| 1238 |
orangered |
53 |
3.5e-03 |
1.000 |
1 |
GO:0150007 |
BP |
clathrin-dependent synaptic vesicle endocytosis |
| 1239 |
orangered |
53 |
3.5e-03 |
1.000 |
1 |
GO:1902504 |
BP |
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint |
| 1240 |
orangered |
53 |
3.9e-03 |
1.000 |
6 |
GO:0051656 |
BP |
establishment of organelle localization |
| 1241 |
orangered1 |
58 |
6.3e-04 |
1.000 |
2 |
GO:1903140 |
BP |
regulation of establishment of endothelial barrier |
| 1242 |
orangered1 |
58 |
6.3e-04 |
1.000 |
2 |
GO:0033130 |
MF |
acetylcholine receptor binding |
| 1243 |
orangered1 |
58 |
7.7e-04 |
1.000 |
2 |
GO:0015165 |
MF |
pyrimidine nucleotide-sugar transmembrane transporter activity |
| 1244 |
orangered1 |
58 |
9.2e-04 |
1.000 |
2 |
GO:0090481 |
BP |
pyrimidine nucleotide-sugar transmembrane transport |
| 1245 |
orangered1 |
58 |
1.1e-03 |
1.000 |
2 |
GO:0005338 |
MF |
nucleotide-sugar transmembrane transporter activity |
| 1246 |
orangered1 |
58 |
1.1e-03 |
1.000 |
7 |
GO:0010720 |
BP |
positive regulation of cell development |
| 1247 |
orangered1 |
58 |
1.5e-03 |
1.000 |
2 |
GO:0030275 |
MF |
LRR domain binding |
| 1248 |
orangered1 |
58 |
1.5e-03 |
1.000 |
3 |
GO:0050805 |
BP |
negative regulation of synaptic transmission |
| 1249 |
orangered1 |
58 |
1.9e-03 |
1.000 |
2 |
GO:2000269 |
BP |
regulation of fibroblast apoptotic process |
| 1250 |
orangered1 |
58 |
2.1e-03 |
1.000 |
6 |
GO:0050804 |
BP |
modulation of chemical synaptic transmission |
| 1251 |
orangered3 |
71 |
3.3e-04 |
1.000 |
2 |
GO:0002826 |
BP |
negative regulation of T-helper 1 type immune response |
| 1252 |
orangered3 |
71 |
7.4e-04 |
1.000 |
7 |
GO:0030900 |
BP |
forebrain development |
| 1253 |
orangered3 |
71 |
8.0e-04 |
1.000 |
2 |
GO:0099550 |
BP |
trans-synaptic signaling, modulating synaptic transmission |
| 1254 |
orangered3 |
71 |
1.0e-03 |
1.000 |
11 |
GO:0007417 |
BP |
central nervous system development |
| 1255 |
orangered3 |
71 |
1.1e-03 |
1.000 |
15 |
GO:0007267 |
BP |
cell-cell signaling |
| 1256 |
orangered3 |
71 |
1.3e-03 |
1.000 |
4 |
GO:0042471 |
BP |
ear morphogenesis |
| 1257 |
orangered3 |
71 |
1.7e-03 |
1.000 |
2 |
GO:0045410 |
BP |
positive regulation of interleukin-6 biosynthetic process |
| 1258 |
orangered3 |
71 |
1.9e-03 |
1.000 |
6 |
GO:0002237 |
BP |
response to molecule of bacterial origin |
| 1259 |
orangered3 |
71 |
1.9e-03 |
1.000 |
31 |
GO:0005886 |
CC |
plasma membrane |
| 1260 |
orangered3 |
71 |
2.0e-03 |
1.000 |
2 |
GO:0002830 |
BP |
positive regulation of type 2 immune response |
| 1261 |
orangered4 |
97 |
4.1e-05 |
0.750 |
17 |
GO:0051248 |
BP |
negative regulation of protein metabolic process |
| 1262 |
orangered4 |
97 |
9.5e-05 |
1.000 |
5 |
GO:0072341 |
MF |
modified amino acid binding |
| 1263 |
orangered4 |
97 |
1.1e-04 |
1.000 |
26 |
GO:0005576 |
CC |
extracellular region |
| 1264 |
orangered4 |
97 |
1.9e-04 |
1.000 |
4 |
GO:0001786 |
MF |
phosphatidylserine binding |
| 1265 |
orangered4 |
97 |
2.5e-04 |
1.000 |
15 |
GO:0032269 |
BP |
negative regulation of cellular protein metabolic process |
| 1266 |
orangered4 |
97 |
3.0e-04 |
1.000 |
12 |
GO:0006954 |
BP |
inflammatory response |
| 1267 |
orangered4 |
97 |
3.6e-04 |
1.000 |
10 |
GO:0071900 |
BP |
regulation of protein serine/threonine kinase activity |
| 1268 |
orangered4 |
97 |
3.8e-04 |
1.000 |
19 |
GO:0006952 |
BP |
defense response |
| 1269 |
orangered4 |
97 |
5.5e-04 |
1.000 |
27 |
GO:0051246 |
BP |
regulation of protein metabolic process |
| 1270 |
orangered4 |
97 |
5.9e-04 |
1.000 |
2 |
GO:0004767 |
MF |
sphingomyelin phosphodiesterase activity |
| 1271 |
paleturquoise |
113 |
1.6e-04 |
1.000 |
9 |
GO:0009913 |
BP |
epidermal cell differentiation |
| 1272 |
paleturquoise |
113 |
2.7e-04 |
1.000 |
8 |
GO:0030216 |
BP |
keratinocyte differentiation |
| 1273 |
paleturquoise |
113 |
3.3e-04 |
1.000 |
2 |
GO:0048133 |
BP |
male germ-line stem cell asymmetric division |
| 1274 |
paleturquoise |
113 |
3.8e-04 |
1.000 |
4 |
GO:0001533 |
CC |
cornified envelope |
| 1275 |
paleturquoise |
113 |
6.6e-04 |
1.000 |
4 |
GO:0030173 |
CC |
integral component of Golgi membrane |
| 1276 |
paleturquoise |
113 |
8.1e-04 |
1.000 |
4 |
GO:0031228 |
CC |
intrinsic component of Golgi membrane |
| 1277 |
paleturquoise |
113 |
1.0e-03 |
1.000 |
6 |
GO:0031424 |
BP |
keratinization |
| 1278 |
paleturquoise |
113 |
1.4e-03 |
1.000 |
9 |
GO:0008544 |
BP |
epidermis development |
| 1279 |
paleturquoise |
113 |
1.5e-03 |
1.000 |
2 |
GO:0042415 |
BP |
norepinephrine metabolic process |
| 1280 |
paleturquoise |
113 |
2.0e-03 |
1.000 |
6 |
GO:0042393 |
MF |
histone binding |
| 1281 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0015904 |
BP |
tetracycline transport |
| 1282 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0061181 |
BP |
regulation of chondrocyte development |
| 1283 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0005503 |
MF |
all-trans retinal binding |
| 1284 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0008493 |
MF |
tetracycline transmembrane transporter activity |
| 1285 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0019115 |
MF |
benzaldehyde dehydrogenase activity |
| 1286 |
paleturquoise4 |
35 |
2.2e-03 |
1.000 |
1 |
GO:0046570 |
MF |
methylthioribulose 1-phosphate dehydratase activity |
| 1287 |
paleturquoise4 |
35 |
3.0e-03 |
1.000 |
2 |
GO:0008536 |
MF |
Ran GTPase binding |
| 1288 |
paleturquoise4 |
35 |
3.5e-03 |
1.000 |
2 |
GO:0009069 |
BP |
serine family amino acid metabolic process |
| 1289 |
paleturquoise4 |
35 |
4.4e-03 |
1.000 |
1 |
GO:0019264 |
BP |
glycine biosynthetic process from serine |
| 1290 |
paleturquoise4 |
35 |
4.4e-03 |
1.000 |
1 |
GO:0033082 |
BP |
regulation of extrathymic T cell differentiation |
| 1291 |
palevioletred |
47 |
1.9e-03 |
1.000 |
2 |
GO:0032402 |
BP |
melanosome transport |
| 1292 |
palevioletred |
47 |
2.1e-03 |
1.000 |
2 |
GO:0032401 |
BP |
establishment of melanosome localization |
| 1293 |
palevioletred |
47 |
2.1e-03 |
1.000 |
2 |
GO:0051904 |
BP |
pigment granule transport |
| 1294 |
palevioletred |
47 |
2.3e-03 |
1.000 |
2 |
GO:0032400 |
BP |
melanosome localization |
| 1295 |
palevioletred |
47 |
3.2e-03 |
1.000 |
2 |
GO:0007271 |
BP |
synaptic transmission, cholinergic |
| 1296 |
palevioletred |
47 |
3.3e-03 |
1.000 |
1 |
GO:0009107 |
BP |
lipoate biosynthetic process |
| 1297 |
palevioletred |
47 |
3.3e-03 |
1.000 |
1 |
GO:0014057 |
BP |
positive regulation of acetylcholine secretion, neurotransmission |
| 1298 |
palevioletred |
47 |
3.3e-03 |
1.000 |
1 |
GO:0018160 |
BP |
peptidyl-pyrromethane cofactor linkage |
| 1299 |
palevioletred |
47 |
3.3e-03 |
1.000 |
1 |
GO:0034681 |
CC |
integrin alpha11-beta1 complex |
| 1300 |
palevioletred |
47 |
3.3e-03 |
1.000 |
1 |
GO:0003842 |
MF |
1-pyrroline-5-carboxylate dehydrogenase activity |
| 1301 |
palevioletred1 |
50 |
3.0e-03 |
1.000 |
16 |
GO:0031090 |
CC |
organelle membrane |
| 1302 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0002300 |
BP |
CD8-positive, alpha-beta intraepithelial T cell differentiation |
| 1303 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0097036 |
BP |
regulation of plasma membrane sterol distribution |
| 1304 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0098629 |
BP |
trans-Golgi network membrane organization |
| 1305 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0005898 |
CC |
interleukin-13 receptor complex |
| 1306 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0004462 |
MF |
lactoylglutathione lyase activity |
| 1307 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0008112 |
MF |
nicotinamide N-methyltransferase activity |
| 1308 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0008792 |
MF |
arginine decarboxylase activity |
| 1309 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0016515 |
MF |
interleukin-13 receptor activity |
| 1310 |
palevioletred1 |
50 |
3.4e-03 |
1.000 |
1 |
GO:0030760 |
MF |
pyridine N-methyltransferase activity |
| 1311 |
palevioletred2 |
63 |
1.7e-04 |
1.000 |
2 |
GO:0098700 |
BP |
neurotransmitter loading into synaptic vesicle |
| 1312 |
palevioletred2 |
63 |
2.6e-04 |
1.000 |
2 |
GO:0044300 |
CC |
cerebellar mossy fiber |
| 1313 |
palevioletred2 |
63 |
1.1e-03 |
1.000 |
2 |
GO:0001833 |
BP |
inner cell mass cell proliferation |
| 1314 |
palevioletred2 |
63 |
2.3e-03 |
1.000 |
2 |
GO:0001832 |
BP |
blastocyst growth |
| 1315 |
palevioletred2 |
63 |
2.4e-03 |
1.000 |
3 |
GO:0006487 |
BP |
protein N-linked glycosylation |
| 1316 |
palevioletred2 |
63 |
2.9e-03 |
1.000 |
2 |
GO:0006490 |
BP |
oligosaccharide-lipid intermediate biosynthetic process |
| 1317 |
palevioletred2 |
63 |
3.5e-03 |
1.000 |
2 |
GO:0004529 |
MF |
exodeoxyribonuclease activity |
| 1318 |
palevioletred2 |
63 |
4.2e-03 |
1.000 |
2 |
GO:0006817 |
BP |
phosphate ion transport |
| 1319 |
palevioletred2 |
63 |
4.2e-03 |
1.000 |
1 |
GO:0042137 |
BP |
sequestering of neurotransmitter |
| 1320 |
palevioletred2 |
63 |
4.2e-03 |
1.000 |
1 |
GO:0046338 |
BP |
phosphatidylethanolamine catabolic process |
| 1321 |
palevioletred3 |
75 |
7.6e-06 |
0.140 |
5 |
GO:0051893 |
BP |
regulation of focal adhesion assembly |
| 1322 |
palevioletred3 |
75 |
2.9e-05 |
0.530 |
5 |
GO:0048041 |
BP |
focal adhesion assembly |
| 1323 |
palevioletred3 |
75 |
4.9e-05 |
0.890 |
5 |
GO:0034333 |
BP |
adherens junction assembly |
| 1324 |
palevioletred3 |
75 |
5.2e-05 |
0.940 |
5 |
GO:1901888 |
BP |
regulation of cell junction assembly |
| 1325 |
palevioletred3 |
75 |
7.6e-05 |
1.000 |
2 |
GO:0060596 |
BP |
mammary placode formation |
| 1326 |
palevioletred3 |
75 |
7.8e-05 |
1.000 |
5 |
GO:0007044 |
BP |
cell-substrate junction assembly |
| 1327 |
palevioletred3 |
75 |
1.6e-04 |
1.000 |
5 |
GO:0001952 |
BP |
regulation of cell-matrix adhesion |
| 1328 |
palevioletred3 |
75 |
2.9e-04 |
1.000 |
5 |
GO:0034332 |
BP |
adherens junction organization |
| 1329 |
palevioletred3 |
75 |
3.7e-04 |
1.000 |
2 |
GO:0007172 |
BP |
signal complex assembly |
| 1330 |
palevioletred3 |
75 |
5.2e-04 |
1.000 |
2 |
GO:0060592 |
BP |
mammary gland formation |
| 1331 |
pink |
219 |
2.0e-04 |
1.000 |
2 |
GO:0036111 |
BP |
very long-chain fatty-acyl-CoA metabolic process |
| 1332 |
pink |
219 |
7.3e-04 |
1.000 |
3 |
GO:0050811 |
MF |
GABA receptor binding |
| 1333 |
pink |
219 |
1.2e-03 |
1.000 |
2 |
GO:0002023 |
BP |
reduction of food intake in response to dietary excess |
| 1334 |
pink |
219 |
2.9e-03 |
1.000 |
2 |
GO:0002326 |
BP |
B cell lineage commitment |
| 1335 |
pink |
219 |
2.9e-03 |
1.000 |
2 |
GO:0070358 |
BP |
actin polymerization-dependent cell motility |
| 1336 |
pink |
219 |
2.9e-03 |
1.000 |
2 |
GO:2001280 |
BP |
positive regulation of unsaturated fatty acid biosynthetic process |
| 1337 |
pink |
219 |
2.9e-03 |
1.000 |
2 |
GO:0042382 |
CC |
paraspeckles |
| 1338 |
pink |
219 |
5.3e-03 |
1.000 |
2 |
GO:0006621 |
BP |
protein retention in ER lumen |
| 1339 |
pink |
219 |
5.3e-03 |
1.000 |
2 |
GO:0035860 |
BP |
glial cell-derived neurotrophic factor receptor signaling pathway |
| 1340 |
pink |
219 |
6.8e-03 |
1.000 |
2 |
GO:0021877 |
BP |
forebrain neuron fate commitment |
| 1341 |
pink1 |
30 |
4.7e-06 |
0.086 |
5 |
GO:0009898 |
CC |
cytoplasmic side of plasma membrane |
| 1342 |
pink1 |
30 |
9.1e-06 |
0.170 |
5 |
GO:0098562 |
CC |
cytoplasmic side of membrane |
| 1343 |
pink1 |
30 |
4.6e-04 |
1.000 |
2 |
GO:1902176 |
BP |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| 1344 |
pink1 |
30 |
6.3e-04 |
1.000 |
3 |
GO:0003727 |
MF |
single-stranded RNA binding |
| 1345 |
pink1 |
30 |
6.5e-04 |
1.000 |
2 |
GO:0031683 |
MF |
G-protein beta/gamma-subunit complex binding |
| 1346 |
pink1 |
30 |
8.0e-04 |
1.000 |
2 |
GO:1902175 |
BP |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| 1347 |
pink1 |
30 |
9.6e-04 |
1.000 |
2 |
GO:0008143 |
MF |
poly(A) binding |
| 1348 |
pink1 |
30 |
1.3e-03 |
1.000 |
2 |
GO:0005834 |
CC |
heterotrimeric G-protein complex |
| 1349 |
pink1 |
30 |
1.4e-03 |
1.000 |
5 |
GO:1902532 |
BP |
negative regulation of intracellular signal transduction |
| 1350 |
pink1 |
30 |
1.4e-03 |
1.000 |
2 |
GO:0008266 |
MF |
poly(U) RNA binding |
| 1351 |
pink2 |
38 |
1.3e-03 |
1.000 |
2 |
GO:0032509 |
BP |
endosome transport via multivesicular body sorting pathway |
| 1352 |
pink2 |
38 |
2.3e-03 |
1.000 |
3 |
GO:0052689 |
MF |
carboxylic ester hydrolase activity |
| 1353 |
pink2 |
38 |
2.4e-03 |
1.000 |
3 |
GO:0099699 |
CC |
integral component of synaptic membrane |
| 1354 |
pink2 |
38 |
2.5e-03 |
1.000 |
2 |
GO:0071985 |
BP |
multivesicular body sorting pathway |
| 1355 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:0002812 |
BP |
biosynthetic process of antibacterial peptides active against Gram-negative bacteria |
| 1356 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:0050783 |
BP |
cocaine metabolic process |
| 1357 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:0070947 |
BP |
neutrophil mediated killing of fungus |
| 1358 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:1901751 |
BP |
leukotriene A4 metabolic process |
| 1359 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:1905956 |
BP |
positive regulation of endothelial tube morphogenesis |
| 1360 |
pink2 |
38 |
2.6e-03 |
1.000 |
1 |
GO:2001303 |
BP |
lipoxin A4 biosynthetic process |
| 1361 |
pink3 |
49 |
1.0e-05 |
0.180 |
2 |
GO:0003826 |
MF |
alpha-ketoacid dehydrogenase activity |
| 1362 |
pink3 |
49 |
1.0e-05 |
0.180 |
2 |
GO:0003863 |
MF |
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity |
| 1363 |
pink3 |
49 |
9.9e-05 |
1.000 |
2 |
GO:0005947 |
CC |
mitochondrial alpha-ketoglutarate dehydrogenase complex |
| 1364 |
pink3 |
49 |
3.5e-04 |
1.000 |
2 |
GO:0019911 |
MF |
structural constituent of myelin sheath |
| 1365 |
pink3 |
49 |
6.9e-04 |
1.000 |
6 |
GO:0001558 |
BP |
regulation of cell growth |
| 1366 |
pink3 |
49 |
7.6e-04 |
1.000 |
2 |
GO:0045239 |
CC |
tricarboxylic acid cycle enzyme complex |
| 1367 |
pink3 |
49 |
1.3e-03 |
1.000 |
2 |
GO:0044305 |
CC |
calyx of Held |
| 1368 |
pink3 |
49 |
1.8e-03 |
1.000 |
2 |
GO:0062009 |
BP |
secondary palate development |
| 1369 |
pink3 |
49 |
2.0e-03 |
1.000 |
2 |
GO:0009083 |
BP |
branched-chain amino acid catabolic process |
| 1370 |
pink3 |
49 |
2.8e-03 |
1.000 |
3 |
GO:0032526 |
BP |
response to retinoic acid |
| 1371 |
pink4 |
56 |
2.0e-04 |
1.000 |
2 |
GO:0015271 |
MF |
outward rectifier potassium channel activity |
| 1372 |
pink4 |
56 |
3.3e-04 |
1.000 |
3 |
GO:0050435 |
BP |
amyloid-beta metabolic process |
| 1373 |
pink4 |
56 |
4.7e-04 |
1.000 |
2 |
GO:0042756 |
BP |
drinking behavior |
| 1374 |
pink4 |
56 |
1.3e-03 |
1.000 |
3 |
GO:0005249 |
MF |
voltage-gated potassium channel activity |
| 1375 |
pink4 |
56 |
1.5e-03 |
1.000 |
2 |
GO:1904706 |
BP |
negative regulation of vascular smooth muscle cell proliferation |
| 1376 |
pink4 |
56 |
1.6e-03 |
1.000 |
7 |
GO:0005929 |
CC |
cilium |
| 1377 |
pink4 |
56 |
2.8e-03 |
1.000 |
3 |
GO:0007631 |
BP |
feeding behavior |
| 1378 |
pink4 |
56 |
3.7e-03 |
1.000 |
1 |
GO:0005999 |
BP |
xylulose biosynthetic process |
| 1379 |
pink4 |
56 |
3.7e-03 |
1.000 |
1 |
GO:0006666 |
BP |
3-keto-sphinganine metabolic process |
| 1380 |
pink4 |
56 |
3.7e-03 |
1.000 |
1 |
GO:0009720 |
BP |
detection of hormone stimulus |
| 1381 |
plum |
68 |
7.1e-04 |
1.000 |
2 |
GO:0015280 |
MF |
ligand-gated sodium channel activity |
| 1382 |
plum |
68 |
3.3e-03 |
1.000 |
2 |
GO:0060602 |
BP |
branch elongation of an epithelium |
| 1383 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0006540 |
BP |
glutamate decarboxylation to succinate |
| 1384 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0070179 |
BP |
D-serine biosynthetic process |
| 1385 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0003921 |
MF |
GMP synthase activity |
| 1386 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0003922 |
MF |
GMP synthase (glutamine-hydrolyzing) activity |
| 1387 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0004351 |
MF |
glutamate decarboxylase activity |
| 1388 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0008721 |
MF |
D-serine ammonia-lyase activity |
| 1389 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0016316 |
MF |
phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity |
| 1390 |
plum |
68 |
4.5e-03 |
1.000 |
1 |
GO:0018114 |
MF |
threonine racemase activity |
| 1391 |
plum1 |
96 |
2.3e-04 |
1.000 |
6 |
GO:0030426 |
CC |
growth cone |
| 1392 |
plum1 |
96 |
2.7e-04 |
1.000 |
6 |
GO:0030427 |
CC |
site of polarized growth |
| 1393 |
plum1 |
96 |
1.6e-03 |
1.000 |
5 |
GO:0004866 |
MF |
endopeptidase inhibitor activity |
| 1394 |
plum1 |
96 |
1.8e-03 |
1.000 |
2 |
GO:0001886 |
BP |
endothelial cell morphogenesis |
| 1395 |
plum1 |
96 |
1.9e-03 |
1.000 |
5 |
GO:0030414 |
MF |
peptidase inhibitor activity |
| 1396 |
plum1 |
96 |
2.1e-03 |
1.000 |
2 |
GO:0097449 |
CC |
astrocyte projection |
| 1397 |
plum1 |
96 |
3.0e-03 |
1.000 |
6 |
GO:0150034 |
CC |
distal axon |
| 1398 |
plum1 |
96 |
4.7e-03 |
1.000 |
4 |
GO:0031644 |
BP |
regulation of neurological system process |
| 1399 |
plum1 |
96 |
5.1e-03 |
1.000 |
2 |
GO:0014850 |
BP |
response to muscle activity |
| 1400 |
plum1 |
96 |
6.4e-03 |
1.000 |
1 |
GO:0001576 |
BP |
globoside biosynthetic process |
| 1401 |
plum2 |
84 |
2.0e-03 |
1.000 |
2 |
GO:0009313 |
BP |
oligosaccharide catabolic process |
| 1402 |
plum2 |
84 |
2.8e-03 |
1.000 |
2 |
GO:0007379 |
BP |
segment specification |
| 1403 |
plum2 |
84 |
3.7e-03 |
1.000 |
10 |
GO:0045055 |
BP |
regulated exocytosis |
| 1404 |
plum2 |
84 |
4.1e-03 |
1.000 |
2 |
GO:0048026 |
BP |
positive regulation of mRNA splicing, via spliceosome |
| 1405 |
plum2 |
84 |
4.1e-03 |
1.000 |
2 |
GO:1904893 |
BP |
negative regulation of STAT cascade |
| 1406 |
plum2 |
84 |
4.2e-03 |
1.000 |
5 |
GO:0007187 |
BP |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| 1407 |
plum2 |
84 |
4.6e-03 |
1.000 |
2 |
GO:0046514 |
BP |
ceramide catabolic process |
| 1408 |
plum2 |
84 |
5.1e-03 |
1.000 |
2 |
GO:0007064 |
BP |
mitotic sister chromatid cohesion |
| 1409 |
plum2 |
84 |
5.5e-03 |
1.000 |
3 |
GO:0030317 |
BP |
flagellated sperm motility |
| 1410 |
plum2 |
84 |
5.7e-03 |
1.000 |
1 |
GO:0002926 |
BP |
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation |
| 1411 |
plum3 |
62 |
3.4e-04 |
1.000 |
2 |
GO:0051096 |
BP |
positive regulation of helicase activity |
| 1412 |
plum3 |
62 |
5.8e-04 |
1.000 |
3 |
GO:0000731 |
BP |
DNA synthesis involved in DNA repair |
| 1413 |
plum3 |
62 |
7.2e-04 |
1.000 |
3 |
GO:0006301 |
BP |
postreplication repair |
| 1414 |
plum3 |
62 |
7.3e-04 |
1.000 |
2 |
GO:0043240 |
CC |
Fanconi anaemia nuclear complex |
| 1415 |
plum3 |
62 |
1.1e-03 |
1.000 |
2 |
GO:0030983 |
MF |
mismatched DNA binding |
| 1416 |
plum3 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0000453 |
BP |
enzyme-directed rRNA 2’-O-methylation |
| 1417 |
plum3 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0007497 |
BP |
posterior midgut development |
| 1418 |
plum3 |
62 |
4.1e-03 |
1.000 |
1 |
GO:0071441 |
BP |
negative regulation of histone H3-K14 acetylation |
| 1419 |
plum3 |
62 |
4.1e-03 |
1.000 |
1 |
GO:1902544 |
BP |
regulation of DNA N-glycosylase activity |
| 1420 |
plum3 |
62 |
4.1e-03 |
1.000 |
1 |
GO:1903699 |
BP |
tarsal gland development |
| 1421 |
plum4 |
48 |
1.9e-03 |
1.000 |
6 |
GO:0071407 |
BP |
cellular response to organic cyclic compound |
| 1422 |
plum4 |
48 |
2.2e-03 |
1.000 |
2 |
GO:0043921 |
BP |
modulation by host of viral transcription |
| 1423 |
plum4 |
48 |
2.4e-03 |
1.000 |
2 |
GO:0071353 |
BP |
cellular response to interleukin-4 |
| 1424 |
plum4 |
48 |
2.6e-03 |
1.000 |
2 |
GO:0070670 |
BP |
response to interleukin-4 |
| 1425 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:0097698 |
BP |
telomere maintenance via base-excision repair |
| 1426 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:1900170 |
BP |
negative regulation of glucocorticoid mediated signaling pathway |
| 1427 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:1902213 |
BP |
positive regulation of prolactin signaling pathway |
| 1428 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:1905802 |
BP |
regulation of cellular response to manganese ion |
| 1429 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:2000706 |
BP |
negative regulation of dense core granule biogenesis |
| 1430 |
plum4 |
48 |
2.9e-03 |
1.000 |
1 |
GO:2000740 |
BP |
negative regulation of mesenchymal stem cell differentiation |
| 1431 |
powderblue |
48 |
8.7e-06 |
0.160 |
2 |
GO:0001507 |
BP |
acetylcholine catabolic process in synaptic cleft |
| 1432 |
powderblue |
48 |
8.7e-06 |
0.160 |
2 |
GO:0006581 |
BP |
acetylcholine catabolic process |
| 1433 |
powderblue |
48 |
1.9e-04 |
1.000 |
10 |
GO:0030054 |
CC |
cell junction |
| 1434 |
powderblue |
48 |
5.6e-04 |
1.000 |
2 |
GO:0043083 |
CC |
synaptic cleft |
| 1435 |
powderblue |
48 |
7.5e-04 |
1.000 |
3 |
GO:0050805 |
BP |
negative regulation of synaptic transmission |
| 1436 |
powderblue |
48 |
7.7e-04 |
1.000 |
2 |
GO:0042447 |
BP |
hormone catabolic process |
| 1437 |
powderblue |
48 |
8.9e-04 |
1.000 |
2 |
GO:0039529 |
BP |
RIG-I signaling pathway |
| 1438 |
powderblue |
48 |
1.1e-03 |
1.000 |
2 |
GO:0042135 |
BP |
neurotransmitter catabolic process |
| 1439 |
powderblue |
48 |
1.4e-03 |
1.000 |
2 |
GO:0039528 |
BP |
cytoplasmic pattern recognition receptor signaling pathway in response to virus |
| 1440 |
powderblue |
48 |
2.1e-03 |
1.000 |
3 |
GO:0044773 |
BP |
mitotic DNA damage checkpoint |
| 1441 |
purple |
202 |
1.0e-03 |
1.000 |
2 |
GO:0021914 |
BP |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning |
| 1442 |
purple |
202 |
1.0e-03 |
1.000 |
2 |
GO:0031731 |
MF |
CCR6 chemokine receptor binding |
| 1443 |
purple |
202 |
1.7e-03 |
1.000 |
2 |
GO:0051792 |
BP |
medium-chain fatty acid biosynthetic process |
| 1444 |
purple |
202 |
1.7e-03 |
1.000 |
2 |
GO:0071376 |
BP |
cellular response to corticotropin-releasing hormone stimulus |
| 1445 |
purple |
202 |
2.2e-03 |
1.000 |
3 |
GO:0032461 |
BP |
positive regulation of protein oligomerization |
| 1446 |
purple |
202 |
2.4e-03 |
1.000 |
7 |
GO:0010921 |
BP |
regulation of phosphatase activity |
| 1447 |
purple |
202 |
3.6e-03 |
1.000 |
40 |
GO:0003677 |
MF |
DNA binding |
| 1448 |
purple |
202 |
4.2e-03 |
1.000 |
3 |
GO:0045879 |
BP |
negative regulation of smoothened signaling pathway |
| 1449 |
purple |
202 |
4.2e-03 |
1.000 |
3 |
GO:0090162 |
BP |
establishment of epithelial cell polarity |
| 1450 |
purple |
202 |
5.4e-03 |
1.000 |
5 |
GO:0010923 |
BP |
negative regulation of phosphatase activity |
| 1451 |
purple2 |
34 |
3.3e-04 |
1.000 |
2 |
GO:1902224 |
BP |
ketone body metabolic process |
| 1452 |
purple2 |
34 |
1.2e-03 |
1.000 |
2 |
GO:0032438 |
BP |
melanosome organization |
| 1453 |
purple2 |
34 |
1.4e-03 |
1.000 |
2 |
GO:0048753 |
BP |
pigment granule organization |
| 1454 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0008057 |
BP |
eye pigment granule organization |
| 1455 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0043438 |
BP |
acetoacetic acid metabolic process |
| 1456 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0045083 |
BP |
negative regulation of interleukin-12 biosynthetic process |
| 1457 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0086072 |
BP |
AV node cell-bundle of His cell adhesion involved in cell communication |
| 1458 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0090730 |
CC |
Las1 complex |
| 1459 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0004503 |
MF |
monophenol monooxygenase activity |
| 1460 |
purple2 |
34 |
2.3e-03 |
1.000 |
1 |
GO:0086082 |
MF |
cell adhesive protein binding involved in AV node cell-bundle of His cell communication |
| 1461 |
red |
274 |
9.7e-05 |
1.000 |
17 |
GO:0043235 |
CC |
receptor complex |
| 1462 |
red |
274 |
3.4e-04 |
1.000 |
2 |
GO:0102294 |
MF |
cholesterol dehydrogenase activity |
| 1463 |
red |
274 |
6.9e-04 |
1.000 |
3 |
GO:0070757 |
BP |
interleukin-35-mediated signaling pathway |
| 1464 |
red |
274 |
8.9e-04 |
1.000 |
13 |
GO:0009897 |
CC |
external side of plasma membrane |
| 1465 |
red |
274 |
9.1e-04 |
1.000 |
8 |
GO:0007259 |
BP |
JAK-STAT cascade |
| 1466 |
red |
274 |
9.4e-04 |
1.000 |
3 |
GO:0006705 |
BP |
mineralocorticoid biosynthetic process |
| 1467 |
red |
274 |
9.5e-04 |
1.000 |
14 |
GO:0018108 |
BP |
peptidyl-tyrosine phosphorylation |
| 1468 |
red |
274 |
1.0e-03 |
1.000 |
2 |
GO:0004694 |
MF |
eukaryotic translation initiation factor 2alpha kinase activity |
| 1469 |
red |
274 |
1.2e-03 |
1.000 |
8 |
GO:0097696 |
BP |
STAT cascade |
| 1470 |
red |
274 |
2.0e-03 |
1.000 |
3 |
GO:0071565 |
CC |
nBAF complex |
| 1471 |
royalblue |
138 |
8.6e-05 |
1.000 |
2 |
GO:0008768 |
MF |
UDP-sugar diphosphatase activity |
| 1472 |
royalblue |
138 |
2.7e-03 |
1.000 |
3 |
GO:0010574 |
BP |
regulation of vascular endothelial growth factor production |
| 1473 |
royalblue |
138 |
2.9e-03 |
1.000 |
3 |
GO:0010573 |
BP |
vascular endothelial growth factor production |
| 1474 |
royalblue |
138 |
3.0e-03 |
1.000 |
2 |
GO:0070513 |
MF |
death domain binding |
| 1475 |
royalblue |
138 |
5.6e-03 |
1.000 |
3 |
GO:0048662 |
BP |
negative regulation of smooth muscle cell proliferation |
| 1476 |
royalblue |
138 |
7.3e-03 |
1.000 |
2 |
GO:1902683 |
BP |
regulation of receptor localization to synapse |
| 1477 |
royalblue |
138 |
7.9e-03 |
1.000 |
3 |
GO:0097120 |
BP |
receptor localization to synapse |
| 1478 |
royalblue |
138 |
8.5e-03 |
1.000 |
7 |
GO:0031965 |
CC |
nuclear membrane |
| 1479 |
royalblue |
138 |
9.3e-03 |
1.000 |
1 |
GO:0015821 |
BP |
methionine transport |
| 1480 |
royalblue |
138 |
9.3e-03 |
1.000 |
1 |
GO:0016269 |
BP |
O-glycan processing, core 3 |
| 1481 |
royalblue2 |
32 |
1.6e-04 |
1.000 |
3 |
GO:0035065 |
BP |
regulation of histone acetylation |
| 1482 |
royalblue2 |
32 |
3.8e-04 |
1.000 |
2 |
GO:0035067 |
BP |
negative regulation of histone acetylation |
| 1483 |
royalblue2 |
32 |
5.6e-04 |
1.000 |
2 |
GO:2000757 |
BP |
negative regulation of peptidyl-lysine acetylation |
| 1484 |
royalblue2 |
32 |
6.3e-04 |
1.000 |
2 |
GO:1901984 |
BP |
negative regulation of protein acetylation |
| 1485 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
3 |
GO:0031056 |
BP |
regulation of histone modification |
| 1486 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
1 |
GO:0006428 |
BP |
isoleucyl-tRNA aminoacylation |
| 1487 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
1 |
GO:0032618 |
BP |
interleukin-15 production |
| 1488 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
1 |
GO:0032738 |
BP |
positive regulation of interleukin-15 production |
| 1489 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
1 |
GO:0035665 |
BP |
TIRAP-dependent toll-like receptor 4 signaling pathway |
| 1490 |
royalblue2 |
32 |
2.1e-03 |
1.000 |
1 |
GO:0044026 |
BP |
DNA hypermethylation |
| 1491 |
royalblue3 |
44 |
3.2e-05 |
0.580 |
3 |
GO:0030194 |
BP |
positive regulation of blood coagulation |
| 1492 |
royalblue3 |
44 |
3.7e-05 |
0.670 |
3 |
GO:0050820 |
BP |
positive regulation of coagulation |
| 1493 |
royalblue3 |
44 |
6.9e-05 |
1.000 |
3 |
GO:0007616 |
BP |
long-term memory |
| 1494 |
royalblue3 |
44 |
1.5e-04 |
1.000 |
3 |
GO:0001953 |
BP |
negative regulation of cell-matrix adhesion |
| 1495 |
royalblue3 |
44 |
3.1e-04 |
1.000 |
2 |
GO:0010763 |
BP |
positive regulation of fibroblast migration |
| 1496 |
royalblue3 |
44 |
3.1e-04 |
1.000 |
2 |
GO:0051918 |
BP |
negative regulation of fibrinolysis |
| 1497 |
royalblue3 |
44 |
3.1e-04 |
1.000 |
2 |
GO:0031095 |
CC |
platelet dense tubular network membrane |
| 1498 |
royalblue3 |
44 |
3.2e-04 |
1.000 |
3 |
GO:0090303 |
BP |
positive regulation of wound healing |
| 1499 |
royalblue3 |
44 |
4.7e-04 |
1.000 |
2 |
GO:0031094 |
CC |
platelet dense tubular network |
| 1500 |
royalblue3 |
44 |
5.5e-04 |
1.000 |
3 |
GO:1903036 |
BP |
positive regulation of response to wounding |
| 1501 |
saddlebrown |
120 |
9.5e-05 |
1.000 |
17 |
GO:0005730 |
CC |
nucleolus |
| 1502 |
saddlebrown |
120 |
3.4e-04 |
1.000 |
7 |
GO:0006364 |
BP |
rRNA processing |
| 1503 |
saddlebrown |
120 |
3.5e-04 |
1.000 |
2 |
GO:0036515 |
BP |
serotonergic neuron axon guidance |
| 1504 |
saddlebrown |
120 |
3.5e-04 |
1.000 |
2 |
GO:0033181 |
CC |
plasma membrane proton-transporting V-type ATPase complex |
| 1505 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:0036514 |
BP |
dopaminergic neuron axon guidance |
| 1506 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:1904938 |
BP |
planar cell polarity pathway involved in axon guidance |
| 1507 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:0005749 |
CC |
mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) |
| 1508 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:0045273 |
CC |
respiratory chain complex II |
| 1509 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:0000104 |
MF |
succinate dehydrogenase activity |
| 1510 |
saddlebrown |
120 |
5.8e-04 |
1.000 |
2 |
GO:0008177 |
MF |
succinate dehydrogenase (ubiquinone) activity |
| 1511 |
salmon |
176 |
5.3e-04 |
1.000 |
6 |
GO:0031623 |
BP |
receptor internalization |
| 1512 |
salmon |
176 |
9.1e-04 |
1.000 |
4 |
GO:0030199 |
BP |
collagen fibril organization |
| 1513 |
salmon |
176 |
1.4e-03 |
1.000 |
2 |
GO:0008504 |
MF |
monoamine transmembrane transporter activity |
| 1514 |
salmon |
176 |
1.6e-03 |
1.000 |
3 |
GO:0001963 |
BP |
synaptic transmission, dopaminergic |
| 1515 |
salmon |
176 |
2.0e-03 |
1.000 |
2 |
GO:0015378 |
MF |
sodium:chloride symporter activity |
| 1516 |
salmon |
176 |
2.1e-03 |
1.000 |
3 |
GO:0016702 |
MF |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
| 1517 |
salmon |
176 |
2.4e-03 |
1.000 |
3 |
GO:0002053 |
BP |
positive regulation of mesenchymal cell proliferation |
| 1518 |
salmon |
176 |
2.4e-03 |
1.000 |
3 |
GO:0016701 |
MF |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen |
| 1519 |
salmon |
176 |
2.8e-03 |
1.000 |
2 |
GO:0042723 |
BP |
thiamine-containing compound metabolic process |
| 1520 |
salmon |
176 |
2.8e-03 |
1.000 |
2 |
GO:0060352 |
BP |
cell adhesion molecule production |
| 1521 |
salmon1 |
49 |
2.5e-04 |
1.000 |
3 |
GO:0043113 |
BP |
receptor clustering |
| 1522 |
salmon1 |
49 |
3.3e-03 |
1.000 |
1 |
GO:1990456 |
BP |
mitochondrion-endoplasmic reticulum membrane tethering |
| 1523 |
salmon1 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0001096 |
MF |
TFIIF-class transcription factor complex binding |
| 1524 |
salmon1 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0031700 |
MF |
adrenomedullin receptor binding |
| 1525 |
salmon1 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0098640 |
MF |
integrin binding involved in cell-matrix adhesion |
| 1526 |
salmon1 |
49 |
3.3e-03 |
1.000 |
1 |
GO:0102264 |
MF |
tRNA-dihydrouridine20 synthase activity |
| 1527 |
salmon1 |
49 |
6.4e-03 |
1.000 |
2 |
GO:0031519 |
CC |
PcG protein complex |
| 1528 |
salmon1 |
49 |
6.6e-03 |
1.000 |
1 |
GO:0006432 |
BP |
phenylalanyl-tRNA aminoacylation |
| 1529 |
salmon1 |
49 |
6.6e-03 |
1.000 |
1 |
GO:0042595 |
BP |
behavioral response to starvation |
| 1530 |
salmon1 |
49 |
6.6e-03 |
1.000 |
1 |
GO:0061086 |
BP |
negative regulation of histone H3-K27 methylation |
| 1531 |
salmon2 |
65 |
5.1e-05 |
0.930 |
2 |
GO:0030091 |
BP |
protein repair |
| 1532 |
salmon2 |
65 |
2.5e-04 |
1.000 |
2 |
GO:0043985 |
BP |
histone H4-R3 methylation |
| 1533 |
salmon2 |
65 |
4.7e-04 |
1.000 |
2 |
GO:0016671 |
MF |
oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor |
| 1534 |
salmon2 |
65 |
1.1e-03 |
1.000 |
2 |
GO:0034969 |
BP |
histone arginine methylation |
| 1535 |
salmon2 |
65 |
1.5e-03 |
1.000 |
2 |
GO:0018216 |
BP |
peptidyl-arginine methylation |
| 1536 |
salmon2 |
65 |
2.0e-03 |
1.000 |
2 |
GO:0071157 |
BP |
negative regulation of cell cycle arrest |
| 1537 |
salmon2 |
65 |
2.1e-03 |
1.000 |
3 |
GO:0006342 |
BP |
chromatin silencing |
| 1538 |
salmon2 |
65 |
2.5e-03 |
1.000 |
2 |
GO:0001223 |
MF |
transcription coactivator binding |
| 1539 |
salmon2 |
65 |
3.4e-03 |
1.000 |
2 |
GO:0003950 |
MF |
NAD+ ADP-ribosyltransferase activity |
| 1540 |
salmon2 |
65 |
3.5e-03 |
1.000 |
3 |
GO:0045814 |
BP |
negative regulation of gene expression, epigenetic |
| 1541 |
salmon4 |
75 |
2.5e-05 |
0.460 |
2 |
GO:0014806 |
BP |
smooth muscle hyperplasia |
| 1542 |
salmon4 |
75 |
1.5e-04 |
1.000 |
2 |
GO:0014805 |
BP |
smooth muscle adaptation |
| 1543 |
salmon4 |
75 |
1.2e-03 |
1.000 |
4 |
GO:0044853 |
CC |
plasma membrane raft |
| 1544 |
salmon4 |
75 |
1.6e-03 |
1.000 |
3 |
GO:0007588 |
BP |
excretion |
| 1545 |
salmon4 |
75 |
2.1e-03 |
1.000 |
5 |
GO:0009952 |
BP |
anterior/posterior pattern specification |
| 1546 |
salmon4 |
75 |
2.9e-03 |
1.000 |
2 |
GO:0060055 |
BP |
angiogenesis involved in wound healing |
| 1547 |
salmon4 |
75 |
3.6e-03 |
1.000 |
5 |
GO:0048872 |
BP |
homeostasis of number of cells |
| 1548 |
salmon4 |
75 |
4.0e-03 |
1.000 |
3 |
GO:0043627 |
BP |
response to estrogen |
| 1549 |
salmon4 |
75 |
4.2e-03 |
1.000 |
3 |
GO:0005901 |
CC |
caveola |
| 1550 |
salmon4 |
75 |
5.1e-03 |
1.000 |
1 |
GO:0006788 |
BP |
heme oxidation |
| 1551 |
sienna |
32 |
2.0e-04 |
1.000 |
2 |
GO:1901894 |
BP |
regulation of calcium-transporting ATPase activity |
| 1552 |
sienna |
32 |
2.9e-04 |
1.000 |
2 |
GO:0032725 |
BP |
positive regulation of granulocyte macrophage colony-stimulating factor production |
| 1553 |
sienna |
32 |
4.0e-04 |
1.000 |
2 |
GO:0032604 |
BP |
granulocyte macrophage colony-stimulating factor production |
| 1554 |
sienna |
32 |
4.0e-04 |
1.000 |
2 |
GO:0032780 |
BP |
negative regulation of ATPase activity |
| 1555 |
sienna |
32 |
1.0e-03 |
1.000 |
2 |
GO:0002230 |
BP |
positive regulation of defense response to virus by host |
| 1556 |
sienna |
32 |
1.1e-03 |
1.000 |
2 |
GO:0035925 |
MF |
mRNA 3’-UTR AU-rich region binding |
| 1557 |
sienna |
32 |
1.2e-03 |
1.000 |
2 |
GO:0017091 |
MF |
AU-rich element binding |
| 1558 |
sienna |
32 |
1.4e-03 |
1.000 |
2 |
GO:0031904 |
CC |
endosome lumen |
| 1559 |
sienna |
32 |
2.1e-03 |
1.000 |
2 |
GO:0050691 |
BP |
regulation of defense response to virus by host |
| 1560 |
sienna |
32 |
2.2e-03 |
1.000 |
1 |
GO:0019853 |
BP |
L-ascorbic acid biosynthetic process |
| 1561 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0045355 |
BP |
negative regulation of interferon-alpha biosynthetic process |
| 1562 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0045358 |
BP |
negative regulation of interferon-beta biosynthetic process |
| 1563 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0071678 |
BP |
olfactory bulb axon guidance |
| 1564 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0097535 |
BP |
lymphoid lineage cell migration into thymus |
| 1565 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:1901787 |
BP |
benzoyl-CoA metabolic process |
| 1566 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0097132 |
CC |
cyclin D2-CDK6 complex |
| 1567 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0004852 |
MF |
uroporphyrinogen-III synthase activity |
| 1568 |
sienna1 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0047962 |
MF |
glycine N-benzoyltransferase activity |
| 1569 |
sienna1 |
33 |
4.4e-03 |
1.000 |
1 |
GO:0006780 |
BP |
uroporphyrinogen III biosynthetic process |
| 1570 |
sienna1 |
33 |
4.4e-03 |
1.000 |
1 |
GO:0018008 |
BP |
N-terminal peptidyl-glycine N-myristoylation |
| 1571 |
sienna2 |
48 |
4.5e-04 |
1.000 |
3 |
GO:0043388 |
BP |
positive regulation of DNA binding |
| 1572 |
sienna2 |
48 |
6.4e-04 |
1.000 |
2 |
GO:0008417 |
MF |
fucosyltransferase activity |
| 1573 |
sienna2 |
48 |
8.8e-04 |
1.000 |
2 |
GO:0006004 |
BP |
fucose metabolic process |
| 1574 |
sienna2 |
48 |
1.2e-03 |
1.000 |
4 |
GO:0051099 |
BP |
positive regulation of binding |
| 1575 |
sienna2 |
48 |
1.3e-03 |
1.000 |
4 |
GO:1901796 |
BP |
regulation of signal transduction by p53 class mediator |
| 1576 |
sienna2 |
48 |
1.5e-03 |
1.000 |
2 |
GO:0036065 |
BP |
fucosylation |
| 1577 |
sienna2 |
48 |
1.6e-03 |
1.000 |
2 |
GO:0002089 |
BP |
lens morphogenesis in camera-type eye |
| 1578 |
sienna2 |
48 |
2.0e-03 |
1.000 |
2 |
GO:0007035 |
BP |
vacuolar acidification |
| 1579 |
sienna2 |
48 |
2.1e-03 |
1.000 |
4 |
GO:0016758 |
MF |
transferase activity, transferring hexosyl groups |
| 1580 |
sienna2 |
48 |
3.2e-03 |
1.000 |
1 |
GO:0018003 |
BP |
peptidyl-lysine N6-acetylation |
| 1581 |
sienna3 |
98 |
4.1e-04 |
1.000 |
2 |
GO:1904058 |
BP |
positive regulation of sensory perception of pain |
| 1582 |
sienna3 |
98 |
7.6e-04 |
1.000 |
3 |
GO:0003401 |
BP |
axis elongation |
| 1583 |
sienna3 |
98 |
1.4e-03 |
1.000 |
2 |
GO:1902459 |
BP |
positive regulation of stem cell population maintenance |
| 1584 |
sienna3 |
98 |
3.0e-03 |
1.000 |
3 |
GO:0005778 |
CC |
peroxisomal membrane |
| 1585 |
sienna3 |
98 |
4.1e-03 |
1.000 |
3 |
GO:0014823 |
BP |
response to activity |
| 1586 |
sienna3 |
98 |
5.1e-03 |
1.000 |
3 |
GO:0045844 |
BP |
positive regulation of striated muscle tissue development |
| 1587 |
sienna3 |
98 |
5.3e-03 |
1.000 |
2 |
GO:0070064 |
MF |
proline-rich region binding |
| 1588 |
sienna3 |
98 |
5.4e-03 |
1.000 |
3 |
GO:1901863 |
BP |
positive regulation of muscle tissue development |
| 1589 |
sienna3 |
98 |
5.7e-03 |
1.000 |
5 |
GO:0007584 |
BP |
response to nutrient |
| 1590 |
sienna3 |
98 |
6.5e-03 |
1.000 |
1 |
GO:0003247 |
BP |
post-embryonic cardiac muscle cell growth involved in heart morphogenesis |
| 1591 |
sienna4 |
52 |
2.8e-04 |
1.000 |
9 |
GO:0005815 |
CC |
microtubule organizing center |
| 1592 |
sienna4 |
52 |
5.7e-04 |
1.000 |
11 |
GO:0015630 |
CC |
microtubule cytoskeleton |
| 1593 |
sienna4 |
52 |
2.5e-03 |
1.000 |
2 |
GO:0002385 |
BP |
mucosal immune response |
| 1594 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:0021998 |
BP |
neural plate mediolateral regionalization |
| 1595 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:0034342 |
BP |
response to type III interferon |
| 1596 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:0048352 |
BP |
paraxial mesoderm structural organization |
| 1597 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:1900062 |
BP |
regulation of replicative cell aging |
| 1598 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:1904414 |
BP |
positive regulation of cardiac ventricle development |
| 1599 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:1905285 |
BP |
fibrous ring of heart morphogenesis |
| 1600 |
sienna4 |
52 |
3.5e-03 |
1.000 |
1 |
GO:0098753 |
CC |
anchored component of the cytoplasmic side of the plasma membrane |
| 1601 |
skyblue |
120 |
5.6e-04 |
1.000 |
3 |
GO:0048741 |
BP |
skeletal muscle fiber development |
| 1602 |
skyblue |
120 |
5.8e-04 |
1.000 |
4 |
GO:0048747 |
BP |
muscle fiber development |
| 1603 |
skyblue |
120 |
8.4e-04 |
1.000 |
3 |
GO:0014904 |
BP |
myotube cell development |
| 1604 |
skyblue |
120 |
1.2e-03 |
1.000 |
2 |
GO:0004128 |
MF |
cytochrome-b5 reductase activity, acting on NAD(P)H |
| 1605 |
skyblue |
120 |
1.6e-03 |
1.000 |
5 |
GO:0007156 |
BP |
homophilic cell adhesion via plasma membrane adhesion molecules |
| 1606 |
skyblue |
120 |
2.4e-03 |
1.000 |
3 |
GO:1900744 |
BP |
regulation of p38MAPK cascade |
| 1607 |
skyblue |
120 |
3.5e-03 |
1.000 |
3 |
GO:0015701 |
BP |
bicarbonate transport |
| 1608 |
skyblue |
120 |
3.5e-03 |
1.000 |
3 |
GO:0038066 |
BP |
p38MAPK cascade |
| 1609 |
skyblue |
120 |
3.8e-03 |
1.000 |
2 |
GO:0003429 |
BP |
growth plate cartilage chondrocyte morphogenesis |
| 1610 |
skyblue |
120 |
3.8e-03 |
1.000 |
2 |
GO:0016653 |
MF |
oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor |
| 1611 |
skyblue1 |
68 |
1.2e-04 |
1.000 |
2 |
GO:0061624 |
BP |
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate |
| 1612 |
skyblue1 |
68 |
1.2e-04 |
1.000 |
2 |
GO:0042806 |
MF |
fucose binding |
| 1613 |
skyblue1 |
68 |
1.1e-03 |
1.000 |
2 |
GO:0044827 |
BP |
modulation by host of viral genome replication |
| 1614 |
skyblue1 |
68 |
1.6e-03 |
1.000 |
2 |
GO:0006000 |
BP |
fructose metabolic process |
| 1615 |
skyblue1 |
68 |
2.1e-03 |
1.000 |
4 |
GO:1903900 |
BP |
regulation of viral life cycle |
| 1616 |
skyblue1 |
68 |
2.7e-03 |
1.000 |
2 |
GO:0019682 |
BP |
glyceraldehyde-3-phosphate metabolic process |
| 1617 |
skyblue1 |
68 |
3.0e-03 |
1.000 |
2 |
GO:0031639 |
BP |
plasminogen activation |
| 1618 |
skyblue1 |
68 |
3.3e-03 |
1.000 |
3 |
GO:1903901 |
BP |
negative regulation of viral life cycle |
| 1619 |
skyblue1 |
68 |
3.4e-03 |
1.000 |
2 |
GO:0000469 |
BP |
cleavage involved in rRNA processing |
| 1620 |
skyblue1 |
68 |
3.4e-03 |
1.000 |
2 |
GO:0051570 |
BP |
regulation of histone H3-K9 methylation |
| 1621 |
skyblue2 |
72 |
6.8e-04 |
1.000 |
2 |
GO:0005225 |
MF |
volume-sensitive anion channel activity |
| 1622 |
skyblue2 |
72 |
9.1e-04 |
1.000 |
3 |
GO:2000179 |
BP |
positive regulation of neural precursor cell proliferation |
| 1623 |
skyblue2 |
72 |
2.1e-03 |
1.000 |
3 |
GO:0072091 |
BP |
regulation of stem cell proliferation |
| 1624 |
skyblue2 |
72 |
2.2e-03 |
1.000 |
2 |
GO:0016500 |
MF |
protein-hormone receptor activity |
| 1625 |
skyblue2 |
72 |
3.7e-03 |
1.000 |
4 |
GO:0017137 |
MF |
Rab GTPase binding |
| 1626 |
skyblue2 |
72 |
4.0e-03 |
1.000 |
3 |
GO:2000177 |
BP |
regulation of neural precursor cell proliferation |
| 1627 |
skyblue2 |
72 |
4.0e-03 |
1.000 |
4 |
GO:0048167 |
BP |
regulation of synaptic plasticity |
| 1628 |
skyblue2 |
72 |
4.0e-03 |
1.000 |
4 |
GO:0055037 |
CC |
recycling endosome |
| 1629 |
skyblue2 |
72 |
4.3e-03 |
1.000 |
3 |
GO:0007589 |
BP |
body fluid secretion |
| 1630 |
skyblue2 |
72 |
4.4e-03 |
1.000 |
1 |
GO:0002398 |
BP |
MHC class Ib protein complex assembly |
| 1631 |
skyblue3 |
96 |
8.4e-06 |
0.150 |
3 |
GO:2000253 |
BP |
positive regulation of feeding behavior |
| 1632 |
skyblue3 |
96 |
8.4e-05 |
1.000 |
3 |
GO:0035259 |
MF |
glucocorticoid receptor binding |
| 1633 |
skyblue3 |
96 |
1.9e-04 |
1.000 |
3 |
GO:0060259 |
BP |
regulation of feeding behavior |
| 1634 |
skyblue3 |
96 |
2.2e-04 |
1.000 |
3 |
GO:0048520 |
BP |
positive regulation of behavior |
| 1635 |
skyblue3 |
96 |
8.1e-04 |
1.000 |
2 |
GO:0044224 |
CC |
juxtaparanode region of axon |
| 1636 |
skyblue3 |
96 |
1.1e-03 |
1.000 |
8 |
GO:0052548 |
BP |
regulation of endopeptidase activity |
| 1637 |
skyblue3 |
96 |
1.2e-03 |
1.000 |
5 |
GO:2001056 |
BP |
positive regulation of cysteine-type endopeptidase activity |
| 1638 |
skyblue3 |
96 |
1.2e-03 |
1.000 |
4 |
GO:0035258 |
MF |
steroid hormone receptor binding |
| 1639 |
skyblue3 |
96 |
1.4e-03 |
1.000 |
3 |
GO:0043028 |
MF |
cysteine-type endopeptidase regulator activity involved in apoptotic process |
| 1640 |
skyblue3 |
96 |
1.6e-03 |
1.000 |
6 |
GO:2000116 |
BP |
regulation of cysteine-type endopeptidase activity |
| 1641 |
skyblue4 |
48 |
1.0e-03 |
1.000 |
3 |
GO:0045454 |
BP |
cell redox homeostasis |
| 1642 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0003251 |
BP |
positive regulation of cell proliferation involved in heart valve morphogenesis |
| 1643 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0009229 |
BP |
thiamine diphosphate biosynthetic process |
| 1644 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0061040 |
BP |
female gonad morphogenesis |
| 1645 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:1905305 |
BP |
negative regulation of cardiac myofibril assembly |
| 1646 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:1905667 |
BP |
negative regulation of protein localization to endosome |
| 1647 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0004788 |
MF |
thiamine diphosphokinase activity |
| 1648 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0022894 |
MF |
Intermediate conductance calcium-activated potassium channel activity |
| 1649 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0030616 |
MF |
transforming growth factor beta receptor, common-partner cytoplasmic mediator activity |
| 1650 |
skyblue4 |
48 |
3.1e-03 |
1.000 |
1 |
GO:0030975 |
MF |
thiamine binding |
| 1651 |
slateblue |
48 |
3.7e-04 |
1.000 |
2 |
GO:0043380 |
BP |
regulation of memory T cell differentiation |
| 1652 |
slateblue |
48 |
4.6e-04 |
1.000 |
2 |
GO:0043379 |
BP |
memory T cell differentiation |
| 1653 |
slateblue |
48 |
9.2e-04 |
1.000 |
2 |
GO:0001921 |
BP |
positive regulation of receptor recycling |
| 1654 |
slateblue |
48 |
2.3e-03 |
1.000 |
2 |
GO:0001919 |
BP |
regulation of receptor recycling |
| 1655 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0002380 |
BP |
immunoglobulin secretion involved in immune response |
| 1656 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0002617 |
BP |
negative regulation of macrophage antigen processing and presentation |
| 1657 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0039502 |
BP |
suppression by virus of host type I interferon-mediated signaling pathway |
| 1658 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0039563 |
BP |
suppression by virus of host STAT1 activity |
| 1659 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0039564 |
BP |
suppression by virus of host STAT2 activity |
| 1660 |
slateblue |
48 |
3.3e-03 |
1.000 |
1 |
GO:0098968 |
BP |
neurotransmitter receptor transport postsynaptic membrane to endosome |
| 1661 |
slateblue1 |
41 |
1.2e-04 |
1.000 |
2 |
GO:0008097 |
MF |
5S rRNA binding |
| 1662 |
slateblue1 |
41 |
5.1e-04 |
1.000 |
2 |
GO:0008195 |
MF |
phosphatidate phosphatase activity |
| 1663 |
slateblue1 |
41 |
5.1e-04 |
1.000 |
2 |
GO:0044548 |
MF |
S100 protein binding |
| 1664 |
slateblue1 |
41 |
1.6e-03 |
1.000 |
5 |
GO:0005667 |
CC |
transcription factor complex |
| 1665 |
slateblue1 |
41 |
2.2e-03 |
1.000 |
3 |
GO:1903828 |
BP |
negative regulation of cellular protein localization |
| 1666 |
slateblue1 |
41 |
2.7e-03 |
1.000 |
3 |
GO:0019218 |
BP |
regulation of steroid metabolic process |
| 1667 |
slateblue1 |
41 |
2.8e-03 |
1.000 |
1 |
GO:0021572 |
BP |
rhombomere 6 development |
| 1668 |
slateblue1 |
41 |
2.8e-03 |
1.000 |
1 |
GO:0045016 |
BP |
mitochondrial magnesium ion transmembrane transport |
| 1669 |
slateblue1 |
41 |
2.8e-03 |
1.000 |
1 |
GO:1904394 |
BP |
negative regulation of skeletal muscle acetylcholine-gated channel clustering |
| 1670 |
slateblue1 |
41 |
2.8e-03 |
1.000 |
1 |
GO:2000424 |
BP |
positive regulation of eosinophil chemotaxis |
| 1671 |
slateblue2 |
30 |
2.8e-04 |
1.000 |
4 |
GO:0050911 |
BP |
detection of chemical stimulus involved in sensory perception of smell |
| 1672 |
slateblue2 |
30 |
2.8e-04 |
1.000 |
4 |
GO:0004984 |
MF |
olfactory receptor activity |
| 1673 |
slateblue2 |
30 |
4.1e-04 |
1.000 |
4 |
GO:0007608 |
BP |
sensory perception of smell |
| 1674 |
slateblue2 |
30 |
5.6e-04 |
1.000 |
4 |
GO:0050907 |
BP |
detection of chemical stimulus involved in sensory perception |
| 1675 |
slateblue2 |
30 |
7.4e-04 |
1.000 |
7 |
GO:0007186 |
BP |
G protein-coupled receptor signaling pathway |
| 1676 |
slateblue2 |
30 |
8.8e-04 |
1.000 |
4 |
GO:0009593 |
BP |
detection of chemical stimulus |
| 1677 |
slateblue2 |
30 |
1.0e-03 |
1.000 |
4 |
GO:0007606 |
BP |
sensory perception of chemical stimulus |
| 1678 |
slateblue2 |
30 |
1.0e-03 |
1.000 |
4 |
GO:0050906 |
BP |
detection of stimulus involved in sensory perception |
| 1679 |
slateblue2 |
30 |
1.1e-03 |
1.000 |
7 |
GO:0050877 |
BP |
nervous system process |
| 1680 |
slateblue2 |
30 |
1.4e-03 |
1.000 |
15 |
GO:0005886 |
CC |
plasma membrane |
| 1681 |
steelblue |
126 |
6.1e-04 |
1.000 |
6 |
GO:0035821 |
BP |
modification of morphology or physiology of other organism |
| 1682 |
steelblue |
126 |
6.8e-04 |
1.000 |
2 |
GO:2000766 |
BP |
negative regulation of cytoplasmic translation |
| 1683 |
steelblue |
126 |
7.4e-04 |
1.000 |
9 |
GO:0045862 |
BP |
positive regulation of proteolysis |
| 1684 |
steelblue |
126 |
1.0e-03 |
1.000 |
3 |
GO:0045671 |
BP |
negative regulation of osteoclast differentiation |
| 1685 |
steelblue |
126 |
1.4e-03 |
1.000 |
7 |
GO:0006898 |
BP |
receptor-mediated endocytosis |
| 1686 |
steelblue |
126 |
1.6e-03 |
1.000 |
13 |
GO:0019900 |
MF |
kinase binding |
| 1687 |
steelblue |
126 |
1.9e-03 |
1.000 |
12 |
GO:0019901 |
MF |
protein kinase binding |
| 1688 |
steelblue |
126 |
1.9e-03 |
1.000 |
2 |
GO:1990124 |
CC |
messenger ribonucleoprotein complex |
| 1689 |
steelblue |
126 |
2.1e-03 |
1.000 |
4 |
GO:0051702 |
BP |
interaction with symbiont |
| 1690 |
steelblue |
126 |
2.8e-03 |
1.000 |
3 |
GO:0070317 |
BP |
negative regulation of G0 to G1 transition |
| 1691 |
tan |
193 |
7.5e-05 |
1.000 |
11 |
GO:0021537 |
BP |
telencephalon development |
| 1692 |
tan |
193 |
2.3e-04 |
1.000 |
3 |
GO:2001241 |
BP |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| 1693 |
tan |
193 |
6.8e-04 |
1.000 |
5 |
GO:0032729 |
BP |
positive regulation of interferon-gamma production |
| 1694 |
tan |
193 |
7.1e-04 |
1.000 |
13 |
GO:0045088 |
BP |
regulation of innate immune response |
| 1695 |
tan |
193 |
8.4e-04 |
1.000 |
3 |
GO:0010226 |
BP |
response to lithium ion |
| 1696 |
tan |
193 |
8.7e-04 |
1.000 |
8 |
GO:0050679 |
BP |
positive regulation of epithelial cell proliferation |
| 1697 |
tan |
193 |
9.7e-04 |
1.000 |
2 |
GO:0060744 |
BP |
mammary gland branching involved in thelarche |
| 1698 |
tan |
193 |
9.7e-04 |
1.000 |
2 |
GO:0060750 |
BP |
epithelial cell proliferation involved in mammary gland duct elongation |
| 1699 |
tan |
193 |
9.7e-04 |
1.000 |
2 |
GO:0098967 |
BP |
exocytic insertion of neurotransmitter receptor to postsynaptic membrane |
| 1700 |
tan |
193 |
1.4e-03 |
1.000 |
6 |
GO:0032609 |
BP |
interferon-gamma production |
| 1701 |
tan2 |
35 |
2.4e-04 |
1.000 |
3 |
GO:0071230 |
BP |
cellular response to amino acid stimulus |
| 1702 |
tan2 |
35 |
8.5e-04 |
1.000 |
2 |
GO:0033081 |
BP |
regulation of T cell differentiation in thymus |
| 1703 |
tan2 |
35 |
9.4e-04 |
1.000 |
2 |
GO:0045943 |
BP |
positive regulation of transcription by RNA polymerase I |
| 1704 |
tan2 |
35 |
1.0e-03 |
1.000 |
3 |
GO:0043200 |
BP |
response to amino acid |
| 1705 |
tan2 |
35 |
1.3e-03 |
1.000 |
6 |
GO:0071363 |
BP |
cellular response to growth factor stimulus |
| 1706 |
tan2 |
35 |
1.6e-03 |
1.000 |
2 |
GO:0006356 |
BP |
regulation of transcription by RNA polymerase I |
| 1707 |
tan2 |
35 |
1.6e-03 |
1.000 |
9 |
GO:0045893 |
BP |
positive regulation of transcription, DNA-templated |
| 1708 |
tan2 |
35 |
1.7e-03 |
1.000 |
6 |
GO:0070848 |
BP |
response to growth factor |
| 1709 |
tan2 |
35 |
2.1e-03 |
1.000 |
4 |
GO:0060326 |
BP |
cell chemotaxis |
| 1710 |
tan2 |
35 |
2.3e-03 |
1.000 |
1 |
GO:1903420 |
BP |
protein localization to endoplasmic reticulum tubular network |
| 1711 |
tan3 |
46 |
1.6e-03 |
1.000 |
4 |
GO:0007188 |
BP |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| 1712 |
tan3 |
46 |
2.5e-03 |
1.000 |
4 |
GO:0007187 |
BP |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| 1713 |
tan3 |
46 |
2.6e-03 |
1.000 |
2 |
GO:0004181 |
MF |
metallocarboxypeptidase activity |
| 1714 |
tan3 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0045234 |
BP |
protein palmitoleylation |
| 1715 |
tan3 |
46 |
3.1e-03 |
1.000 |
1 |
GO:1903387 |
BP |
positive regulation of homophilic cell adhesion |
| 1716 |
tan3 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0035841 |
CC |
new growing cell tip |
| 1717 |
tan3 |
46 |
3.1e-03 |
1.000 |
1 |
GO:0030527 |
MF |
structural constituent of chromatin |
| 1718 |
tan3 |
46 |
5.4e-03 |
1.000 |
2 |
GO:0004180 |
MF |
carboxypeptidase activity |
| 1719 |
tan3 |
46 |
6.0e-03 |
1.000 |
2 |
GO:2000772 |
BP |
regulation of cellular senescence |
| 1720 |
tan3 |
46 |
6.1e-03 |
1.000 |
1 |
GO:0090402 |
BP |
oncogene-induced cell senescence |
| 1721 |
tan4 |
48 |
6.7e-05 |
1.000 |
4 |
GO:0042775 |
BP |
mitochondrial ATP synthesis coupled electron transport |
| 1722 |
tan4 |
48 |
7.1e-05 |
1.000 |
4 |
GO:0042773 |
BP |
ATP synthesis coupled electron transport |
| 1723 |
tan4 |
48 |
1.7e-04 |
1.000 |
4 |
GO:0022904 |
BP |
respiratory electron transport chain |
| 1724 |
tan4 |
48 |
1.7e-04 |
1.000 |
3 |
GO:0046688 |
BP |
response to copper ion |
| 1725 |
tan4 |
48 |
2.2e-04 |
1.000 |
4 |
GO:0006119 |
BP |
oxidative phosphorylation |
| 1726 |
tan4 |
48 |
3.0e-04 |
1.000 |
3 |
GO:0032589 |
CC |
neuron projection membrane |
| 1727 |
tan4 |
48 |
7.9e-04 |
1.000 |
3 |
GO:0001618 |
MF |
virus receptor activity |
| 1728 |
tan4 |
48 |
1.2e-03 |
1.000 |
4 |
GO:0022900 |
BP |
electron transport chain |
| 1729 |
tan4 |
48 |
1.4e-03 |
1.000 |
4 |
GO:0045333 |
BP |
cellular respiration |
| 1730 |
tan4 |
48 |
1.6e-03 |
1.000 |
4 |
GO:0032838 |
CC |
plasma membrane bounded cell projection cytoplasm |
| 1731 |
thistle |
63 |
9.8e-05 |
1.000 |
2 |
GO:0014834 |
BP |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration |
| 1732 |
thistle |
63 |
1.2e-03 |
1.000 |
2 |
GO:0033038 |
MF |
bitter taste receptor activity |
| 1733 |
thistle |
63 |
2.4e-03 |
1.000 |
2 |
GO:0008527 |
MF |
taste receptor activity |
| 1734 |
thistle |
63 |
4.0e-03 |
1.000 |
5 |
GO:0046677 |
BP |
response to antibiotic |
| 1735 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0007225 |
BP |
patched ligand maturation |
| 1736 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0009441 |
BP |
glycolate metabolic process |
| 1737 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0019310 |
BP |
inositol catabolic process |
| 1738 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0035351 |
BP |
heme transmembrane transport |
| 1739 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0045167 |
BP |
asymmetric protein localization involved in cell fate determination |
| 1740 |
thistle |
63 |
4.1e-03 |
1.000 |
1 |
GO:0061736 |
BP |
engulfment of target by autophagosome |
| 1741 |
thistle1 |
83 |
2.9e-04 |
1.000 |
2 |
GO:0003308 |
BP |
negative regulation of Wnt signaling pathway involved in heart development |
| 1742 |
thistle1 |
83 |
4.0e-04 |
1.000 |
6 |
GO:0007254 |
BP |
JNK cascade |
| 1743 |
thistle1 |
83 |
4.1e-04 |
1.000 |
5 |
GO:0046330 |
BP |
positive regulation of JNK cascade |
| 1744 |
thistle1 |
83 |
6.0e-04 |
1.000 |
2 |
GO:0001939 |
CC |
female pronucleus |
| 1745 |
thistle1 |
83 |
6.8e-04 |
1.000 |
4 |
GO:0048259 |
BP |
regulation of receptor-mediated endocytosis |
| 1746 |
thistle1 |
83 |
8.2e-04 |
1.000 |
5 |
GO:0032874 |
BP |
positive regulation of stress-activated MAPK cascade |
| 1747 |
thistle1 |
83 |
8.4e-04 |
1.000 |
5 |
GO:0070304 |
BP |
positive regulation of stress-activated protein kinase signaling cascade |
| 1748 |
thistle1 |
83 |
8.8e-04 |
1.000 |
3 |
GO:0035176 |
BP |
social behavior |
| 1749 |
thistle1 |
83 |
1.3e-03 |
1.000 |
2 |
GO:0051852 |
BP |
disruption by host of symbiont cells |
| 1750 |
thistle1 |
83 |
1.4e-03 |
1.000 |
9 |
GO:0071396 |
BP |
cellular response to lipid |
| 1751 |
thistle2 |
83 |
6.0e-04 |
1.000 |
2 |
GO:0044806 |
BP |
G-quadruplex DNA unwinding |
| 1752 |
thistle2 |
83 |
8.8e-04 |
1.000 |
4 |
GO:0071013 |
CC |
catalytic step 2 spliceosome |
| 1753 |
thistle2 |
83 |
9.6e-04 |
1.000 |
4 |
GO:0004222 |
MF |
metalloendopeptidase activity |
| 1754 |
thistle2 |
83 |
1.4e-03 |
1.000 |
3 |
GO:0120163 |
BP |
negative regulation of cold-induced thermogenesis |
| 1755 |
thistle2 |
83 |
1.9e-03 |
1.000 |
5 |
GO:0005681 |
CC |
spliceosomal complex |
| 1756 |
thistle2 |
83 |
2.5e-03 |
1.000 |
2 |
GO:0030903 |
BP |
notochord development |
| 1757 |
thistle2 |
83 |
4.2e-03 |
1.000 |
9 |
GO:0019904 |
MF |
protein domain specific binding |
| 1758 |
thistle2 |
83 |
4.4e-03 |
1.000 |
5 |
GO:0060090 |
MF |
molecular adaptor activity |
| 1759 |
thistle2 |
83 |
5.2e-03 |
1.000 |
6 |
GO:0000398 |
BP |
mRNA splicing, via spliceosome |
| 1760 |
thistle2 |
83 |
5.4e-03 |
1.000 |
1 |
GO:0038184 |
BP |
cell surface bile acid receptor signaling pathway |
| 1761 |
thistle3 |
63 |
1.0e-04 |
1.000 |
2 |
GO:0032237 |
BP |
activation of store-operated calcium channel activity |
| 1762 |
thistle3 |
63 |
1.7e-04 |
1.000 |
2 |
GO:1901341 |
BP |
positive regulation of store-operated calcium channel activity |
| 1763 |
thistle3 |
63 |
2.5e-04 |
1.000 |
2 |
GO:0045008 |
BP |
depyrimidination |
| 1764 |
thistle3 |
63 |
2.5e-04 |
1.000 |
2 |
GO:1901339 |
BP |
regulation of store-operated calcium channel activity |
| 1765 |
thistle3 |
63 |
3.4e-04 |
1.000 |
3 |
GO:0002534 |
BP |
cytokine production involved in inflammatory response |
| 1766 |
thistle3 |
63 |
3.5e-04 |
1.000 |
2 |
GO:0006285 |
BP |
base-excision repair, AP site formation |
| 1767 |
thistle3 |
63 |
5.2e-04 |
1.000 |
3 |
GO:0031593 |
MF |
polyubiquitin modification-dependent protein binding |
| 1768 |
thistle3 |
63 |
6.0e-04 |
1.000 |
2 |
GO:0009223 |
BP |
pyrimidine deoxyribonucleotide catabolic process |
| 1769 |
thistle3 |
63 |
7.5e-04 |
1.000 |
2 |
GO:0072425 |
BP |
signal transduction involved in G2 DNA damage checkpoint |
| 1770 |
thistle3 |
63 |
7.5e-04 |
1.000 |
2 |
GO:0019104 |
MF |
DNA N-glycosylase activity |
| 1771 |
thistle4 |
51 |
3.7e-04 |
1.000 |
3 |
GO:0016538 |
MF |
cyclin-dependent protein serine/threonine kinase regulator activity |
| 1772 |
thistle4 |
51 |
5.6e-04 |
1.000 |
2 |
GO:0004861 |
MF |
cyclin-dependent protein serine/threonine kinase inhibitor activity |
| 1773 |
thistle4 |
51 |
1.2e-03 |
1.000 |
2 |
GO:0007096 |
BP |
regulation of exit from mitosis |
| 1774 |
thistle4 |
51 |
2.7e-03 |
1.000 |
2 |
GO:2000108 |
BP |
positive regulation of leukocyte apoptotic process |
| 1775 |
thistle4 |
51 |
2.7e-03 |
1.000 |
2 |
GO:0071889 |
MF |
14-3-3 protein binding |
| 1776 |
thistle4 |
51 |
3.0e-03 |
1.000 |
3 |
GO:0000079 |
BP |
regulation of cyclin-dependent protein serine/threonine kinase activity |
| 1777 |
thistle4 |
51 |
3.3e-03 |
1.000 |
1 |
GO:0002845 |
BP |
positive regulation of tolerance induction to tumor cell |
| 1778 |
thistle4 |
51 |
3.3e-03 |
1.000 |
1 |
GO:0021660 |
BP |
rhombomere 3 formation |
| 1779 |
thistle4 |
51 |
3.3e-03 |
1.000 |
1 |
GO:0021666 |
BP |
rhombomere 5 formation |
| 1780 |
thistle4 |
51 |
3.3e-03 |
1.000 |
1 |
GO:0046786 |
BP |
viral replication complex formation and maintenance |
| 1781 |
tomato |
48 |
4.0e-06 |
0.073 |
9 |
GO:0051051 |
BP |
negative regulation of transport |
| 1782 |
tomato |
48 |
4.5e-05 |
0.820 |
3 |
GO:0032369 |
BP |
negative regulation of lipid transport |
| 1783 |
tomato |
48 |
1.5e-04 |
1.000 |
2 |
GO:0010807 |
BP |
regulation of synaptic vesicle priming |
| 1784 |
tomato |
48 |
4.8e-04 |
1.000 |
4 |
GO:0055088 |
BP |
lipid homeostasis |
| 1785 |
tomato |
48 |
6.4e-04 |
1.000 |
2 |
GO:0032375 |
BP |
negative regulation of cholesterol transport |
| 1786 |
tomato |
48 |
6.7e-04 |
1.000 |
6 |
GO:0019216 |
BP |
regulation of lipid metabolic process |
| 1787 |
tomato |
48 |
7.0e-04 |
1.000 |
12 |
GO:0046903 |
BP |
secretion |
| 1788 |
tomato |
48 |
8.7e-04 |
1.000 |
11 |
GO:0006629 |
BP |
lipid metabolic process |
| 1789 |
tomato |
48 |
8.8e-04 |
1.000 |
2 |
GO:0036148 |
BP |
phosphatidylglycerol acyl-chain remodeling |
| 1790 |
tomato |
48 |
9.2e-04 |
1.000 |
8 |
GO:0051046 |
BP |
regulation of secretion |
| 1791 |
tomato2 |
33 |
7.1e-05 |
1.000 |
2 |
GO:0021873 |
BP |
forebrain neuroblast division |
| 1792 |
tomato2 |
33 |
7.1e-04 |
1.000 |
2 |
GO:0048103 |
BP |
somatic stem cell division |
| 1793 |
tomato2 |
33 |
9.8e-04 |
1.000 |
2 |
GO:0021846 |
BP |
cell proliferation in forebrain |
| 1794 |
tomato2 |
33 |
1.1e-03 |
1.000 |
3 |
GO:0072089 |
BP |
stem cell proliferation |
| 1795 |
tomato2 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0006583 |
BP |
melanin biosynthetic process from tyrosine |
| 1796 |
tomato2 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0021849 |
BP |
neuroblast division in subventricular zone |
| 1797 |
tomato2 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0004773 |
MF |
steryl-sulfatase activity |
| 1798 |
tomato2 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0005148 |
MF |
prolactin receptor binding |
| 1799 |
tomato2 |
33 |
2.2e-03 |
1.000 |
1 |
GO:0033678 |
MF |
5’-3’ DNA/RNA helicase activity |
| 1800 |
tomato2 |
33 |
2.6e-03 |
1.000 |
2 |
GO:0017145 |
BP |
stem cell division |
| 1801 |
turquoise |
859 |
1.1e-03 |
1.000 |
5 |
GO:0016226 |
BP |
iron-sulfur cluster assembly |
| 1802 |
turquoise |
859 |
2.4e-03 |
1.000 |
4 |
GO:0016281 |
CC |
eukaryotic translation initiation factor 4F complex |
| 1803 |
turquoise |
859 |
2.5e-03 |
1.000 |
7 |
GO:0045124 |
BP |
regulation of bone resorption |
| 1804 |
turquoise |
859 |
3.1e-03 |
1.000 |
9 |
GO:0051536 |
MF |
iron-sulfur cluster binding |
| 1805 |
turquoise |
859 |
3.2e-03 |
1.000 |
3 |
GO:0033085 |
BP |
negative regulation of T cell differentiation in thymus |
| 1806 |
turquoise |
859 |
3.2e-03 |
1.000 |
3 |
GO:0060304 |
BP |
regulation of phosphatidylinositol dephosphorylation |
| 1807 |
turquoise |
859 |
3.2e-03 |
1.000 |
2 |
GO:0000711 |
BP |
meiotic DNA repair synthesis |
| 1808 |
turquoise |
859 |
3.2e-03 |
1.000 |
2 |
GO:0034057 |
MF |
RNA strand-exchange activity |
| 1809 |
turquoise |
859 |
3.2e-03 |
1.000 |
12 |
GO:0001824 |
BP |
blastocyst development |
| 1810 |
turquoise |
859 |
4.4e-03 |
1.000 |
5 |
GO:0032967 |
BP |
positive regulation of collagen biosynthetic process |
| 1811 |
violet |
104 |
1.1e-04 |
1.000 |
3 |
GO:0036035 |
BP |
osteoclast development |
| 1812 |
violet |
104 |
1.4e-04 |
1.000 |
2 |
GO:2001206 |
BP |
positive regulation of osteoclast development |
| 1813 |
violet |
104 |
1.7e-04 |
1.000 |
4 |
GO:0060038 |
BP |
cardiac muscle cell proliferation |
| 1814 |
violet |
104 |
2.1e-04 |
1.000 |
5 |
GO:0030316 |
BP |
osteoclast differentiation |
| 1815 |
violet |
104 |
2.7e-04 |
1.000 |
7 |
GO:0045637 |
BP |
regulation of myeloid cell differentiation |
| 1816 |
violet |
104 |
2.8e-04 |
1.000 |
2 |
GO:1990578 |
CC |
perinuclear endoplasmic reticulum membrane |
| 1817 |
violet |
104 |
2.8e-04 |
1.000 |
3 |
GO:0097038 |
CC |
perinuclear endoplasmic reticulum |
| 1818 |
violet |
104 |
3.8e-04 |
1.000 |
5 |
GO:0016101 |
BP |
diterpenoid metabolic process |
| 1819 |
violet |
104 |
6.8e-04 |
1.000 |
5 |
GO:1905477 |
BP |
positive regulation of protein localization to membrane |
| 1820 |
violet |
104 |
6.9e-04 |
1.000 |
2 |
GO:0019249 |
BP |
lactate biosynthetic process |
| 1821 |
wheat3 |
29 |
1.4e-03 |
1.000 |
2 |
GO:0015026 |
MF |
coreceptor activity |
| 1822 |
wheat3 |
29 |
1.7e-03 |
1.000 |
1 |
GO:0003142 |
BP |
cardiogenic plate morphogenesis |
| 1823 |
wheat3 |
29 |
1.7e-03 |
1.000 |
1 |
GO:0060807 |
BP |
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
| 1824 |
wheat3 |
29 |
1.7e-03 |
1.000 |
1 |
GO:0110059 |
BP |
negative regulation of blood vessel endothelial cell differentiation |
| 1825 |
wheat3 |
29 |
1.7e-03 |
1.000 |
1 |
GO:2000043 |
BP |
regulation of cardiac cell fate specification |
| 1826 |
wheat3 |
29 |
1.7e-03 |
1.000 |
1 |
GO:0004883 |
MF |
glucocorticoid receptor activity |
| 1827 |
wheat3 |
29 |
3.1e-03 |
1.000 |
2 |
GO:0016459 |
CC |
myosin complex |
| 1828 |
wheat3 |
29 |
3.5e-03 |
1.000 |
1 |
GO:0001828 |
BP |
inner cell mass cellular morphogenesis |
| 1829 |
wheat3 |
29 |
3.5e-03 |
1.000 |
1 |
GO:0007493 |
BP |
endodermal cell fate determination |
| 1830 |
wheat3 |
29 |
3.5e-03 |
1.000 |
1 |
GO:0060912 |
BP |
cardiac cell fate specification |
| 1831 |
white |
117 |
3.6e-04 |
1.000 |
2 |
GO:0008430 |
MF |
selenium binding |
| 1832 |
white |
117 |
4.9e-04 |
1.000 |
4 |
GO:0044304 |
CC |
main axon |
| 1833 |
white |
117 |
6.0e-04 |
1.000 |
2 |
GO:0098843 |
CC |
postsynaptic endocytic zone |
| 1834 |
white |
117 |
3.0e-03 |
1.000 |
3 |
GO:0043209 |
CC |
myelin sheath |
| 1835 |
white |
117 |
3.2e-03 |
1.000 |
2 |
GO:0046541 |
BP |
saliva secretion |
| 1836 |
white |
117 |
3.2e-03 |
1.000 |
2 |
GO:0030898 |
MF |
actin-dependent ATPase activity |
| 1837 |
white |
117 |
3.8e-03 |
1.000 |
3 |
GO:0001917 |
CC |
photoreceptor inner segment |
| 1838 |
white |
117 |
5.0e-03 |
1.000 |
5 |
GO:0005741 |
CC |
mitochondrial outer membrane |
| 1839 |
white |
117 |
6.0e-03 |
1.000 |
2 |
GO:0016327 |
CC |
apicolateral plasma membrane |
| 1840 |
white |
117 |
6.6e-03 |
1.000 |
3 |
GO:0048306 |
MF |
calcium-dependent protein binding |
| 1841 |
whitesmoke |
41 |
7.8e-05 |
1.000 |
2 |
GO:0060073 |
BP |
micturition |
| 1842 |
whitesmoke |
41 |
1.6e-04 |
1.000 |
3 |
GO:0045776 |
BP |
negative regulation of blood pressure |
| 1843 |
whitesmoke |
41 |
2.8e-04 |
1.000 |
2 |
GO:0098691 |
CC |
dopaminergic synapse |
| 1844 |
whitesmoke |
41 |
8.1e-04 |
1.000 |
2 |
GO:0003085 |
BP |
negative regulation of systemic arterial blood pressure |
| 1845 |
whitesmoke |
41 |
1.3e-03 |
1.000 |
2 |
GO:0035024 |
BP |
negative regulation of Rho protein signal transduction |
| 1846 |
whitesmoke |
41 |
1.7e-03 |
1.000 |
3 |
GO:0043473 |
BP |
pigmentation |
| 1847 |
whitesmoke |
41 |
2.2e-03 |
1.000 |
3 |
GO:0044853 |
CC |
plasma membrane raft |
| 1848 |
whitesmoke |
41 |
2.8e-03 |
1.000 |
1 |
GO:0001985 |
BP |
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure |
| 1849 |
whitesmoke |
41 |
2.8e-03 |
1.000 |
1 |
GO:0021771 |
BP |
lateral geniculate nucleus development |
| 1850 |
whitesmoke |
41 |
2.8e-03 |
1.000 |
1 |
GO:0035921 |
BP |
desmosome disassembly |
| 1851 |
yellow |
269 |
9.2e-04 |
1.000 |
2 |
GO:0060298 |
BP |
positive regulation of sarcomere organization |
| 1852 |
yellow |
269 |
1.6e-03 |
1.000 |
4 |
GO:0000421 |
CC |
autophagosome membrane |
| 1853 |
yellow |
269 |
1.7e-03 |
1.000 |
3 |
GO:0042809 |
MF |
vitamin D receptor binding |
| 1854 |
yellow |
269 |
1.8e-03 |
1.000 |
2 |
GO:0046340 |
BP |
diacylglycerol catabolic process |
| 1855 |
yellow |
269 |
2.6e-03 |
1.000 |
18 |
GO:0030425 |
CC |
dendrite |
| 1856 |
yellow |
269 |
2.7e-03 |
1.000 |
18 |
GO:0097447 |
CC |
dendritic tree |
| 1857 |
yellow |
269 |
2.9e-03 |
1.000 |
22 |
GO:0036477 |
CC |
somatodendritic compartment |
| 1858 |
yellow |
269 |
3.0e-03 |
1.000 |
2 |
GO:0005663 |
CC |
DNA replication factor C complex |
| 1859 |
yellow |
269 |
3.0e-03 |
1.000 |
2 |
GO:1990635 |
CC |
proximal dendrite |
| 1860 |
yellow |
269 |
3.0e-03 |
1.000 |
2 |
GO:0005042 |
MF |
netrin receptor activity |
| 1861 |
yellow2 |
49 |
1.4e-04 |
1.000 |
2 |
GO:0060372 |
BP |
regulation of atrial cardiac muscle cell membrane repolarization |
| 1862 |
yellow2 |
49 |
9.8e-04 |
1.000 |
4 |
GO:0009408 |
BP |
response to heat |
| 1863 |
yellow2 |
49 |
1.1e-03 |
1.000 |
3 |
GO:1900034 |
BP |
regulation of cellular response to heat |
| 1864 |
yellow2 |
49 |
1.2e-03 |
1.000 |
4 |
GO:0009166 |
BP |
nucleotide catabolic process |
| 1865 |
yellow2 |
49 |
1.2e-03 |
1.000 |
3 |
GO:0006110 |
BP |
regulation of glycolytic process |
| 1866 |
yellow2 |
49 |
1.4e-03 |
1.000 |
4 |
GO:1901292 |
BP |
nucleoside phosphate catabolic process |
| 1867 |
yellow2 |
49 |
1.5e-03 |
1.000 |
3 |
GO:0060964 |
BP |
regulation of gene silencing by miRNA |
| 1868 |
yellow2 |
49 |
2.1e-03 |
1.000 |
2 |
GO:0086019 |
BP |
cell-cell signaling involved in cardiac conduction |
| 1869 |
yellow2 |
49 |
2.1e-03 |
1.000 |
3 |
GO:2001169 |
BP |
regulation of ATP biosynthetic process |
| 1870 |
yellow2 |
49 |
2.3e-03 |
1.000 |
5 |
GO:0009165 |
BP |
nucleotide biosynthetic process |
| 1871 |
yellow3 |
55 |
4.3e-04 |
1.000 |
2 |
GO:0001055 |
MF |
RNA polymerase II activity |
| 1872 |
yellow3 |
55 |
9.3e-04 |
1.000 |
2 |
GO:0005665 |
CC |
RNA polymerase II, core complex |
| 1873 |
yellow3 |
55 |
1.1e-03 |
1.000 |
2 |
GO:0042228 |
BP |
interleukin-8 biosynthetic process |
| 1874 |
yellow3 |
55 |
1.1e-03 |
1.000 |
4 |
GO:0051092 |
BP |
positive regulation of NF-kappaB transcription factor activity |
| 1875 |
yellow3 |
55 |
1.4e-03 |
1.000 |
3 |
GO:0035019 |
BP |
somatic stem cell population maintenance |
| 1876 |
yellow3 |
55 |
1.4e-03 |
1.000 |
2 |
GO:0060008 |
BP |
Sertoli cell differentiation |
| 1877 |
yellow3 |
55 |
2.0e-03 |
1.000 |
2 |
GO:0033688 |
BP |
regulation of osteoblast proliferation |
| 1878 |
yellow3 |
55 |
2.1e-03 |
1.000 |
3 |
GO:0070301 |
BP |
cellular response to hydrogen peroxide |
| 1879 |
yellow3 |
55 |
2.1e-03 |
1.000 |
3 |
GO:0016591 |
CC |
RNA polymerase II, holoenzyme |
| 1880 |
yellow3 |
55 |
2.7e-03 |
1.000 |
2 |
GO:0033687 |
BP |
osteoblast proliferation |
| 1881 |
yellow4 |
70 |
2.6e-05 |
0.480 |
5 |
GO:0009953 |
BP |
dorsal/ventral pattern formation |
| 1882 |
yellow4 |
70 |
9.9e-05 |
1.000 |
3 |
GO:0021904 |
BP |
dorsal/ventral neural tube patterning |
| 1883 |
yellow4 |
70 |
5.4e-04 |
1.000 |
3 |
GO:0021532 |
BP |
neural tube patterning |
| 1884 |
yellow4 |
70 |
5.7e-04 |
1.000 |
2 |
GO:0042355 |
BP |
L-fucose catabolic process |
| 1885 |
yellow4 |
70 |
9.1e-04 |
1.000 |
2 |
GO:0034380 |
BP |
high-density lipoprotein particle assembly |
| 1886 |
yellow4 |
70 |
1.3e-03 |
1.000 |
4 |
GO:0032355 |
BP |
response to estradiol |
| 1887 |
yellow4 |
70 |
1.3e-03 |
1.000 |
2 |
GO:0008417 |
MF |
fucosyltransferase activity |
| 1888 |
yellow4 |
70 |
1.5e-03 |
1.000 |
3 |
GO:0006826 |
BP |
iron ion transport |
| 1889 |
yellow4 |
70 |
1.6e-03 |
1.000 |
2 |
GO:0060831 |
BP |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
| 1890 |
yellow4 |
70 |
1.7e-03 |
1.000 |
4 |
GO:0007224 |
BP |
smoothened signaling pathway |
| 1891 |
yellowgreen |
100 |
6.0e-05 |
1.000 |
6 |
GO:0008528 |
MF |
G protein-coupled peptide receptor activity |
| 1892 |
yellowgreen |
100 |
8.3e-05 |
1.000 |
6 |
GO:0001653 |
MF |
peptide receptor activity |
| 1893 |
yellowgreen |
100 |
1.1e-03 |
1.000 |
11 |
GO:0048729 |
BP |
tissue morphogenesis |
| 1894 |
yellowgreen |
100 |
2.2e-03 |
1.000 |
4 |
GO:0004896 |
MF |
cytokine receptor activity |
| 1895 |
yellowgreen |
100 |
2.4e-03 |
1.000 |
2 |
GO:2001256 |
BP |
regulation of store-operated calcium entry |
| 1896 |
yellowgreen |
100 |
3.3e-03 |
1.000 |
41 |
GO:0007275 |
BP |
multicellular organism development |
| 1897 |
yellowgreen |
100 |
4.1e-03 |
1.000 |
4 |
GO:0051928 |
BP |
positive regulation of calcium ion transport |
| 1898 |
yellowgreen |
100 |
4.4e-03 |
1.000 |
2 |
GO:0071682 |
CC |
endocytic vesicle lumen |
| 1899 |
yellowgreen |
100 |
5.1e-03 |
1.000 |
2 |
GO:0001848 |
MF |
complement binding |
| 1900 |
yellowgreen |
100 |
5.5e-03 |
1.000 |
20 |
GO:0009888 |
BP |
tissue development |